
<html lang="en"     class="pb-page"  data-request-id="b13bf47b-91d5-48f2-8951-47fa979f558b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2017.60.issue-3;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.6b01607;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis" /></meta><meta name="dc.Creator" content="Silvia  Bua" /></meta><meta name="dc.Creator" content="Lorenzo  Di Cesare Mannelli" /></meta><meta name="dc.Creator" content="Daniela  Vullo" /></meta><meta name="dc.Creator" content="Carla  Ghelardini" /></meta><meta name="dc.Creator" content="Gianluca  Bartolucci" /></meta><meta name="dc.Creator" content="Andrea  Scozzafava" /></meta><meta name="dc.Creator" content="Claudiu T.  Supuran" /></meta><meta name="dc.Creator" content="Fabrizio  Carta" /></meta><meta name="dc.Description" content="We report the synthesis of a series of hybrid compounds incorporating 6- and 7-substituted coumarins (carbonic anhydrase, CA inhibitors) derivatized with clinically used NSAIDs (indomethacin, sulin..." /></meta><meta name="Description" content="We report the synthesis of a series of hybrid compounds incorporating 6- and 7-substituted coumarins (carbonic anhydrase, CA inhibitors) derivatized with clinically used NSAIDs (indomethacin, sulin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 23, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01607" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01607" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01607" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01607" /></link>
        
    
    

<title>Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01607" /></meta><meta property="og:title" content="Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0007.jpeg" /></meta><meta property="og:description" content="We report the synthesis of a series of hybrid compounds incorporating 6- and 7-substituted coumarins (carbonic anhydrase, CA inhibitors) derivatized with clinically used NSAIDs (indomethacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) as agents for the management of rheumatoid arthritis (RA). Most compounds were effective in inhibiting the RA overexpressed hCA IX and XII, with KI values in the low nanomolar–subnanomolar ranges. The antihyperalgesic activity of such compounds was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model. Among all tested compounds, the 7-coumarine hybrid with ibuprofen showed potent and persistent antihyperalgesic effect up to 60 min after administration." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="We report the synthesis of a series of hybrid compounds incorporating 6- and 7-substituted coumarins (carbonic anhydrase, CA inhibitors) derivatized with clinically used NSAIDs (indomethacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) as agents for the management of rheumatoid arthritis (RA). Most compounds were effective in inhibiting the RA overexpressed hCA IX and XII, with KI values in the low nanomolar–subnanomolar ranges. The antihyperalgesic activity of such compounds was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model. Among all tested compounds, the 7-coumarine hybrid with ibuprofen showed potent and persistent antihyperalgesic effect up to 60 min after administration." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0007.jpeg" /></meta><meta name="twitter:title" content="Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01607"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01607">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01607&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01607&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01607&amp;href=/doi/10.1021/acs.jmedchem.6b01607" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1159-1170</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01548" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01673" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Bua">Silvia Bua</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lorenzo++Di+Cesare+Mannelli">Lorenzo Di Cesare Mannelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Vullo">Daniela Vullo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carla++Ghelardini">Carla Ghelardini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gianluca++Bartolucci">Gianluca Bartolucci</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Scozzafava">Andrea Scozzafava</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudiu+T.++Supuran">Claudiu T. Supuran</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-4262-0323" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Carta">Fabrizio Carta</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-1141-6146" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">NEUROFARBA, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Neuroscience, Psychology, Drug Research and Child Health, NEUROFARBA—Pharmacology and Toxicology Section, University of Florence, 50019 Florence, Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Polo Scientifico, Laboratorio di Chimica Bioinorganica, University of Florence, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy</span></div><div class="corresp-info"><strong>*</strong>C.T.S.: phone, +39-055-4573729; fax, +39-055-4573385; e-mail, <a href="/cdn-cgi/l/email-protection#50333c31253439257e2325202522313e10253e3936397e3924"><span class="__cf_email__" data-cfemail="6407080511000d114a1711141116050a24110a0d020d4a0d10">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>F.C.: phone, +39-055-4573666; fax, +39-055-4573385; e-mail, <a href="/cdn-cgi/l/email-protection#f6909794849f8c9f99d89597848297b683989f909fd89f82"><span class="__cf_email__" data-cfemail="06606764746f7c6f692865677472674673686f606f286f72">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01607&amp;href=/doi/10.1021%2Facs.jmedchem.6b01607" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1159–1170</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 11, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 October 2016</li><li><span class="item_label"><b>Published</b> online</span>23 January 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 February 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01607" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01607</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1159%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSilvia%2BBua%252C%2BLorenzo%2BDi%2BCesare%2BMannelli%252C%2BDaniela%2BVullo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D3%26contentID%3Dacs.jmedchem.6b01607%26title%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BNonsteroidal%2BAnti-Inflammatory%2BDrugs%2Band%2BCarbonic%2BAnhydrase%2BInhibitors%2BHybrids%2B%2528NSAIDs%25E2%2580%2593CAIs%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BRheumatoid%2BArthritis%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1170%26publicationDate%3DFebruary%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01607"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2113</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">62</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01607" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Treatment of Rheumatoid Arthritis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Bua&quot;},{&quot;first_name&quot;:&quot;Lorenzo&quot;,&quot;last_name&quot;:&quot;Di Cesare Mannelli&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Vullo&quot;},{&quot;first_name&quot;:&quot;Carla&quot;,&quot;last_name&quot;:&quot;Ghelardini&quot;},{&quot;first_name&quot;:&quot;Gianluca&quot;,&quot;last_name&quot;:&quot;Bartolucci&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Scozzafava&quot;},{&quot;first_name&quot;:&quot;Claudiu&quot;,&quot;last_name&quot;:&quot;T. Supuran&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Carta&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;1159-1170&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01607&quot;},&quot;abstract&quot;:&quot;We report the synthesis of a series of hybrid compounds incorporating 6- and 7-substituted coumarins (carbonic anhydrase, CA inhibitors) derivatized with clinically used NSAIDs (indomethacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) as agents for the management of rheumatoid arthritis (RA). Most compounds were effective in inhibiting the RA overexpressed hCA IX and XII, with KI values in the low nanomolar–subnanomolar ranges. The antihyperalgesic activity of such compounds was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model. Among all tested compounds, the 7-coumarine hybrid with ibuprofen showed potent and persistent antihyperalgesic effect up to 60 min after administration.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01607&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01607" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01607&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01607" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01607&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01607" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01607&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01607&amp;href=/doi/10.1021/acs.jmedchem.6b01607" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01607" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01607" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01607%26sid%3Dliteratum%253Aachs%26pmid%3D28075587%26genre%3Darticle%26aulast%3DBua%26date%3D2017%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BNonsteroidal%2BAnti-Inflammatory%2BDrugs%2Band%2BCarbonic%2BAnhydrase%2BInhibitors%2BHybrids%2B%2528NSAIDs%25E2%2580%2593CAIs%2529%2Bfor%2Bthe%2BTreatment%2Bof%2BRheumatoid%2BArthritis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D3%26spage%3D1159%26epage%3D1170%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291301" title="Salts">Salts</a>,</li><li><a href="/action/doSearch?ConceptID=291594" title="Silica">Silica</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291152" title="Gels">Gels</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/3" title="Go to Volume 60, Issue 3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/jmcmar.2017.60.issue-3/20170209/jmcmar.2017.60.issue-3.largecover.jpg" alt="Go to Volume 60, Issue 3"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We report the synthesis of a series of hybrid compounds incorporating 6- and 7-substituted coumarins (carbonic anhydrase, CA inhibitors) derivatized with clinically used NSAIDs (indomethacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc., cyclooxygenase inhibitors) as agents for the management of rheumatoid arthritis (RA). Most compounds were effective in inhibiting the RA overexpressed hCA IX and XII, with <i>K</i><sub>I</sub> values in the low nanomolar–subnanomolar ranges. The antihyperalgesic activity of such compounds was assessed by means of the paw-pressure and incapacitance tests using an in vivo RA model. Among all tested compounds, the 7-coumarine hybrid with ibuprofen showed potent and persistent antihyperalgesic effect up to 60 min after administration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease caused by a faulty autoimmune response, which primary affects the lining of the joints, thus causing erosion of the cartilage, bone damage, and joints deformity at the later stages. The dimension and the impact of RA in the society are well reported within the Rochester Epidemiology Project.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Data showed that in the period 1995–2007, each year about 4.1% of the American population was diagnosed with RA. The incidence of the disease was strictly age dependent, being present in 0.9% among patients aged 18–34 years, 5.4% among those aged over 85 years, with the peak (8.9%) in the population aged between 65 and 74 years. Data analysis of the same period among gender showed that the incidence rates increased to 2.5% each year in women; conversely a decrease of about 0.5% was observed in men.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">RA symptoms have high impact on the life quality of the affected patients, who are progressively unable to carry out activities in every domain of their lives such as work, social relations, and leisure.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">State-of-the-art RA pharmacological treatments include two main classes: (i) drugs acting to slow or stop the course of the disease and to inhibit the joints tissutal damages and (ii) those acting to ease the symptoms.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> The first class of drugs include the disease-modifying antirheumatic drugs (DMARDs), biologics, JAK-inhibitors, and corticosteroids; the latter drugs are represented by the nonsteroidal anti-inflammatory drugs (NSAIDs). Usually a therapeutic RA protocol accounts for the combination of both drug classes along with the recommendation to conduct proper physical activities, with the intent to tackle the symptoms as well as the progression of the pathology.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div><div class="NLM_p">Despite recent progresses in RA treatment, there is still no effective cure. Many research efforts are constantly reported in the literature, thus offering innovative diagnostic tools, new biological targets, and a multitude of potential drug lead compounds.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a></div><div class="NLM_p last">Recently, we reported that human (h) carbonic anhydrases (CAs, EC 4.2.1.1) isoforms IX and XII are overexpressed in inflamed synovium of patients affected by juvenile idiopathic arthritis (JIA), which is the most common RA disease in pediatric age.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Previous studies also showed abnormal expressions of the hCAs I, III, and IV in specimens of RA affected patients, but only antibodies against these isoforms have been detected, with our measurements of the enzymatic activity in the synovium of the affected patients.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8-11)</a> On the other hand, in the above-mentioned study,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> we have demonstrated overexpression of CA IX/XII (by using RT-PCR) as well as an increased enzymatic activity due to these isoforms in the samples from JIA patients. In order to better clarify the physiological/pathological role of CAs in RA, we kept turning our attention toward the carbon dioxide hydration reaction (CO<sub>2</sub> + H<sub>2</sub>O ↔ HCO<sub>3</sub><sup>–</sup> + H<sup>+</sup>), which is the main transformation catalyzed by these enzymes.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> According to the equilibrium reaction, CA overexpression increases the ionic species concentrations. Since bicarbonate ions are vital building blocks in cell life and are quickly recycled, a local extracellular acidosis is established. The dependence between low-pH values with the intensity of inflammation processes and their related pain symptoms were demonstrated in RA affected patients.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> In addition tissue acidosis was found to be detrimental for both the humoral and cellular immunity processes.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Considering thus the interplay between various CA isoforms and the arthritis-like diseases, we attempt here to target several of the enzymes presumably involved in this condition by dual inhibitors incorporating both a CA-binding moiety (of the coumarin type) and a cyclooxygenase inhibitor of the NSAID type, the most widely used pain-relief medication to date.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Herein we report the design, synthesis of low molecular weight hybrid compounds containing a selective hCA IX and/or XII inhibitor head, such as the coumarin one,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> linked through a physiological cleavable linker to a commercially available, clinically used NSAID tail, of the carboxylic acid type cyclooxygenase inhibitor (indomethacin, sulindac, ketoprofen, ibuprofen, diclofenac, ketorolac, etc.). The ability of such compounds to inhibit the relevant hCAs activity as well as to reduce the pain symptoms was assessed by means of in vitro kinetics and in vivo RA model, respectively. Our scope was not to investigate cyclooxygenase inhibition role in RA with the hybrid compounds, which is well documented for decades, but to show that CA IX/XII inhibition may represent an additional anti-inflammatory mechanism, poorly investigated at this moment for the management of RA.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Synthesis of Compounds</h3><div class="NLM_p">The drug design rationale of this project is based upon the synthesis of small molecular hybrids containing a selective hCA IX (XII) inhibitor head linked through a physiological cleavable linker to a carboxylic acid NSAID (COX inhibitor) tail in a 1:1 ratio (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). As mentioned above, we do not expect COX inhibitory activity of our compounds once the COOH moiety essential for this COX inhibition has been derivatized.<a onclick="showRef(event, 'cit17d'); return false;" href="javascript:void(0);" class="ref cit17d">(17d)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design of the hybrids herein reported.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the 6- and 7-substituted coumarins are usually reported selective inhibitors of the hCA IX/XII over the other isoforms,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> we planned our hybrids on these moieties, thus ensuring they are committed with our recent findings on hCA IX and XII overexpression in synovium specimen of JIA affected patients.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> For the scope of this work we considered a simple two-carbon linear unit spacer connecting the hCA IX (XII) inhibitor head and the NSAID terminal section. In particular, we focused on the ethanolamine fragment, which allows us (i) to insert a physiologically cleavable moiety, such as the amide, by making use of the NSAID carboxylic function and (ii) to install the biologically compatible and not cleavable ether moiety, thus virtually ensuring a single break point on the hybrid, and (iii) all needed synthetic intermediates are easily accessible by means of efficient procedures.</div><div class="NLM_p">As reported in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the 6- and 7-coumarin substituted hybrids <b>4a</b>–<b>h</b> and <b>5a</b>–<b>h</b> respectively were obtained by coupling the commercially available NSAIDs <b>1a</b>–<b>h</b> by means of their <i>N</i>-hydroxysuccinamide (NHS) activated esters <b>2a</b>–<b>h</b>, with the in situ liberated amines <b>3a</b> and <b>b</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Scheme of Hybrid Compounds <b>4a</b>–<b>h</b> and <b>5a</b>–<b>h</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The key intermediates <b>3a</b>,<b>b</b> were obtained by means of Williamson’s etherification of the commercially available 6-and 7-hydroxycoumarins with the Boc-protected 1-bromoethylamine <b>6</b>, followed by deprotection with trifluoroacetic acid (TFA) (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Key Intermediates <b>3a</b>,<b>b</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All final compounds (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) as well as their intermediates were characterized by means of <sup>1</sup>H, <sup>13</sup>C, <sup>19</sup>F NMR spectroscopy and HRMS and were >95% pure, as determined by HPLC (see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Protocols">Experimental Protocols</a> for details).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of the compounds <b>4a</b>–<b>h</b> and <b>5a</b>–<b>h</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Carbonic Anhydrase Inhibition</h3><div class="NLM_p">All synthesized compounds, <b>4a</b>–<b>h</b> and <b>5a</b>–<b>h</b>, were tested in vitro for their inhibitory properties against the physiological relevant hCA isoforms (I, II, IV, VII, IX, and XII) by means of the stopped-flow carbon dioxide hydration assay,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and their activities were compared to the standard CAI acetazolamide (AAZ) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. hCA I, II, IV, VII, IX, and XII Inhibition Data with Compounds <b>4a</b>–<b>h</b> and <b>5a</b>–<b>h</b> by a Stopped-Flow CO<sub>2</sub> Hydrase Assay<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center"><i>K</i><sub>I</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hCA I</th><th class="colsep0 rowsep0" align="center">hCA II</th><th class="colsep0 rowsep0" align="center">hCA IV</th><th class="colsep0 rowsep0" align="center">hCA VII</th><th class="colsep0 rowsep0" align="center">hCA IX<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hCA XII</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">31.3</td><td class="colsep0 rowsep0" align="left">59.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">30.8</td><td class="colsep0 rowsep0" align="left">81.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">54.7</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.44</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">28.9</td><td class="colsep0 rowsep0" align="left">92.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">23.5</td><td class="colsep0 rowsep0" align="left">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">31.8</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.73</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">20.1</td><td class="colsep0 rowsep0" align="left">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">27.9</td><td class="colsep0 rowsep0" align="left">7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">85.4</td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">57.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">39.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">89.7</td><td class="colsep0 rowsep0" align="left">80.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">9.4</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">80.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AAZ</td><td class="colsep0 rowsep0" align="left">250</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">74.2</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">25.1</td><td class="colsep0 rowsep0" align="left">5.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Mean values from three different assays. Errors were within ±5–10% of the reported values (data not shown).</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Catalytic domain.</p></div></div></div><div class="NLM_p">Overall, the data reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> clearly showed that all compounds were ineffective in inhibiting the highly abundant cytosolic hCA I and II as well as the central nervous system (CNS) expressed hCA VII (<i>K</i><sub>I</sub> > 100 nM). The only exception was represented from the coumarine substituted at 7-position with ketoprofen (<b>5c</b>), which was a high nanomolar hCA II inhibitor (<i>K</i><sub>I</sub> = 85.4 nM).</div><div class="NLM_p">The following structure–activity-relationships (SARs) for the remaining hCA isoforms are reported.</div><div class="NLM_p">(i) The membrane bound hCA IV, which is of interest since it seems to be overexpressed in RA (at least antibodies against this isoform were reported in the RA patients samples),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> was highly inhibited by the compounds included in this study. All compounds showed <i>K</i><sub>I</sub> values in the low nanomolar range and between 0.44 and 9.8 nM, thus significantly more potent when compared to the standard CAI acetazolamide (<i>K</i><sub>I</sub> = 74.2 nM). The 6-substituted coumarins (<b>4a</b>–<b>h</b>) were 1.2- to 20.7-fold more potent than the 7-substituted ones (<b>5a</b>–<b>h</b>) in inhibiting the hCA IV isoform.</div><div class="NLM_p">(ii) Interesting data were obtained for the tumor associated<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and RA overexpressed<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> hCA IX isoform, as the 6-substituted compounds <b>4a</b>,<b>b</b> and <b>4e</b>–<b>g</b> showed <i>K</i><sub>I</sub> values of 23.5 and 31.8, thus comparable to the standard CAI AAZ (<i>K</i><sub>I</sub> = 25.1 nM). The introduction at the 6-position of the coumarine scaffold of either ibuprofen (<b>4d</b>) or naproxen (<b>4h</b>) determined loss of the inhibitory activity (<i>K</i><sub>I</sub> values of >100 nM). Within the 7-substituted series, only the compounds <b>5a</b> and <b>b</b> were effective inhibitors of hCA IX (<i>K</i><sub>I</sub> values of 20.1 and 27.9 nM, respectively), whereas the dichlofenac counterpart (<b>5e</b>) was a high nanomolar inhibitor (<i>K</i><sub>I</sub> of 89.7 nM). All other compounds were ineffective, thus demonstrating that the substitution position at the coumarine ring resulted in potent effects on the inhibition potencies of these compounds.</div><div class="NLM_p last">(iii) The second RA relevant hCA isoform (i.e., XII)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> was potently inhibited by the 6-coumarin substituted flurbiprofen derivative <b>4f</b> (<i>K</i><sub>I</sub> = 5.9 nM), with a potency comparable to the standard CAI AAZ (5.7 nM). The introduction at the same position of the coumarin scaffold of all the NSAIDs herein considered determined either decrease (<b>4a</b>,<b>b</b>,<b>e</b>) or loss (<b>4c</b>,<b>d</b>,<b>g</b>,<b>h</b>) of the hCA XII inhibition potency (see data in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Swap of the NSAID moieties from the 6- to the 7-position of the coumarin ring determined a significant increase of the inhibition potency of the derivatives <b>5a</b>–<b>d</b> with <i>K</i><sub>I</sub> values in the low–medium nM range (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Noteworthy the indomethacin and the sulindac derivatives (<b>5a</b>,<b>b</b>) were particularly active in inhibiting the hCA XII, with <i>K</i><sub>I</sub> values of 6.5 and 7.7 nM, respectively, thus comparable to the standard CAI AAZ (5.7 nM). Conversely, introduction of the dichlofenac and naproxen moieties at the 7-position of the coumarin scaffold (<b>5e</b> and <b>5h</b>) determined a slight increase of the inhibition potencies with <i>K</i><sub>I</sub> values of 80.8 and 92.6 nM, respectively. Finally the inhibition activities of the ketorolac <b>5g</b> and flurbiprofen <b>5f</b> derivatives were unvaried and worsened compared to their 6-substituted counterparts (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Pain Relief Efficacy Tests</h3><div class="NLM_p">The pain relief efficacy of compounds <b>4a</b>, <b>4f</b>, and <b>5a</b>–<b>g</b> (10 mg kg<sup>–1</sup> po) was evaluated in a rat model of rheumatoid arthiritis induced by intra-articular (ia) complete Freund’s adjuvant (CFA) injection. The effects of compounds herein reported were compared with 100 mg kg<sup>–1</sup> ibuprofen, the classical NSAID administered at the active dosage usually employed in this model.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The hypersensitivity to a mechanical noxious stimulus (paw pressure test) is reported in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acute pain relieving effect of <b>4a</b>, <b>5b</b>, <b>5d</b>, <b>5f</b>, <b>5g</b>, and ibuprofen in a rat model of rheumatoid arthritis induced by CFA ia injection. Compounds were administered po at a dose of 10 mg kg<sup>–1</sup>, while ibuprofen was administered (po) at a dose of 100 mg kg<sup>–1</sup>. The paw pressure test was performed to evaluate the hypersensitivity to noxious mechanical stimuli. Measurements were performed on day 14 after CFA intra-articular injection. Compounds were suspended in 1% CMC and orally administered, evaluating the pain threshold over time. Control animals were treated with vehicle. The values represent the mean of eight rats performed in two different experimental sets. (∧∧) <i>P</i> < 0.01 vs vehicle + vehicle treated animals. (∗) <i>P</i> < 0.05 and (∗∗) <i>P</i> < 0.01 vs time 0 min of the same group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Data collection at day 14 after CFA injection showed that the reference group (vehicle + vehicle; 1% CMC) had a nociceptive threshold stable over the time course of the experiments and that the pain threshold of the ipsilateral paw of the CFA + vehicle group was significantly decreased when compared to the reference (47.6 ± 1.2 g and 65.3 ± 1.0 g, respectively). A single oral administration of the 7-susbstituted coumarin ibuprofen derivative (<b>5d</b>) was able to significantly increase the weight tolerated on the ipsilateral paw at 15 min (58.7 ± 1.3 g) and with a maximum effect between 30 and 45 min (63.8 ± 1.3 g and 61.3 ± 1.3 g, respectively) after treatment. The antinociceptive effect completely disappeared at 75 min (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Interestingly, the effect of ibuprofen per se administered at a 10-fold higher dosage peaked 15 min after administration lasting up to 30 min. The sulindac derivative <b>5b</b> increased the pain threshold of the ipsilateral paw starting 15 min after administration (56.7 ± 0.8 g), and the antihypersensitivity effect was still significant after 30 and 45 min. Compounds <b>4a</b>, <b>5f</b>, and <b>5g</b> induced a significant reduction of hypersensitivity showing comparable efficacy (about 56 g). The effect peaked at 15 min and disappeared 45 min after treatment (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Compounds <b>4f</b>, <b>5a</b>, <b>5c</b>, and <b>5e</b> were not able to counteract the hypersensitivity induced by CFA ia injection (data not shown). Moreover, none of the compounds herein considered altered the pain threshold of the contralateral paw, thus suggesting that these molecules do not influence the normal pain sensitivity.</div><div class="NLM_p">The compound efficacies were also evaluated by means of the incapacitance test against the spontaneous pain. We measured the hind limb weight bearing alterations caused by unilateral damage (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Acute pain relieving effect of <b>4a</b>, <b>5b</b>, <b>5d</b>, <b>5f</b>, and <b>5g</b> and ibuprofen in a rat model of rheumatoid arthritis induced by CFA ia injection. Compounds were administered po at a dose of 10 mg kg<sup>–1</sup>, while ibuprofen was administered (po) at a dose of 100 mg kg<sup>–1</sup>. The incapacitance test was performed to evaluate the hind limb weight bearing alterations measured as postural imbalance related to pain. Data are expressed as the difference between the weight applied on the contralateral and ipsilateral limb (Δweight). Measurements were performed on day 14 after CFA ia injection. Compounds were suspended in 1% CMC and orally administered, evaluating the postural balance over time. Control animals were treated with vehicle. The values represent the mean of eight rats performed in two different experimental sets. (∧∧) <i>P</i> < 0.01 vs vehicle + vehicle treated animals. (∗) <i>P</i> < 0.05 and (∗∗) <i>P</i> < 0.01 vs time 0 min of the same group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As above-reported, the difference between the weight burdened on the contralateral and the ipsilateral paw (Δweight) was significantly increased in the CFA + vehicle treated animals compared to the control group (45.6 ± 3.5 g and 2.5 ± 3.4 g, respectively). Such results obtained after compounds acute treatments matched those recorded with the paw pressure test previously reported in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. The best performing compound was the 7-coumarin substituted ibuprofen (<b>5d</b>) at a concentration of 10 mg kg<sup>–1</sup>, which was able to fully reduce the Δweight between 30 and 45 min after treatment (7.9 ± 1.3 g and 11.1 ± 1.6 g, respectively). The effect lasted up to 60 min. On the contrary compounds <b>4a</b>, <b>5b</b>, and <b>5f</b> partially reduced the postural imbalance starting from 15 min until 30 min after administration. The effect of ibuprofen (100 mg kg<sup>–1</sup>) per se was comparable to that induced from these latter compounds.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Herein we report for the first time the design and synthesis of a series of low molecular weight NSAID–CAI hybrids as agents for the treatment of RA and related inflammatory diseases. Most compounds showed in vitro potency as inhibitors of the RA overexpressed hCA IV, IX, and XII, with <i>K</i><sub>I</sub> values in the low nanomolar range. The ability of the obtained compounds to affect the inflammation process was assessed by means of the paw-pressure and incapacitance tests on a CFA induced arthritis model in rats. Among the compounds considered, the 7-coumarin substituted ibuprofen derivative <b>5d</b> showed a potent antihyperalgesic effect, which was maintained for 60 min after administration.The hybrid <b>5d</b>, which is the most relevant compound in this research, showed interesting antihyperalgesic effects, and its inhibitory activity on hCAs was limited to the isoforms IV and XII and not IX. Such a result is in apparent contradiction with our expectations, which accounted for the full engagement of both hCA IX and XII in the RA inflammation processes.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In our previous investigation we reported, by means of quantitative real time PCR experiments, that JIA derived fibroblasts possessed significantly higher hCA XII mRNA levels when compared to healthy synovial fibroblasts. Opposite data were obtained for the mRNA hCA IX. Since the densitometric experiments showed that both hCA IX and XII protein levels were highly increased in JIA affected patients, we postulated and were in agreement with the literature<a onclick="showRef(event, 'cit12a ref32'); return false;" href="javascript:void(0);" class="ref cit12a ref32">(12a, 32)</a> that the hypoxic condition present in closed compartments, such as the joints, is the main cause sustaining the hCA IX overexpression. Among the compounds here reported the dual hybrid <b>5d</b> was the only one in the series able to selectively inhibit the hCA IV and XII and to show spectacular antihyperalgesic effects. Inhibitors of the hCA IV, IX, and XII, such as <b>4a</b>, <b>5b</b>, and <b>5d</b>, failed in the in vivo RA model. This might suggest that the role of the hCA IX in the RA inflammation process is somehow different as initially postulated. Future work on dual NSAID–CA hybrids will be directed toward a better definition of the role of the hCA IX in RA diseases. It should be however mentioned that the hCA IV activity was not measured in the synovial samples from RA or JIA patients so far, and only antibodies against this isoform were detected in patients with RA.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Thus, our results suggest that probably CA IV and eventually other membrane-associated CAs (e.g., CA XIV and/or CA XV) may be involved in inflammatory conditions. Work is in progress in our laboratories to assess whether indeed CA IV may be the most relevant isoform in such conditions.</div><div class="NLM_p last">We demonstrated for the first time that NSAID–CAI hybrids are highly promising tools for the treatment of symptoms, such as pain, originating from RA and related diseases in an animal model of this disease. Furthermore, the inhibition of the RA overexpressed hCA isoforms IV, IX, and XII can significantly contribute to reduction of the joint local acidosis and thus to restore the humoral and cellular immunity processes which are hampered in such pathologies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Protocols</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p last">Anhydrous solvents and all reagents were purchased from Sigma-Aldrich, Alfa Aesar, and TCI. All reactions involving air- or moisture-sensitive compounds were performed under a nitrogen atmosphere using dried glassware and syringe techniques to transfer solutions. Nuclear magnetic resonance (<sup>1</sup>H NMR, <sup>13</sup>C NMR, <sup>19</sup>F NMR) spectra were recorded using a Bruker Advance III 400 MHz spectrometer in DMSO-<i>d</i><sub>6</sub>. Chemical shifts are reported in parts per million (ppm), and the coupling constants (<i>J</i>) are expressed in hertz (Hz). Splitting patterns are designated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; brs, broad singlet; dd, doublet of doublets. The assignment of exchangeable protons (O<i>H</i> and N<i>H</i>) was confirmed by the addition of D<sub>2</sub>O. Analytical thin-layer chromatography (TLC) was carried out on Merck silica gel F-254 plates. Flash chromatography purifications were performed on Merck silica gel 60 (230–400 mesh ASTM) as the stationary phase, and ethyl acetate/<i>n</i>-hexane were used as eluents. Melting points (mp) were measured in open capillary tubes with a Gallenkamp MPD350.BM3.5 apparatus and are uncorrected. HPLC was performed by using a Waters 2690 separation module coupled with a photodiode array detector (PDA Waters 996) and, as column, a Nova-Pak C18 4 μm, 3.9 mm × 150 mm (Waters), silica-based reverse phase column. Sample was dissolved in acetonitrile 10%, and an injection volume of 45 μL was used. The mobile phase, at a flow rate of 1 mL/min, was a gradient of water + trifluoroacetic acid (TFA) 0.1% (A) and acetonitrile + TFA 0.1% (B), with steps as follows: (A%:B%), 0–10 min 90:10, 10–25 min gradient to 60:40, 26:28 min isocratic 20:80, 29–35 min isocratic 90:10. TFA 0.1% in water as well as in acetonitrile was used as counterion. All compounds reported here were >96% HPLC pure. The solvents used in MS measurements were acetone, acetonitrile (Chromasolv grade), purchased from Sigma-Aldrich (Milan, Italy), and mQ water 18 MΩ, obtained from Millipore’s Simplicity system (Milan, Italy). The mass spectra were obtained using a Varian 1200L triple quadrupole system (Palo Alto, CA, USA) equipped with electrospray source (ESI) operating in both positive and negative ions. Stock solutions of analytes were prepared in acetone at 1.0 mg mL<sup>–1</sup> and stored at 4 °C. Working solutions of each analyte were freshly prepared by diluting stock solutions in a mixture of mQ H<sub>2</sub>O/ACN 1/1 (v/v) up to a concentration of 1.0 μg mL<sup>–1</sup> The mass spectra of each analyte were acquired by introducing, via syringe pump at 10/L min<sup>–1</sup>, the working solution. Raw data were collected and processed by Varian Workstation, version 6.8, software.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedure for the Synthesis of Acids <b>1d</b>, <b>1e</b>, <b>1g</b>, and <b>1h</b></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0008.gif" alt="" id="fx1" /></img><div class="NLM_p last">The appropriate carboxylic acid salt was treated with a 6.0 or 12.0 M aqueous solution of hydrochloric acid. The reaction was vigorously stirred at 0 °C and warmed to room temperature until starting material was consumed (TLC monitoring). The formed white precipitate was collected by filtration, dried under vacuo to afford the title compounds <b>1d</b>, <b>1e</b>, <b>1g</b>, and <b>1h</b> as white solids.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Synthesis of (±)-2-(4-Isobutylphenyl)propanoic Acid ((±)-Ibuprofen) <b>1d</b></h3><div class="NLM_p last">Compound <b>1d</b> was obtained according to the general procedure earlier reported using a 6.0 M aqueous solution of hydrochloric acid and (±)-ibuprofen sodium salt (0.5 g, 1.0 equiv): 89.3% yield; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.81 (ethyl acetate/<i>n</i>-hexane 60% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 0.89 (6H, d, <i>J</i> = 6.8, 2 × C<i>H</i><sub>3</sub>), 1.37 (3H, d, <i>J</i> = 6.8, C<i>H</i><sub>3</sub>), 1.83 (1H, m, CH<sub>3</sub>C<i>H</i>), 3.36 (2H, s, C<i>H</i><sub>2</sub>), 3.65 (1H, m, (CH<sub>3</sub>)<sub>2</sub>C<i>H</i>), 7.13 (2H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 7.22 (2H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 12.29 (1H, m, exchange with D<sub>2</sub>O, COO<i>H</i>).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis of 2-(2-((2,6-Dichlorophenyl)amino)phenyl)acetic Acid (Diclofenac) <b>1e</b></h3><div class="NLM_p last">Compound <b>1e</b> was obtained according to the general procedure earlier reported using a 12.0 M aqueous solution of hydrochloric acid and diclofenac sodium salt (0.5 g, 1.0 equiv): 70% yield; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.45 (ethyl acetate/<i>n</i>-hexane 30% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 3.74 (2H, s, COC<i>H</i><sub>2</sub>), 6.32 (1H, d, <i>J</i> = 7.2, Ar-<i>H</i>), 6.89 (1H, m, Ar-<i>H</i>), 7.10 (1H, m, Ar-<i>H</i>), 7.24 (3H, m, Ar-<i>H</i>), 7.57 (2H, d, <i>J</i> = 8.0, Ar-<i>H</i> and N<i>H</i>), 12.70 (1H, m, exchange with D<sub>2</sub>O, COO<i>H</i>).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of (±)-5-Benzoyl-2,3-dihydro-1<i>H</i>-pyrrolizine-1-carboxylic Acid ((±)-Ketorolac) <b>1g</b></h3><div class="NLM_p last">Compound <b>1g</b> was obtained according to the general procedure earlier reported using a 12.0 M aqueous solution of hydrochloric acid and (±)-ketorolac tris salt (0.3 g, 1.0 equiv): 83.6% yield; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.31 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 2.78 (2H, q, <i>J</i> = 7.2, 2 × CH<i>H</i><sub>ax</sub>), 4.12 (1H, t, <i>J</i> = 7.4, COC<i>H</i>), 4.33 (1H, m, CH<i>H</i><sub><i>eq</i></sub>), 4.44 (1H, m, CH<i>H</i><sub><i>eq</i></sub>), 6.12 (1H, d, <i>J</i> = 3.8, pyrrole-<i>H</i>), 6.81 (1H, d, <i>J</i> = 3.8, pyrrole-<i>H</i>), 7.55 (2H, t, <i>J</i> = 7.6, Ar-<i>H</i>), 7.64 (1H, t, <i>J</i> = 7.2, Ar-<i>H</i>), 7.79 (2H, d, <i>J</i> = 7.6, Ar-<i>H</i>), 12.65 (1H, m, exchange with D<sub>2</sub>O, COO<i>H</i>).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthesis of (<i>S</i>)-2-(6-Methoxynaphthalen-2-yl)propanoic Acid ((<i>S</i>)-(+)-Naproxen) <b>1h</b></h3><div class="NLM_p last">Three tablets of Momendol containing 0.220 g each of naproxen sodium salt were crushed, and the obtained powder was dissolved in EtOAc and treated with a 6.0 M aqueous solution of hydrochloric acid. The mixture was vigorously stirred at room temperature until consumption of starting materials (TLC monitoring). The mixture was filtered off, and the filtrate was extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give a pale yellow oil that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 30% v/v to afford the title compound <b>1h</b> as a white solid: 82.2% yield; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.61 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 1.48 (3H, d, <i>J</i> = 7.6, C<i>H</i><sub>3</sub>), 3.83 (1H, q, <i>J</i> = 7.2, CH<sub>3</sub>C<i>H</i>), 3.90 (3H, s, OC<i>H</i><sub>3</sub>), 7.18 (1H, dd, <i>J</i> = 8.8, 3.8, Ar-<i>H</i>), 7.32 (1H, s, Ar-<i>H</i>), 7.44 (1H, d, <i>J</i> = 7.2, Ar-<i>H</i>), 7.74 (1H, s, Ar-<i>H</i>), 7.82 (2H, t, <i>J</i> = 9.6, Ar-<i>H</i>), 12.34 (1H, m, exchange with D<sub>2</sub>O, COO<i>H</i>).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure for the Synthesis of 2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammonium Trifluoroacetate Salt <b>3a</b> and 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium Trifluoroacetate Salt <b>3b</b></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0009.gif" alt="" id="fx2" /></img><div class="NLM_p"><i>Step 1.</i><i>tert</i>-Butyl (2-bromoethyl)carbamate <b>6</b> (1.0 g, 1.0 equiv) was treated with 6-hydroxy-2<i>H</i>-chromen-2-one (<b>6-OH</b>) and K<sub>2</sub>CO<sub>3</sub> (3.0 equiv) in acetone or alternatively with 7-hydroxy-2<i>H</i>-chromen-2-one (<b>7-OH</b>) (1.0 equiv) in the same conditions using dry <i>N</i>,<i>N</i>-dimethylformamide (5.0 mL) as solvent and under N<sub>2</sub> atmosphere. The reaction mixtures were stirred at 60 °C overnight until consumption of starting materials (TLC monitoring), then cooled to room temperature and treated respectively as follows.<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(i)</td><td colspan="5" valign="top" class="paragraph"><p class="last">The white precipitate was filtered off, and the obtained filtrate was concentrated under vacuo to afford the <b>7a</b> as an orange residue.</p></td></tr><tr class="li1"><td valign="top">(ii)</td><td colspan="5" valign="top" class="paragraph"><p class="last">The reaction was quenched with a 3.0 M aqueous hydrochloric acid solution to give a precipitate which was collected by filtration and triturated with diethyl ether to afford the <b>7b</b> as a white solid.</p></td></tr></table></div><div class="NLM_p last"><i>Step 2.</i><i>tert</i>-Butyl (2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)carbamate <b>7a</b> (1.0 equiv) and <i>tert</i>-butyl (2-((2-oxo-2<i>H</i>-chromen-7-yl)oxy)ethyl)carbamate <b>7b</b> (1.0 equiv) were dissolved in DCM, and TFA (6.0 equiv) was added dropwise to the suspension. The solution was stirred at 0 °C and then at room temperature until starting materials were consumed (TLC monitoring). The solvent was evaporated and the obtained residue dried under vacuo to afford the title compounds <b>3a</b> and <b>3b</b> as white solids.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-aminium 2,2,2-Trifluoroacetate <b>3a</b></h3><div class="NLM_p last">20.0% yield; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.55 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 3.30 (2H, q, <i>J</i> = 5.2, C<i>H</i><sub>2</sub>NH-), 4.25 (2H, t, <i>J</i> = 5.0, C<i>H</i><sub>2</sub>O), 6.54 (1H, d, <i>J</i> = 9.2, Ar-<i>H</i>), 7.29 (1H, d, <i>J</i> = 3.2, Ar-<i>H</i>), 7.36 (1H, d, <i>J</i> = 2.8, Ar-<i>H</i>), 7.41 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 8.06 (1H, d, <i>J</i> = 9.2, Ar-<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 39.3, 66.0, 112.7, 117.7, 118.5, 120.2, 121.0, 144.9, 149.2, 155.1, 161.1; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>) −74.84.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-aminium 2,2,2-Trifluoroacetate <b>3b</b></h3><div class="NLM_p last">61.3% yield; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.50 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 3.31 (2H, q, <i>J</i> = 5.2, C<i>H</i><sub>2</sub>NH-), 4.31 (2H, t, <i>J</i> = 5.16, C<i>H</i><sub>2</sub>O), 6.36 (1H, d, <i>J</i> = 9.02, Ar-<i>H</i>), 7.03 (1H, dd, <i>J</i> = 8.6, 2.5, Ar-<i>H</i>), 7.07 (1H, d, <i>J</i> = 2.3, Ar-<i>H</i>), 7.70 (1H, d, <i>J</i> = 8.66, Ar-<i>H</i>), 8.05 (1H, d, <i>J</i> = 9.2, Ar-<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 38.2, 65.2, 101.5, 112.8, 112.9, 113.0, 129.7, 144.4, 115.3, 160.3, 160.9; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>) −74.23.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Synthesis of <i>tert</i>-Butyl (2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)carbamates <b>4a</b>–<b>h</b> and <i>tert</i>-Butyl (2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethyl)carbamates <b>5a</b>–<b>h</b></h3><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0010.gif" alt="" id="fx3" /></img><div class="NLM_p last"><i>N</i>-Hydroxysuccinimide (NHS) (1.5 equiv) and EDCI·HCl (1.5 equiv) were added to a solution of the appropriate carboxylic acid <b>1a</b>–<b>h</b> (0.5 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction was stirred at room temperature until starting materials were consumed (TLC monitoring), followed by addition of 2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammoniun trifluoroacetate salt <b>3a</b> (1.0 equiv) or 2-((2-oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3b</b> (1.0 equiv) and triethylamine (Et<sub>3</sub>N) (1.0 equiv). The mixture was stirred at 60 °C until starting materials were consumed (TLC monitoring), then quenched with H<sub>2</sub>O (10 mL) to afford a precipitate which was collected by filtration, or alternatively the reaction solution was extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give a solid that was purified by silica gel column chromatography, eluting with the appropriate mixture of EtOAc/<i>n</i>-hexane to afford the desired compounds.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1<i>H</i>-indol-3-yl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)acetamide <b>4a</b></h3><div class="NLM_p last">Compound <b>4a</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of indometacin <b>1a</b> (0.3 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>A</b> (TLC monitoring, not isolated). Then 2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3a</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture, which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL). The formed brown precipitate was filtered off, dried under vacuo to give a residue that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 50% v/v to afford the title compound <b>4a</b> as a white solid: 65.8% yield; mp 181–183 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.35 (ethyl acetate/<i>n</i>-hexane 90% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 2.24 (3H, s, C<i>H</i><sub>3</sub>), 3.51 (2H, q, <i>J</i> = 6.3, C<i>H</i><sub>2</sub>NH<i>-</i>), 3.58 (2H, s, C<i>H</i><sub>2</sub>CO), 3.78 (3H, s, OC<i>H</i><sub>3</sub>), 4.09 (2H, t, <i>J</i> = 5.2, OC<i>H</i><sub>2</sub>), 6.53 (1H, d, <i>J</i> = 9.4, Ar-<i>H</i>), 6.73 (1H, dd, <i>J</i> = 8.0, 2.4, Ar-<i>H</i>), 6.98 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 7.15 (1H, d, <i>J</i> = 2.0, Ar-<i>H</i>), 7.19 (1H, dd, <i>J</i> = 8.0, 2.4, Ar-<i>H</i>), 7.29 (1H, d, <i>J</i> = 2.8, Ar-<i>H</i>), 7.36 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 7.65 (2H, d, <i>J</i> = 8.4, Ar-<i>H</i>), 7.71 (2H, d, <i>J</i> = 8.4, Ar-<i>H</i>), 8.01 (1H, d, <i>J</i> = 9.4, Ar-<i>H</i>), 8.34 (1H, t, <i>J</i> = 6.3, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 13.5, 31.2, 38.5, 55.5, 67.1, 102.0, 111.3, 111.6, 114.3, 114.6, 116.7, 117.4, 119.3, 119.9, 129.1, 130.4, 130.9, 131.2, 134.3, 135.3, 137.6, 144.1, 148.0, 154.8, 155.7, 160.2, 167.9, 169.9; <i>m</i>/<i>z</i> (ESI positive) 545.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis of (<i>Z</i>)-2-(5-Fluoro-2-methyl-1-(3-(methylsulfinyl)benzylidene)-1<i>H</i>-inden-3-yl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)acetamide <b>4b</b></h3><div class="NLM_p last">Compound <b>4b</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of Sulindac <b>1b</b> (0.3 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>B</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3a</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture, which was stirred at 60 °C overnight followed by 80 °C for 3 h. Then the reaction mixture was quenched with H<sub>2</sub>O (10 mL) and the formed precipitate was filtered off and concentrated under vacuo to give a yellow precipitate that was triturated with acetone to afford the title compound <b>4b</b> as a yellow solid: 54.7% yield; mp 152–153 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.19 (ethyl acetate 100%); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 2.21 (3H, s, C<i>H</i><sub>3</sub>), 2.85 (3H, s, SOC<i>H</i><sub>3</sub>), 3.51 (4H, m, C<i>H</i><sub>2</sub>CO and NHC<i>H</i><sub>2</sub>), 4.09 (2H, t, <i>J</i> = 5.4, OC<i>H</i><sub>2</sub>), 6.53 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.71 (1H, dt, <i>J</i> = 8.2 8.0, Ar-<i>H</i>), 7.18 (3H, m, Ar-<i>H</i>), 7.31 (1H, s, Ar- <i>H</i>), 7.36 (2H, s, Ar-<i>H</i>), 7.75 (2H, d, <i>J</i> = 8.1, Ar-<i>H</i>), 7.82 (2H, d, <i>J</i> = 8.1, Ar-<i>H</i>), 8.02 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.46 (1H, t, <i>J</i> = 5.0, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 10.5, 32.8, 38.6, 43.2, 67.1, 106.2, 110.4 (<i>J</i><sup>2</sup><sub><i>C–F</i></sub> = 23), 111.6, 116.7, 117.4, 119.3, 119.9, 123.1 (<i>J</i><sup>2</sup><sub><i>C–F</i></sub> = 9), 124.0, 129.3, 129.5 (<i>J</i><sup>3</sup><sub><i>C–F</i></sub> = 3), 130.0, 133.7, 137.9, 138.7, 140.6, 144.1, 146.3, 147.3 (<i>J</i><sup>2</sup><sub><i>C–F</i></sub> = 9), 148.0, 154.9, 160.2, 162.6 (<i>J</i><sup>1</sup><sub><i>C–F</i></sub> = 243), 169.3; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>) −113.49 (1F, s); <i>m</i>/<i>z</i> (ESI positive) 544.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of (±)-2-(3-Benzoylphenyl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)propanamide <b>4c</b></h3><div class="NLM_p last">Compound <b>4c</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of (±)-ketoprofen <b>1c</b> (0.3 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>C</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3a</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture, and that was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), and the mixture was extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give a yellow bright semisolid that was purified by silica gel column chromatography, eluting with an increasing amount of EtOAc/<i>n</i>-hexane from 50% to 70% v/v to afford the title compound <b>4c</b> as a white solid: 38.4% yield; mp 101–103 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.23 (ethyl acetate/<i>n</i>-hexane 90% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 1.39 (3H, d, <i>J</i> = 6.8 C<i>H</i><sub>3</sub>), 3.46 (2H, q, <i>J</i> = 5.6, C<i>H</i><sub>2</sub>NH), 3.79 (1H, q, <i>J</i> = 6.8), 4.04 (2H, t, <i>J</i> = 5.6, OC<i>H</i><sub>2</sub>), 6.51 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 7.15 (1H, dd, <i>J</i> = 9.2, 3.2, Ar-<i>H</i>), 7.27 (1H, d, <i>J</i> = 2.8 Ar-<i>H</i>), 7.32 (1H, d, <i>J</i> = 9.2, Ar-<i>H</i>), 7.51 (1H, t, <i>J</i> = 7.6, Ar-<i>H</i>), 7.56 (1H, s, Ar-<i>H</i>), 7.59 (2H, dd, <i>J</i> = 8.0, 3.0, Ar-<i>H</i>), 7.67 (1H, t, <i>J</i> = 6.8, Ar-<i>H</i>), 7.70 (1H, s, Ar-<i>H</i>), 7.71 (3H, d, <i>J</i> = 1.2 Ar-<i>H</i>), 7.99 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.38 (1H, t, <i>J</i> = 5.4 exchange with D<sub>2</sub>O, CON<i>H</i>). δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 18.6, 38.4, 44.8, 67.1, 111.7, 116.7, 117.4, 119.3, 119.9, 128.2, 128.5, 128.60, 128.63, 129.7, 131.7, 132.8, 136.9, 137.1, 142.8, 144.1, 147.9, 154.8, 160.2, 173.4, 195.8; <i>m</i>/<i>z</i> (ESI positive) 442.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthesis of (±)-2-(4-Isobutylphenyl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)propanamide <b>4d</b></h3><div class="NLM_p last">Compound <b>4d</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of (±)-ibuprofen <b>1d</b> (0.58 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>D</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3a</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), extracted with EtOAc (3 × 10 mL), and the combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give a white semisolid that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 50% v/v to afford the title compound <b>4d</b> as a white solid: 25.3% yield; mp 99–101 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.24 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 0.85 (6H, d, <i>J</i> = 6.8, 2 × C<i>H</i><sub>3</sub>), 1.33 (3H, d, <i>J</i> = 7.2, C<i>H</i><sub>3</sub>), 1.78 (1H, sept, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 2.40 (2H, d, <i>J</i> = 7.2, C<i>H</i><sub>2</sub>), 3.46 (2H, q, <i>J</i> = 5.6, NHC<i>H</i><sub>2</sub>), 3.62 (1H, q, <i>J</i> = 7.0, C<i>H</i>CH<sub>3</sub>), 4.04 (2H, t, <i>J</i> = 5.6, OC<i>H</i><sub>2</sub>), 6.52 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 7.05 (2H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 7.16 (1H, dd, <i>J</i> = 8.8, 3.0, Ar-<i>H</i>), 7.23 (2H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 7.29 (1H, d, <i>J</i> = 2.8, Ar-<i>H</i>), 7.35 (1H, d, <i>J</i> = 8.8, Ar- <i>H</i>), 8.02 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.25 (1H, t, <i>J</i> = 5.6 exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 18.6, 22.1, 22.2, 29.7, 38.4, 44.3, 44.7, 67.1, 111.6, 116.6, 117.4, 119.3, 119.9, 127.0, 128.8, 139.2, 139.5, 144.1, 147.9, 154.8, 160.2, 173.9; <i>m</i>/<i>z</i> (ESI positive) 394.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of 2-(2-((2,6-Dichlorophenyl)amino)phenyl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)acetamide <b>4e</b></h3><div class="NLM_p last">Compound <b>4e</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of diclofenac <b>1e</b> (0.3 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>E</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3a</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL). The formed precipitate was filtered off and dried under vacuo to give a white residue which was triturated with acetone to afford the title compound <b>4e</b> as a white solid: 34.8% yield; mp 176–178 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.33 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 3.52 (2H, q, <i>J</i> = 4.8, NHC<i>H</i><sub>2</sub>), 3.65 (2H, s, C<i>H</i><sub>2</sub>), 4.11 (2H, t, <i>J</i> = 5.0, OC<i>H</i><sub>2</sub>), 6.32 (1H. d, <i>J</i> = 8.0, Ar-<i>H</i>), 6.53 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.87 (1H, appt, <i>J</i> = 7.4, Ar-<i>H</i>), 7.07 (1H, appt, <i>J</i> = 8.2, Ar-<i>H</i>), 7.20 (3H, m, Ar-<i>H</i>), 7.35 (2H, m, Ar-<i>H</i>), 7.52 (2H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 8.02 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.34 (1H, s, exchange with D<sub>2</sub>O, N<i>H</i>), 8.71 (1H, t, <i>J</i> = 4.8, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 39.5, 40.4, 67.9, 112.6, 116.9, 117.6, 118.3, 120.2, 120.9, 121.6, 126.0, 126.3, 128.2, 130.1, 130.4, 131.4, 138.1, 143.9, 144.9, 148.9, 155.7, 161.1, 172.9; <i>m</i>/<i>z</i> (ESI positive) 483.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthesis of (±)-2-(2-Fluoro-[1,1′-biphenyl]-4-yl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)propanamide <b>4f</b></h3><div class="NLM_p last">Compound <b>4f</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of (±)-flurbiprofen <b>1f</b> (0.2 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>F</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3a</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at room temperature until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), and the mixture was extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give an orange oil that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 60% v/v to afford the title compounds <b>4f</b> as a white solid: 61.4% yield; mp 130–131 °C; silica gel TLC R<sub><i>f</i></sub> 0.25 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 1.39 (3H, d, <i>J</i> = 6.8, C<i>H</i><sub>3</sub>), 3.46 (2H, q, <i>J</i> = 5.4, NHC<i>H</i><sub>2</sub>), 3.75 (1H, q, <i>J</i> = 7.1, C<i>H</i>CH<sub>3</sub>), 4.06 (2H, t, <i>J</i> = 5.4, OC<i>H</i><sub>2</sub>), 6.51 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 7.20 (2H, dd, <i>J</i> = 8.8, 4.0, Ar-<i>H</i>), 7.28 (2H, m, Ar-<i>H</i>), 7.35 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 7.41 (2H, d, <i>J</i> = 6.4, Ar-<i>H</i>), 7.44 (1H, d, <i>J</i> = 4.0, Ar-<i>H</i>), 7.47 (2H, d, <i>J</i> = 4.0, Ar-<i>H</i>), 7.51 (1H, t, <i>J</i> = 7.6, Ar-<i>H</i>), 8.01 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.36 (1H, t, <i>J</i> = 5.4, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 19.3, 39.3, 45.4, 67.9, 112.5, 115.7 (<i>J</i><sup>2</sup><sub><i>C–F</i></sub> 23), 117.5, 118.3, 120.2, 120.8, 124.7 (<i>J</i><sup>5</sup><sub><i>C–F</i></sub> = 3), 127.2 (<i>J</i><sup>5</sup><sub><i>C–F</i></sub> = 3), 128.7, 129.5, 129.6 (<i>J</i><sup>5</sup><sub><i>C–F</i></sub> = 3), 131.4, 135.9, 145.0, 145.1 (<i>J</i><sup>4</sup><sub><i>C–F</i></sub> = 8), 148.9, 155.7, 159.0 (<i>J</i><sup>1</sup><sub><i>C–F</i></sub> = 245), 161.1, 174.1; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>) −118.75 (1F, s); <i>m</i>/<i>z</i> (ESI positive) 432.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis of (±)-5-Benzoyl-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)-2,3-dihydro-1<i>H</i>-pyrrolizine-1-carboxamide <b>4g</b></h3><div class="NLM_p last">Compound <b>4g</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI HCl (1.5 equiv) in a solution of (±)-ketorolac <b>1g</b> (0.17 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>G</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3a</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), extracted with EtOAc (3 × 10 mL), and the combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give a brown residue that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 80% v/v to afford the title compound <b>4g</b> as a white solid: 33.9% yield; mp 198–199 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.25 (ethyl acetate/<i>n</i>-hexane 80% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 2.75 (2H, m, 2 × CH<i>H</i><sub>ax</sub>), 3.54 (2H, q, <i>J</i> = 4.9, NHC<i>H</i><sub>2</sub>), 4.03 (1H, dd, <i>J</i> = 8.8, 4.8, C<i>H</i>), 4.11 (2H, t, <i>J</i> = 5.6, OC<i>H</i><sub>2</sub>), 4.39 (2H, m, 2 × CH<i>H</i><sub>eq</sub>), 6.02 (1H, dd, <i>J</i> = 4.0, pyrrole-<i>H</i>), 6.53 (1H, d, <i>J</i> = 9.2, Ar-<i>H</i>), 6.75 (1H, d, <i>J</i> = 4.0, pyrrole-<i>H</i>), 7.26 (2H, dd, <i>J</i> = 9.0, 4.0, Ar-<i>H</i>), 7.35 (1H, d, <i>J</i> = 3.2, Ar-<i>H</i>), 7.40 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 7.54 (2H, m), 7.62 (1H, m), 7.76 (1H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 8.05 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.58 (1H, t, <i>J</i> = 6.0, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 38.6, 42.8, 47.9, 67.0, 102.4, 111.7, 116.7, 117.5, 119.31, 119.33, 120.0, 124.5, 126.1, 128.4, 128.5, 131.5, 139.0, 144.1, 145.5, 148.0, 154.9, 160.2, 170.8, 183.5; <i>m</i>/<i>z</i> (ESI positive) 443.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Synthesis of (<i>S</i>)-(+)-2-(6-Methoxynaphthalen-2-yl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)propanamide <b>4h</b></h3><div class="NLM_p last">Compound <b>4h</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of (<i>S</i>)-(+)-naproxen free acid <b>1h</b> (0.23 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>H</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-6-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3a</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL) and extraction with EtOAc (3 × 10 mL). The combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and dried under vacuo to give an oil which was triturated with diethyl ether. The residue obtained was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 60% v/v to afford the title compound <b>4h</b> as a white solid: 43.2% yield; mp 126–128 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.22 (ethyl acetate/<i>n</i>-hexane 60% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 1.43 (3H, d, <i>J</i> = 6.8, C<i>H</i><sub>3</sub>), 3.72 (2H, q, <i>J</i> = 5.3, NHC<i>H</i><sub>2</sub>), 3.80 (1H, q, <i>J</i> = 6.9, C<i>H</i>), 3.88 (3H, s, OC<i>H</i><sub>3</sub>), 4.04 (2H, t, <i>J</i> = 5.6, OC<i>H</i><sub>2</sub>), 6.51 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 7.15 (2H, m, Ar-<i>H</i>), 7.28 (3H, m), 7.46 (2H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 7.74 (2H, m, Ar-<i>H</i>), 7.97 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.31 (1H, t, <i>J</i> = 5.3, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 18.6, 38.4, 45.0, 55.2, 67.1, 105.7, 111.7, 116.6, 117.4, 118.6, 119.2, 119.9, 125.3, 126.5, 126.7, 128.4, 129.1, 133.2, 137.4, 144.1, 147.9, 154.8, 157.1, 160.2, 173.9; <i>m</i>/<i>z</i> (ESI positive) 418.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1<i>H</i>-indol-3-yl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-7-yl)oxy)ethyl)acetamide <b>5a</b></h3><div class="NLM_p last">Compound <b>5a</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of indometacin <b>1a</b> (0.5 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>A</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3b</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture, which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), and the formed precipitate was filtered off, dried under vacuo to afford the title compound <b>5a</b> as a yellow solid: 79.2% yield; mp 157–158 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.26 (ethyl acetate/<i>n</i>-hexane 70% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 2.24 (3H, s, C<i>H</i><sub>3</sub>), 3.50 (2H, q, <i>J</i> = 5.4, NHC<i>H</i><sub>2</sub>), 3.57 (2H, s, COC<i>H</i><sub>2</sub>), 3.74 (3H, s, OC<i>H</i><sub>3</sub>), 4.15 (2H, t, <i>J</i> = 5.0, OC<i>H</i><sub>2</sub>), 6.33 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.73 (1H, dd, <i>J</i> = 9.0, 3.87, Ar-<i>H</i>), 6.93 (1H, dd, <i>J</i> = 8.8, 3.73, Ar-<i>H</i>), 6.99 (2H, m, Ar-<i>H</i>), 7.14 (1H, d, <i>J</i> = 2.4, Ar-<i>H</i>), 7.64 (1H, d, <i>J</i> = 7.2, Ar-<i>H</i>), 7.65 (2H, d, <i>J</i> = 8.72, Ar-<i>H</i>), 7.71 (2H, d, <i>J</i> = 8.6, Ar-<i>H</i>), 8.02 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.32 (1H, t, <i>J</i> = 5.8, exchange with D<sub>2</sub>O CON<i>H);</i> δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 13.5, 31.2, 38.3, 55.5, 67.1, 101.3, 102.0, 111.2, 112.5, 112.6, 112.7, 114.3, 114.6, 129.1, 129.6, 130.4, 131.0, 131.2, 134.3, 135.3, 137.6, 144.4, 155.4, 155.6, 160.4, 161.7, 168.0, 170.0; <i>m</i>/<i>z</i> (ESI positive) 545.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Synthesis of (<i>Z</i>)-2-(5-Fluoro-2-methyl-1-(3-(methylsulfinyl)benzylidene)-1<i>H</i>-inden-3-yl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-7-yl)oxy)ethyl)acetamide <b>5b</b></h3><div class="NLM_p last">Compound <b>5b</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of sulindac <b>1b</b> (0.5 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>B</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3b</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), and the formed precipitate was filtered off, dried under vacuo to give a residue was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 80% v/v to afford the title compound <b>5b</b> as a yellow solid: 51.4% yield; mp 152–153 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.15 (ethyl acetate/<i>n</i>-hexane 80% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 2.21 (3H, s, C<i>H<sub>3</sub></i>), 2.86 (3H, s, SOC<i>H</i><sub>3</sub>), 3.52 (4H, m, C<i>H</i><sub>2</sub>CO and NHC<i>H</i><sub>2</sub>), 4.17 (2H, t, <i>J</i> = 5.2, OC<i>H</i><sub>2</sub>), 6.33 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.71 (1H, dt, <i>J</i> = 9.1 9.0, Ar-<i>H</i>), 6.97 (1H, dd, <i>J</i> = 8.8, 3.7, Ar-<i>H</i>), 7.01 (1H, d, <i>J</i> = 2.4, Ar-<i>H</i>), 7.13 (1H, dd, <i>J</i> = 9.30, 3.9, Ar-<i>H</i>), 7.19 (1H, q, <i>J</i> = 4.4, Ar-<i>H</i>), 7.38 (1H, s, Ar-<i>H</i>), 7.66 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 7.75 (2H, d, <i>J</i> = 8.2, Ar-<i>H</i>), 7.82 (2H, d, <i>J</i> = 8.2, Ar-<i>H</i>), 8.03 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>) 8.44 (1H, t, <i>J</i> = 5.2, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 10.5, 32.8, 38.4, 43.2, 67.1, 101.4, 112.6, 112.7, 112.7, 124.0, 129.3, 129.5, 129.6, 129.6, 130.0, 133.6, 133.6, 133.6, 137.9, 138.7, 140.6, 144.4, 146.3, 146.3, 147.3, 147.4, 147.4, 155.5, 160.4, 161.7, 169.3; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>) −113,52(1F, s); <i>m</i>/<i>z</i> (ESI positive) 544.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Synthesis of (±)-2-(3-Benzoylphenyl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-7-yl)oxy)ethyl)propanamide <b>5c</b></h3><div class="NLM_p last">Compound <b>5c</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of (±)-ketoprofen <b>1c</b> (0.5 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>C</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3b</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), extracted with EtOAc (3 × 10 mL), and the combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and dried under vacuo to give a white residue that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 50% v/v to afford the title compound <b>5c</b> as a white solid: 44.7% yield; mp 116–118 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.16 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 1.39 (3H, d, <i>J</i> = 6.8, C<i>H</i><sub>3</sub>), 3.46 (2H, <i>J</i> = 5.4, NHC<i>H</i><sub>2</sub>), 3.79 (1H, q, <i>J</i> = 6.8, C<i>H</i>), 4.11 (2H, t, <i>J</i> = 5.4, OC<i>H</i><sub>2</sub>), 6.31 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.90 (1H, dd, <i>J</i> = 8.6, 3.6, Ar-<i>H</i>), 6.97 (1H, d, <i>J</i> = 2.4, Ar-<i>H</i>), 7.66 (1H, d, <i>J</i> = 7.2, Ar-H), 7.68 (9H, m, Ar-<i>H</i>), 7.99 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.35 (1H, t, <i>J</i> = 5.22, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 18.6, 38.2, 44.8, 67.1, 101.4, 112.5, 112.6, 112.7, 128.2, 128.5, 128.6, 128.7, 129.6, 129.7, 131.7, 132.7, 136.9, 137.1, 142.7, 144.4, 155.4, 160.4, 161.6, 173.4, 195.8; <i>m</i>/<i>z</i> (ESI positive) 442.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis of (±)-2-(4-Isobutylphenyl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-6-yl)oxy)ethyl)propanamide <b>5d</b></h3><div class="NLM_p last">Compound <b>5d</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of (±)-ibuprofen <b>1d</b> (0.09 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>D</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3b</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), extracted with EtOAc (3 × 10 mL), and the combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give a brown residue that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 50% v/v to afford a colorless oil that was triturated with diethyl ether to afford the title compound <b>5d</b> as a white solid: 64.3% yield; mp 106–108 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.25 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 0.85 (6H, d, <i>J</i> = 6.6, 2 × C<i>H</i><sub>3</sub>), 1.34 (3H, d, <i>J</i> = 7.1, C<i>H</i><sub>3</sub>), 1.78 (1H, sept, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 2.40 (2H, d, <i>J</i> = 7.2, C<i>H</i><sub>2</sub>), 3.46 (2H, q, <i>J</i> = 5.5, NHC<i>H</i><sub>2</sub>), 3.62 (1H, q, <i>J</i> = 6.7, C<i>H</i>CH<sub>3</sub>), 4.11 (2H, t, <i>J</i> = 5.4, OC<i>H</i><sub>2</sub>), 6.33 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.95 (1H, dd, <i>J</i> = 8.4, 3.6, Ar-<i>H</i>), 6.99 (1H, d, <i>J</i> = 2.4, Ar-<i>H</i>), 7.05 (2H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 7.23 (2H, d, <i>J</i> = 8, Ar-<i>H</i>), 7.65 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 8.02 (1H, d, <i>J</i> = 9.6,Ar-<i>H</i>), 8.22 (1H, t, <i>J</i> = 5.5, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 18.6, 22.2 (2 × <i>C</i>H<sub>3</sub>), 29.7, 38.2, 44.3, 44.7, 67.1, 101.4, 112.5, 112.6, 112.7, 127.0, 128.8, 129.6, 139.2, 139.5, 144.4, 155.4, 160.4, 161.7, 173.9; <i>m</i>/<i>z</i> (ESI positive) 394.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Synthesis of 2-(2-((2,6-Dichlorophenyl)amino)phenyl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-7-yl)oxy)ethyl)acetamide <b>5e</b></h3><div class="NLM_p last">Compound <b>5e</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of diclofenac <b>1e</b> (0.25 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>E</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3b</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), extracted with EtOAc (3 × 10 mL), and the combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give a white residue that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 50% v/v to afford the title compound <b>5e</b> as a white solid: 40.4% yield; mp 195–196 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.30 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 3.53 (2H, q, <i>J</i> = 5.4, NHC<i>H</i><sub>2</sub>), 3.65 (2H, s, C<i>H</i><sub>2</sub>), 4.18 (2H, t, <i>J</i> = 5.6, OC<i>H</i><sub>2</sub>), 6.32 (1H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 6.33 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.87 (1H, appt, <i>J</i> = 7.4, Ar-<i>H</i>), 6.98 (1H, dd, <i>J</i> = 8.6, 3.6, Ar-<i>H</i>), 7.03 (1H, d, <i>J</i> = 2.0, Ar-<i>H</i>), 7.07 (1H, appt, <i>J</i> = 7.4, Ar-<i>H</i>), 7.18 (1H, d, <i>J</i> = 8.4, Ar-<i>H</i>), 7.22 (1H, t, <i>J</i> = 5.4, Ar-<i>H</i>), 7,54 (2H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 7.65 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 8.03 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.30 (1H, s, N<i>H</i>), 8.69 (1H, t, <i>J</i> = 5.4, exchange with D<sub>2</sub>O, CON<i>H</i>). δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 38.4, 67.1, 101.5, 112.6, 112.7, 112.8, 116.0, 120.7, 125.2, 125.4, 127.3, 129.3, 129.6, 130.6, 137.3, 143.1, 144.4, 155.4, 160.4, 161.6, 172.1; <i>m</i>/<i>z</i> (ESI positive) 483.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Synthesis of (±)-2-(2-Fluoro-[1,1′-biphenyl]-4-yl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-7-yl)oxy)ethyl)propanamide <b>5f</b></h3><div class="NLM_p last">Compound <b>5f</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of (±)-flurbiprofen <b>1f</b> (0.5 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>F</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3b</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), extracted with EtOAc (3 × 10 mL), and the combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give a residue that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 50% v/v to afford the title compound <b>5f</b> as a white solid: 31.7% yield; mp 139–140 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.14 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 1.40 (3H, d, <i>J</i> = 6.8, C<i>H</i><sub>3</sub>), 3.50 (2H, q, <i>J</i> = 5.4, NHC<i>H</i><sub>2</sub>), 3.75 (1H, q, <i>J</i> = 6.8, C<i>H</i>CH<sub>3</sub>), 4.14 (2H, t, <i>J</i> = 5.6, OC<i>H</i><sub>2</sub>), 6.32 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.95 (1H, dd, <i>J</i> = 8.8, 3.7, Ar-<i>H</i>), 7.01 (1H, d, <i>J</i> = 2.0, Ar-<i>H),</i> 7.25 (1H, s, Ar-<i>H</i>), 7.27 (1H, d, <i>J</i> = 3.2, Ar-<i>H</i>), 7.46 (6H, m, Ar-<i>H</i>), 7.64 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 8.01 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.36 (1H, t, <i>J</i> = 5.4, exchange with D<sub>2</sub>O, CON<i>H)</i>; δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 19.3, 39.1, 45.4, 67.9, 102.3, 113.4, 113.5 (<i>J</i><sup>4</sup><sub><i>C–F</i></sub> = 6), 115.6, 115.9, 124.7 (<i>J</i><sup>5</sup><sub><i>C–F</i></sub> = 3), 127.3 (<i>J</i><sup>5</sup><sub><i>C–F</i></sub> = 13), 128.7, 129.5, 129.6, 130.5, 131.4 (<i>J</i><sup>5</sup><sub><i>C–F</i></sub> = 3), 135.9, 145.0 (<i>J</i><sup>4</sup><sub><i>C–F</i></sub> = 6), 145.2, 156.3, 157.4 (<i>J</i><sup>1</sup><sub><i>C–F</i></sub> = 245), 161.2, 162.6, 174.1; δ<sub>F</sub> (376 MHz, DMSO-<i>d</i><sub>6</sub>) −118.75 (1F, s); <i>m</i>/<i>z</i> (ESI positive) 432.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Synthesis of (±)-5-Benzoyl-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-7-yl)oxy)ethyl)-2,3-dihydro-1<i>H</i>-pyrrolizine-1-carboxamide <b>5g</b></h3><div class="NLM_p last">Compound <b>5g</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of (±)-ketorolac <b>1g</b> (0.2 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>G</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3b</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), and the formed precipitate was filtered off and dried under vacuo to give a residue that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 80% v/v to afford the title compound <b>5g</b> as a white solid: 75.4% yield; mp 148–149 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.14 (ethyl acetate/<i>n</i>-hexane 60% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 2.76 (2H, m, 2 × CH<i>H</i><sub><i>ax</i></sub>), 3.55 (2H, q, <i>J</i> = 5.4, NHC<i>H</i><sub>2</sub>), 4.03 (1H, q, <i>J</i> = 4.8, C<i>H</i>), 4.18 (2H, t, <i>J</i> = 5.1, OC<i>H</i><sub>2</sub>), 4.25 (2H, m, 2 × CH<i>H</i><sub><i>eq</i></sub>), 6.02 (1H, d, <i>J</i> = 3.8, pyrrole-<i>H</i>), 6.34 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.75 (1H, d, <i>J</i> = 3.8, pyrrole-<i>H</i>), 7.01 (1H, dd, <i>J</i> = 8.8, 4.4, Ar-<i>H</i>), 7.06 (1H, d, <i>J</i> = 2.4, Ar-<i>H</i>), 7.54 (2H, m, Ar-<i>H</i>), 7.63 (1H, m, Ar-<i>H</i>), 7.68 (1H, d, <i>J</i> = 8.4, Ar-<i>H</i>), 7.77 (2H, d, <i>J</i> = 8.0, Ar-<i>H</i>), 8.04 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 8.59 (1H, t, <i>J</i> = 5.4, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 30.8, 38.4, 42.8, 47.8, 67.0, 101.4, 102.4, 112.6, 112.7, 112.8, 124.5, 126.1, 128.4, 128.5, 129.7, 131.5, 139.0, 144.4, 145.4, 155.5, 160.4, 161.7, 170.9, 183.5; <i>m</i>/<i>z</i> (ESI positive) 443.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Synthesis of (<i>S</i>)-(+)-2-(6-Methoxynaphthalen-2-yl)-<i>N</i>-(2-((2-oxo-2<i>H</i>-chromen-7-yl)oxy)ethyl)propanamide <b>5h</b></h3><div class="NLM_p last">Compound <b>5h</b> was obtained according to the general procedure earlier reported using NHS (1.5 equiv) and EDCI·HCl (1.5 equiv) in a solution of (<i>S</i>)-(+)-naproxen <b>1h</b> (0.23 g, 1.0 equiv) in dry DMF (3.0 mL) under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature until the formation of the activated ester intermediate <b>H</b> (TLC monitoring, not isolated). 2-((2-Oxo-2<i>H</i>-chromen-7-yl)oxy)ethan-1-ammonium trifluoroacetate salt <b>3b</b> and triethylamine (Et<sub>3</sub>N) were added to the mixture which was stirred at 60 °C until starting materials were consumed (TLC monitoring), followed by quenching with H<sub>2</sub>O (10 mL), and the formed precipitate was filtered off and dried under vacuo to give a residue that was purified by silica gel column chromatography, eluting with EtOAc/<i>n</i>-hexane 60% v/v to afford the title compound <b>5h</b> as a white solid: 24% yield; mp 140–141 °C; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.26 (ethyl acetate/<i>n</i>-hexane 60% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 1.44 (3H, d, <i>J</i> = 7.0, C<i>H</i><sub>3</sub>), 3.48 (2H, q, <i>J</i> = 5.5, NHC<i>H</i><sub>2</sub>), 3.79 (1H, q, <i>J</i> = 6.9, C<i>H</i>), 3.89 (3H, s, OC<i>H</i><sub>3</sub>), 4.12 (2H, t, <i>J</i> = 5.6, OC<i>H</i><sub>2</sub>), 6.32 (1H, d, <i>J</i> = 9.6, Ar-<i>H</i>), 6.92 (1H, dd, <i>J</i> = 8.6, 3.6, Ar-<i>H</i>), 6.97 (1H, d, <i>J</i> = 2.0, Ar-<i>H</i>), 7.13 (1H, dd, <i>J</i> = 8.8, 3.8, Ar-<i>H</i>), 7.27 (1H, d, <i>J</i> = 2.4, Ar-<i>H</i>), 7.46 (1H, dd, <i>J</i> = 8.0, 3.3, Ar-<i>H</i>), 7.61 (1H, d, <i>J</i> = 8.8, Ar-<i>H</i>), 7.74 (3H, m, Ar-<i>H</i>), 8.01 (1H, d, <i>J</i> = 9.44, Ar-<i>H</i>), 8.29 (1H, t, <i>J</i> = 5.6, exchange with D<sub>2</sub>O, CON<i>H</i>); δ<sub>C</sub> (100 MHz, DMSO-<i>d</i><sub>6</sub>) 19.5, 39.1, 45.9, 56.1, 67.9, 102.3, 106.6, 113.4, 113.5, 113.6, 119.5, 126.2, 127.4, 127.6, 129.3, 130.0, 130.4, 134.1, 138.3, 145.3, 156.3, 157.9, 161.3, 162.5, 174.8; <i>m</i>/<i>z</i> (ESI positive) 418.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Synthesis of <i>tert</i>-Butyl (2-Bromoethyl)carbamate <b>6</b></h3><div class="NLM_p">2-Bromoethan-1-amine hydrobromide salt (1.0 g, 1.0 equiv) was dissolved in dichloromethane (DCM) (5.0 mL) and treated with a 1.0 M NaOH aqueous solution and di-<i>tert</i>-butyl dicarbonate (Boc)<sub>2</sub>O (1.0 equiv). The mixture was vigorously stirred at room temperature until consumption of starting materials (TLC monitoring). The reaction was quenched with a 1.0 M hydrochloric acid aqueous solution and extracted with EtOAc (3 × 15 mL). The combined organic layers were washed with H<sub>2</sub>O (3 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered off, and concentrated under vacuo to give the title product <b>6</b> as a colorless oil: 91% yield; silica gel TLC <i>R</i><sub><i>f</i></sub> = 0.78 (ethyl acetate/<i>n</i>-hexane 50% v/v); δ<sub>H</sub> (400 MHz, DMSO-<i>d</i><sub>6</sub>) 1.42 (9H, s, 3 × C<i>H</i><sub>3</sub>), 3.32 (2H, q, <i>J</i> = 6.2, NHC<i>H</i><sub>2</sub>), 3.46 (2H, t, <i>J</i> = 6.4, BrC<i>H</i><sub>2</sub>), 7.13 (1H, t, <i>J</i> = 5.2,exchange with D<sub>2</sub>O, CON<i>H</i>).</div><div class="NLM_p last">Experimental data are in agreement with reported data<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Carbonic Anhydrase Inhibition</h3><div class="NLM_p last">An Applied Photophysics stopped-flow instrument has been used for assaying the CA-catalyzed CO<sub>2</sub> hydration activity. Phenol red (at a concentration of 0.2 mM) has been used as a pH indicator, working at the absorbance maximum of 557 nm, with 20 mM Hepes (pH 7.5) as the buffer and 20 mM Na<sub>2</sub>SO<sub>4</sub> (for maintaining constant the ionic strength), following the initial rates of the CA-catalyzed CO<sub>2</sub> hydration reaction for a period of 10–100 s.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The CO<sub>2</sub> concentrations ranged from 1.7 to 17 mM for the determination of the kinetic parameters and inhibition constants. For each inhibitor, at least six traces of the initial 5–10% of the reaction have been used for determining the initial velocity. The uncatalyzed rates were determined in the same manner and subtracted from the total observed rates. Stock solutions of inhibitor (0.1 mM) were prepared in distilled–deionized water, and dilutions up to 0.01 nM were done thereafter with distilled–deionized water. Inhibitor and enzyme solutions were preincubated together for 15 min at room temperature prior to assay to allow for the formation of the E–I complex. The inhibition constants were obtained by nonlinear least-squares methods using PRISM 3, as reported earlier<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26">(22-26)</a> and represent the mean from at least three different determinations. All CA isofoms were recombinant ones obtained in house as reported earlier.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26">(22-26)</a></div></div><div id="sec4_28_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Animals</h3><div class="NLM_p">Sprague Dawley rats (Harlan, Varese, Italy) weighing 200–250 g at the beginning of the experimental procedure were used. Animals were housed in the Centro Stabulazione Animali da Laboratorio (University of Florence) and used at least 1 week after their arrival. Four rats were housed per cage (size 26 cm × 41 cm); animals were fed a standard laboratory diet and tap water ad libitum and kept at 23 ± 1 °C with a 12 h light/dark cycle (light at 7 a.m.). All animal manipulations were carried out according to the European Community guidelines for animal Care [DL 116/92, Application of the European Communities Council Directive of November 24, 1986 (86/609/EEC)]. The ethical policy of the University of Florence complies with the Guide for the Care and Use of Laboratory Animals of the U.S. National Institutes of Health (NIH Publication No. 85-23, revised 1996; University of Florence Assurance No. A5278-01). Formal approval to conduct the experiments described was obtained from the Animal Subjects Review Board of the University of Florence. Experiments involving animals have been reported according to ARRIVE (Animal Research: Reporting of in Vivo Experiments) guidelines.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> All efforts were made to minimize animal suffering and to reduce the number of animals used.</div><div id="sec4_28_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Complete Freund’s Adjuvant-Induced Arthritis</h4><div class="NLM_p last">Articular damage was induced by injection of complete Freund’s adjuvant (CFA; Sigma-Aldrich, St Louis, MO, USA), containing 1 mg/mL of heat-killed and dried <i>Mycobacterium tuberculosis</i> in paraffin oil and mannide monooleate, into the tibiotarsal joint.<a onclick="showRef(event, 'ref20 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref20 ref28 ref29">(20, 28, 29)</a> Briefly, the rats were lightly anesthetized by 2% isoflurane, the left leg skin was sterilized with 75% ethyl alcohol and the lateral malleolus located by palpation. A 28-gauge needle was then inserted vertically to penetrate the skin and turned distally for insertion into the articular cavity at the gap between the tibiofibular and tarsal bone until a distinct loss of resistance was felt. A volume of 50 μL of CFA was then injected (day 0). Control rats received 50 μL of saline solution (day 0) in the tibiotarsal joint. Behavioral experiments were performed 14 days after.</div></div><div id="sec4_28_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Administration of Compounds</h4><div class="NLM_p last">Compounds <b>4a</b>, <b>4f</b>, and <b>5a</b>–<b>g</b> were suspended in a 1% solution of carboxymethylcellulose sodium salt (CMC) and administered per os (po) once on day 14. All compounds were tested at a dose of 10 mg kg<sup>–1</sup>; <b>5d</b> was also administered at a dose of 1 mg kg<sup>–1</sup>. Ibuprofen was administered po at 10 mg kg<sup>–1</sup>; the effectiveness of this dosage was previously demonstrated in the same model, whereas the compound was ineffective when administered at 15 mg kg<sup>–1</sup>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec4_28_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Paw-Pressure Test</h4><div class="NLM_p last">The nociceptive threshold of rats was determined with an analgesimeter (Ugo Basile, Varese, Italy), according to the method described by Leighton et al.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Briefly, a constantly increasing pressure was applied to a small area of the dorsal surface of the hind paw using a blunt conical probe by a mechanical device. Mechanical pressure was increased until vocalization, or a withdrawal reflex occurred while rats were lightly restrained. Vocalization or withdrawal reflex thresholds were expressed in grams. Rats scoring below 40 g or over 75 g during the test before drug administration were rejected (25%). For analgesia measures, mechanical pressure application was stopped at 120 g.</div></div><div id="sec4_28_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Incapacitance Test</h4><div class="NLM_p last">Weight-bearing changes were measured using an incapacitance apparatus (Linton Instrumentation, Norfolk, U.K.) to detect changes in postural equilibrium after a hind limb injury.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Rats were trained to stand on their hind paws in a box with an inclined plane (65° from horizontal). This box was placed above the incapacitance apparatus. This allowed us to independently measure the weight that the animal applied on each hind limb. The value reported for each animal is the mean of five consecutive measurements. In the absence of hind limb injury, rats applied an equal weight on both hind limbs, indicating postural equilibrium, whereas an unequal distribution of weight on the hind limbs indicated a monolateral decreased pain threshold. Data are expressed as the difference between the weight applied to the limb contralateral to the injury and the weight applied to the ipsilateral limb (Δweight).</div></div><div id="sec4_28_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Statistical Analysis</h4><div class="NLM_p last">Behavioral measurements were performed on eight rats for each treatment carried out in two different experimental sets. Results were expressed as mean (SEM) with one-way analysis of variance. A Bonferroni’s significant difference procedure was used as a post hoc comparison. <i>P</i>-values of <0.05 or <0.01 were considered significant. Data were analyzed using the Origin 9 software (OriginLab, Northampton, MA, USA).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01607">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01607" class="ext-link">10.1021/acs.jmedchem.6b01607</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES representation for compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01607/suppl_file/jm6b01607_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01607/suppl_file/jm6b01607_si_001.csv">jm6b01607_si_001.csv (1.15 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01607" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudiu T. Supuran</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA,
Sezione di Scienze Farmaceutiche, University
of Florence, Via Ugo
Schiff 6, 50019 Sesto
Fiorentino, Florence, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4262-0323" title="Orcid link">http://orcid.org/0000-0003-4262-0323</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7417181501101d015a0701040106151a34011a1d121d5a1d00"><span class="__cf_email__" data-cfemail="197a75786c7d706c376a6c696c6b7877596c77707f7037706d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Carta</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA,
Sezione di Scienze Farmaceutiche, University
of Florence, Via Ugo
Schiff 6, 50019 Sesto
Fiorentino, Florence, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1141-6146" title="Orcid link">http://orcid.org/0000-0002-1141-6146</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c1a1d1e0e15061513521f1d0e081d3c0912151a15521508"><span class="__cf_email__" data-cfemail="dabcbbb8a8b3a0b3b5f4b9bba8aebb9aafb4b3bcb3f4b3ae">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Bua</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA,
Sezione di Scienze Farmaceutiche, University
of Florence, Via Ugo
Schiff 6, 50019 Sesto
Fiorentino, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorenzo Di Cesare Mannelli</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Psychology, Drug Research and Child Health, NEUROFARBA—Pharmacology
and Toxicology Section, University of Florence, 50019 Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Vullo</span> - <span class="hlFld-Affiliation affiliation">Polo
Scientifico, Laboratorio di Chimica Bioinorganica, University of Florence, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carla Ghelardini</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Psychology, Drug Research and Child Health, NEUROFARBA—Pharmacology
and Toxicology Section, University of Florence, 50019 Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gianluca Bartolucci</span> - <span class="hlFld-Affiliation affiliation">NEUROFARBA,
Sezione di Scienze Farmaceutiche, University
of Florence, Via Ugo
Schiff 6, 50019 Sesto
Fiorentino, Florence, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Scozzafava</span> - <span class="hlFld-Affiliation affiliation">Polo
Scientifico, Laboratorio di Chimica Bioinorganica, University of Florence, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino, Florence, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ACK-d7e5361-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was financed by two EU grants of the 7th Framework Program (Metoxia and Dynano projects to A.S. and C.T.S.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> Abbreviations Used</h2><tr><td class="NLM_term">CAI(s)</td><td class="NLM_def"><p class="first last">carbonic anhydrase inhibitor(s)</p></td></tr><tr><td class="NLM_term">AAZ</td><td class="NLM_def"><p class="first last">acetazolamide</p></td></tr><tr><td class="NLM_term">(h)CA</td><td class="NLM_def"><p class="first last">(human) carbonic anhydrase</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>I</sub></td><td class="NLM_def"><p class="first last">inhibition constant</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Myasoedova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therneau, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S. E.</span><span> </span><span class="NLM_article-title">Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955–2007</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1576</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1002/art.27425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.27425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=20191579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3cvps1yqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1576-1582&author=E.+Myasoedovaauthor=C.+S.+Crowsonauthor=H.+M.+Kremersauthor=T.+M.+Therneauauthor=S.+E.+Gabriel&title=Is+the+incidence+of+rheumatoid+arthritis+rising%3F%3A+results+from+Olmsted+County%2C+Minnesota%2C+1955%E2%80%932007&doi=10.1002%2Fart.27425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007</span></div><div class="casAuthors">Myasoedova Elena; Crowson Cynthia S; Kremers Hilal Maradit; Therneau Terry M; Gabriel Sherine E</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1576-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To examine trends in the incidence and prevalence of rheumatoid arthritis (RA) from 1995 to 2007.  METHODS:  To augment our preexisting inception cohort of patients with RA (1955-1994), we assembled a population-based incidence cohort of individuals >or=18 years of age who first fulfilled the American College of Rheumatology 1987 criteria for the classification of RA between January 1, 1995 and December 31, 2007 and a cohort of patients with prevalent RA on January 1, 2005.  Incidence and prevalence rates were estimated and were age-and sex-adjusted to the white population in the US in 2000.  Trends in incidence rates were examined using Poisson regression methods.  RESULTS:  The 1995-2007 incidence cohort comprised 466 patients (mean age 55.6 years), 69% of whom were female and 66% of whom were rheumatoid factor positive.  The overall age- and sex-adjusted annual RA incidence was 40.9/100,000 population.  The age-adjusted incidence in women was 53.1/100,000 population (versus 27.7/100,000 population in men).  During the period of time from 1995 to 2007, the incidence of RA increased moderately in women (P = 0.02) but not in men (P = 0.74).  The increase was similar among all age groups.  The overall age- and sex-adjusted prevalence on January 1, 2005 was 0.72% (95% confidence interval [95% CI] 0.66, 0.77), which is an increase when compared with a prevalence of 0.62% (95% CI 0.55, 0.69) in 1995 (P < 0.001).  Applying the prevalence on January 1, 2005 to the US population in 2005 showed that an estimated 1.5 million US adults were affected by RA.  This is an increase from the previously reported 1.3 million adults with RA in the US.  CONCLUSION:  The incidence of RA in women appears to have increased during the period of time from 1995 to 2007.  The reasons for this recent increase are unknown, but environmental factors may play a role.  A corresponding increase in the prevalence of RA was also observed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQI-35xnnxjhRLDWw4HIq2sfW6udTcc2eYQyLOrPePkeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cvps1yqtw%253D%253D&md5=b2f5693bbfe2f2cdb97b002ed94e975f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fart.27425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27425%26sid%3Dliteratum%253Aachs%26aulast%3DMyasoedova%26aufirst%3DE.%26aulast%3DCrowson%26aufirst%3DC.%2BS.%26aulast%3DKremers%26aufirst%3DH.%2BM.%26aulast%3DTherneau%26aufirst%3DT.%2BM.%26aulast%3DGabriel%26aufirst%3DS.%2BE.%26atitle%3DIs%2520the%2520incidence%2520of%2520rheumatoid%2520arthritis%2520rising%253F%253A%2520results%2520from%2520Olmsted%2520County%252C%2520Minnesota%252C%25201955%25E2%2580%25932007%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D1576%26epage%3D1582%26doi%3D10.1002%2Fart.27425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yelin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, W.</span><span> </span><span class="NLM_article-title">The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=3668977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADyaL1c%252FjsFyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1987&pages=710-717&author=E.+Yelinauthor=D.+Lubeckauthor=H.+Holmanauthor=W.+Epstein&title=The+impact+of+rheumatoid+arthritis+and+osteoarthritis%3A+the+activities+of+patients+with+rheumatoid+arthritis+and+osteoarthritis+compared+to+controls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls</span></div><div class="casAuthors">Yelin E; Lubeck D; Holman H; Epstein W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of rheumatology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">710-7</span>
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    </div><div class="casAbstract">We measured the impact of rheumatoid arthritis (RA) and osteoarthritis (OA) by comparing the activities of patients with these illnesses to controls matched for age, sex, and community of residence.  Our results indicate that patients with RA experience more losses than controls in every domain of human activity and that patients with OA experience more losses in the performance of household chores, shopping and errands, and leisure activities.  The methods described here provide a simple, reliable way to assess the impacts of illness in the same terms for all dimensions of human activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQI2S3ZhUeOWw5nADWVYHg1fW6udTcc2eYQyLOrPePkeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252FjsFyksw%253D%253D&md5=6f0e79449f64d6cca2b7d928a130941e</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYelin%26aufirst%3DE.%26aulast%3DLubeck%26aufirst%3DD.%26aulast%3DHolman%26aufirst%3DH.%26aulast%3DEpstein%26aufirst%3DW.%26atitle%3DThe%2520impact%2520of%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%253A%2520the%2520activities%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%2520compared%2520to%2520controls%26jtitle%3DJ.%2520Rheumatol.%26date%3D1987%26volume%3D14%26spage%3D710%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yelin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, W.</span><span> </span><span class="NLM_article-title">The work dynamics of the person with rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1002/art.1780300504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.1780300504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=3593434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADyaL2s3ktFOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=507-512&author=E.+Yelinauthor=C.+Henkeauthor=W.+Epstein&title=The+work+dynamics+of+the+person+with+rheumatoid+arthritis&doi=10.1002%2Fart.1780300504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The work dynamics of the person with rheumatoid arthritis</span></div><div class="casAuthors">Yelin E; Henke C; Epstein W</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-12</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">This paper traces the work history of patients with rheumatoid arthritis (RA) from the year of diagnosis to 1985.  The paper also describes the risk factors for work loss among patients with RA.  It uses data from a panel of 698 RA patients, observed for 4 years, from the practices of a random sample of northern California rheumatologists.  Of these 698, 353 had worked for pay at some point in their lives.  Three hundred six of the 353 had worked when diagnosed as having RA.  Of these 306, 157 (51%) were no longer working in 1985.  Forty-seven individuals started working after the onset of illness, but of these, approximately one-third had stopped working by 1985.  In all, 50% of RA patients with some work experience stopped working within a decade of diagnosis, 60% within 15 years, and 90% within 30 years.  We found that the probability of work loss is lessened among persons in jobs that have few physical requirements, among those with high levels of discretion over the pace and activities of work, and among those who were able to stay on the job held when the diagnosis was made.  The probability of work loss is increased among service workers.  The findings of this longitudinal study, showing that work characteristics profoundly alter the probability of work loss among persons with RA, are consistent with the findings of our earlier cross-sectional studies of work outcome and RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOCSTunNuI7A20zIbnCCI3fW6udTcc2eYQyLOrPePkeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s3ktFOmsg%253D%253D&md5=139f479967b8d4b6435044c279ca6814</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1002%2Fart.1780300504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780300504%26sid%3Dliteratum%253Aachs%26aulast%3DYelin%26aufirst%3DE.%26aulast%3DHenke%26aufirst%3DC.%26aulast%3DEpstein%26aufirst%3DW.%26atitle%3DThe%2520work%2520dynamics%2520of%2520the%2520person%2520with%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1987%26volume%3D30%26spage%3D507%26epage%3D512%26doi%3D10.1002%2Fart.1780300504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Singh, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saag, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, S. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akl, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannuru, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaysbrot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNaughton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmerling, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furst, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteson, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schousboe, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drevlow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginsberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grober, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Clair, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tindall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlindon, T.</span><span> </span><span class="NLM_article-title">2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1002/art.39480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.39480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=26545940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC28zpvVGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=1-26&author=J.+A.+Singhauthor=K.+G.+Saagauthor=S.+L.+Bridgesauthor=E.+A.+Aklauthor=R.+R.+Bannuruauthor=M.+C.+Sullivanauthor=E.+Vaysbrotauthor=C.+McNaughtonauthor=M.+Osaniauthor=R.+H.+Shmerlingauthor=J.+R.+Curtisauthor=D.+E.+Furstauthor=D.+Parksauthor=A.+Kavanaughauthor=J.+O%E2%80%99Dellauthor=C.+Kingauthor=A.+Leongauthor=E.+L.+Mattesonauthor=J.+T.+Schousboeauthor=B.+Drevlowauthor=S.+Ginsbergauthor=J.+Groberauthor=E.+W.+St.+Clairauthor=E.+Tindallauthor=A.+S.+Millerauthor=T.+McAlindon&title=2015+American+college+of+rheumatology+guideline+for+the+treatment+of+rheumatoid+arthritis&doi=10.1002%2Fart.39480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis</span></div><div class="casAuthors">Singh Jasvinder A; Saag Kenneth G; Bridges S Louis Jr; Curtis Jeffrey R; Akl Elie A; Bannuru Raveendhara R; Sullivan Matthew C; Vaysbrot Elizaveta; McNaughton Christine; Osani Mikala; McAlindon Timothy; Shmerling Robert H; Furst Daniel E; Parks Deborah; Kavanaugh Arthur; O'Dell James; King Charles; Leong Amye; Matteson Eric L; Schousboe John T; Drevlow Barbara; Grober James; Ginsberg Seth; St Clair E William; Tindall Elizabeth; Miller Amy S</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & rheumatology (Hoboken, N.J.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA).  METHODS:  We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options.  We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to rate the quality of evidence.  We employed a group consensus process to grade the strength of recommendations (either strong or conditional).  A strong recommendation indicates that clinicians are certain that the benefits of an intervention far outweigh the harms (or vice versa).  A conditional recommendation denotes uncertainty over the balance of benefits and harms and/or more significant variability in patient values and preferences.  RESULTS:  The guideline covers the use of traditional disease-modifying antirheumatic drugs (DMARDs), biologic agents, tofacitinib, and glucocorticoids in early (<6 months) and established (≥6 months) RA.  In addition, it provides recommendations on using a treat-to-target approach, tapering and discontinuing medications, and the use of biologic agents and DMARDs in patients with hepatitis, congestive heart failure, malignancy, and serious infections.  The guideline addresses the use of vaccines in patients starting/receiving DMARDs or biologic agents, screening for tuberculosis in patients starting/receiving biologic agents or tofacitinib, and laboratory monitoring for traditional DMARDs.  The guideline includes 74 recommendations: 23% are strong and 77% are conditional.  CONCLUSION:  This RA guideline should serve as a tool for clinicians and patients (our two target audiences) for pharmacologic treatment decisions in commonly encountered clinical situations.  These recommendations are not prescriptive, and the treatment decisions should be made by physicians and patients through a shared decision-making process taking into account patients' values, preferences, and comorbidities.  These recommendations should not be used to limit or deny access to therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI9Xng6yKjfjEC-75aqa5AfW6udTcc2eYSFeu-B_-hVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zpvVGnsA%253D%253D&md5=b00a30744da179f257667fdb7f40ed2f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fart.39480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39480%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%2BA.%26aulast%3DSaag%26aufirst%3DK.%2BG.%26aulast%3DBridges%26aufirst%3DS.%2BL.%26aulast%3DAkl%26aufirst%3DE.%2BA.%26aulast%3DBannuru%26aufirst%3DR.%2BR.%26aulast%3DSullivan%26aufirst%3DM.%2BC.%26aulast%3DVaysbrot%26aufirst%3DE.%26aulast%3DMcNaughton%26aufirst%3DC.%26aulast%3DOsani%26aufirst%3DM.%26aulast%3DShmerling%26aufirst%3DR.%2BH.%26aulast%3DCurtis%26aufirst%3DJ.%2BR.%26aulast%3DFurst%26aufirst%3DD.%2BE.%26aulast%3DParks%26aufirst%3DD.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLeong%26aufirst%3DA.%26aulast%3DMatteson%26aufirst%3DE.%2BL.%26aulast%3DSchousboe%26aufirst%3DJ.%2BT.%26aulast%3DDrevlow%26aufirst%3DB.%26aulast%3DGinsberg%26aufirst%3DS.%26aulast%3DGrober%26aufirst%3DJ.%26aulast%3DSt.%2BClair%26aufirst%3DE.%2BW.%26aulast%3DTindall%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DA.%2BS.%26aulast%3DMcAlindon%26aufirst%3DT.%26atitle%3D2015%2520American%2520college%2520of%2520rheumatology%2520guideline%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D1%26epage%3D26%26doi%3D10.1002%2Fart.39480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Agca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heslinga, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollefstad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heslinga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvien, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atzeni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primdahl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Södergren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallberg Jonsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rompay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabalan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vlam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Gay, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semb, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitas, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulders, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szekanecz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symmons, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmohamed, M. T.</span><span> </span><span class="NLM_article-title">EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2016-209775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1136%2Fannrheumdis-2016-209775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=27697765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC2svlslWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=17-28&author=R.+Agcaauthor=S.+C.+Heslingaauthor=S.+Rollefstadauthor=M.+Heslingaauthor=I.+B.+McInnesauthor=M.+J.+Petersauthor=T.+K.+Kvienauthor=M.+Dougadosauthor=H.+Radnerauthor=F.+Atzeniauthor=J.+Primdahlauthor=A.+S%C3%B6dergrenauthor=S.+Wallberg+Jonssonauthor=J.+van+Rompayauthor=C.+Zabalanauthor=T.+R.+Pedersenauthor=L.+Jacobssonauthor=K.+de+Vlamauthor=M.+A.+Gonzalez-Gayauthor=A.+G.+Sembauthor=G.+D.+Kitasauthor=Y.+M.+Smuldersauthor=Z.+Szekaneczauthor=N.+Sattarauthor=D.+P.+Symmonsauthor=M.+T.+Nurmohamed&title=EULAR+recommendations+for+cardiovascular+disease+risk+management+in+patients+with+rheumatoid+arthritis+and+other+forms+of+inflammatory+joint+disorders%3A+2015%2F2016+update&doi=10.1136%2Fannrheumdis-2016-209775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update</span></div><div class="casAuthors">Agca R; Heslinga S C; Heslinga M; Rollefstad S; Semb A G; McInnes I B; Peters M J L; Smulders Y M; Kvien T K; Dougados M; Radner H; Atzeni F; Primdahl J; Primdahl J; Primdahl J; Sodergren A; Wallberg Jonsson S; van Rompay J; Zabalan C; Pedersen T R; Jacobsson L; Jacobsson L; de Vlam K; Gonzalez-Gay M A; Kitas G D; Szekanecz Z; Sattar N; Symmons D P M; Nurmohamed M T</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population.  In 2009, the European League Against Rheumatism (EULAR) taskforce recommended screening, identification of CVD risk factors and CVD risk management largely based on expert opinion.  In view of substantial new evidence, an update was conducted with the aim of producing CVD risk management recommendations for patients with IJD that now incorporates an increasing evidence base.  A multidisciplinary steering committee (representing 13 European countries) comprised 26 members including patient representatives, rheumatologists, cardiologists, internists, epidemiologists, a health professional and fellows.  Systematic literature searches were performed and evidence was categorised according to standard guidelines.  The evidence was discussed and summarised by the experts in the course of a consensus finding and voting process.  Three overarching principles were defined.  First, there is a higher risk for CVD in patients with RA, and this may also apply to ankylosing spondylitis and psoriatic arthritis.  Second, the rheumatologist is responsible for CVD risk management in patients with IJD.  Third, the use of non-steroidal anti-inflammatory drugs and corticosteroids should be in accordance with treatment-specific recommendations from EULAR and Assessment of Spondyloarthritis International Society.  Ten recommendations were defined, of which one is new and six were changed compared with the 2009 recommendations.  Each designated an appropriate evidence support level.  The present update extends on the evidence that CVD risk in the whole spectrum of IJD is increased.  This underscores the need for CVD risk management in these patients.  These recommendations are defined to provide assistance in CVD risk management in IJD, based on expert opinion and scientific evidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzCYVs9aAtomHOrQ6qeX-mfW6udTcc2eYSFeu-B_-hVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svlslWjtQ%253D%253D&md5=a0755bf22a92e5469f33f04a835d4474</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2016-209775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2016-209775%26sid%3Dliteratum%253Aachs%26aulast%3DAgca%26aufirst%3DR.%26aulast%3DHeslinga%26aufirst%3DS.%2BC.%26aulast%3DRollefstad%26aufirst%3DS.%26aulast%3DHeslinga%26aufirst%3DM.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DPeters%26aufirst%3DM.%2BJ.%26aulast%3DKvien%26aufirst%3DT.%2BK.%26aulast%3DDougados%26aufirst%3DM.%26aulast%3DRadner%26aufirst%3DH.%26aulast%3DAtzeni%26aufirst%3DF.%26aulast%3DPrimdahl%26aufirst%3DJ.%26aulast%3DS%25C3%25B6dergren%26aufirst%3DA.%26aulast%3DWallberg%2BJonsson%26aufirst%3DS.%26aulast%3Dvan%2BRompay%26aufirst%3DJ.%26aulast%3DZabalan%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DT.%2BR.%26aulast%3DJacobsson%26aufirst%3DL.%26aulast%3Dde%2BVlam%26aufirst%3DK.%26aulast%3DGonzalez-Gay%26aufirst%3DM.%2BA.%26aulast%3DSemb%26aufirst%3DA.%2BG.%26aulast%3DKitas%26aufirst%3DG.%2BD.%26aulast%3DSmulders%26aufirst%3DY.%2BM.%26aulast%3DSzekanecz%26aufirst%3DZ.%26aulast%3DSattar%26aufirst%3DN.%26aulast%3DSymmons%26aufirst%3DD.%2BP.%26aulast%3DNurmohamed%26aufirst%3DM.%2BT.%26atitle%3DEULAR%2520recommendations%2520for%2520cardiovascular%2520disease%2520risk%2520management%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520other%2520forms%2520of%2520inflammatory%2520joint%2520disorders%253A%25202015%252F2016%2520update%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2017%26volume%3D76%26spage%3D17%26epage%3D28%26doi%3D10.1136%2Fannrheumdis-2016-209775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Agarwal, S. K.</span><span> </span><span class="NLM_article-title">Core management principles in rheumatoid arthritis to help guide managed care professionals</span> <span class="citation_source-journal">J. Manag. Care. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S03</span><span class="NLM_x">–</span> <span class="NLM_lpage">S08</span><span class="refDoi"> DOI: 10.18553/jmcp.2011.17.s9-b.S03</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.18553%2Fjmcp.2011.17.s9-b.S03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=22073933" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=S03-S08&author=S.+K.+Agarwal&title=Core+management+principles+in+rheumatoid+arthritis+to+help+guide+managed+care+professionals&doi=10.18553%2Fjmcp.2011.17.s9-b.S03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.18553%2Fjmcp.2011.17.s9-b.S03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18553%252Fjmcp.2011.17.s9-b.S03%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%2BK.%26atitle%3DCore%2520management%2520principles%2520in%2520rheumatoid%2520arthritis%2520to%2520help%2520guide%2520managed%2520care%2520professionals%26jtitle%3DJ.%2520Manag.%2520Care.%2520Pharm.%26date%3D2011%26volume%3D17%26spage%3DS03%26epage%3DS08%26doi%3D10.18553%2Fjmcp.2011.17.s9-b.S03" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kharlamova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potempa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israelsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirke, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yucel-Lindberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potempa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfredsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundberg, K.</span><span> </span><span class="NLM_article-title">Antibodies to porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology</span> <span class="citation_source-journal">Arthritis Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span><span class="refDoi"> DOI: 10.1002/art.39491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.39491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=26554752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFejs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=604-613&author=N.+Kharlamovaauthor=X.+Jiangauthor=N.+Sherinaauthor=B.+Potempaauthor=L.+Israelssonauthor=A.+M.+Quirkeauthor=K.+Erikssonauthor=T.+Yucel-Lindbergauthor=P.+J.+Venablesauthor=J.+Potempaauthor=L.+Alfredssonauthor=K.+Lundberg&title=Antibodies+to+porphyromonas+gingivalis+indicate+interaction+between+oral+infection%2C+smoking%2C+and+risk+genes+in+rheumatoid+arthritis+etiology&doi=10.1002%2Fart.39491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology</span></div><div class="casAuthors">Kharlamova, Nastya; Jiang, Xia; Sherina, Natalia; Potempa, Barbara; Israelsson, Lena; Quirke, Anne-Marie; Eriksson, Kaja; Yucel-Lindberg, Tuelay; Venables, Patrick J.; Potempa, Jan; Alfredsson, Lars; Lundberg, Karin</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">604-613</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To investigate the role of the periodontal pathogen Porphyromonas gingivalis in the etiol. of rheumatoid arthritis (RA) by analyzing the antibody response to the P gingivalis virulence factor arginine gingipain type B (RgpB) in relation to anti-citrullinated protein antibodies (ACPAs), smoking, and HLA-DRB1 shared epitope (SE) alleles in patients with periodontitis, patients with RA, and controls.  Methods: Anti-RgpB IgG was measured by ELISA in 65 periodontitis patients and 59 controls without periodontitis, and in 1,974 RA patients and 377 controls without RA from the Swedish population-based case-control Epidemiol. Investigation of Rheumatoid Arthritis (EIRA) study.  Autoantibody status, smoking habits, and genetic data were retrieved from the EIRA database.  Differences in antibody levels were examd. using the Mann-Whitney U test.  Unconditional logistic regression was used to calc. odds ratios (ORs) with 95% confidence intervals (95% CIs) for the assocn. of anti-RgpB IgG with different subsets of RA patients.  Results: Anti-RgpB antibody levels were significantly elevated in periodontitis patients compared to controls without periodontitis, in RA patients compared to controls without RA, and in ACPA-pos. RA patients compared to ACPA-neg. RA patients.  There was a significant assocn. between anti-RgpB IgG and RA (OR 2.96 [95% CI 2.00, 4.37]), which was even stronger than the assocn. between smoking and RA (OR 1.37 [95% CI 1.07, 1.74]), and in ACPA-pos. RA there were interactions between anti-RgpB antibodies and both smoking and the HLA-DRB1 SE.  Conclusion: Our study suggests that the previously reported link between periodontitis and RA could be accounted for by P gingivalis infection, and we conclude that P gingivalis is a credible candidate for triggering and/or driving autoimmunity and autoimmune disease in a subset of RA patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZVz8WqP0kLVg90H21EOLACvtfcHk0liQ1tXXIdDmbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFejs7g%253D&md5=eb120132bcdd1e4feff9d2f70178d92c</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Fart.39491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39491%26sid%3Dliteratum%253Aachs%26aulast%3DKharlamova%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSherina%26aufirst%3DN.%26aulast%3DPotempa%26aufirst%3DB.%26aulast%3DIsraelsson%26aufirst%3DL.%26aulast%3DQuirke%26aufirst%3DA.%2BM.%26aulast%3DEriksson%26aufirst%3DK.%26aulast%3DYucel-Lindberg%26aufirst%3DT.%26aulast%3DVenables%26aufirst%3DP.%2BJ.%26aulast%3DPotempa%26aufirst%3DJ.%26aulast%3DAlfredsson%26aufirst%3DL.%26aulast%3DLundberg%26aufirst%3DK.%26atitle%3DAntibodies%2520to%2520porphyromonas%2520gingivalis%2520indicate%2520interaction%2520between%2520oral%2520infection%252C%2520smoking%252C%2520and%2520risk%2520genes%2520in%2520rheumatoid%2520arthritis%2520etiology%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D604%26epage%3D613%26doi%3D10.1002%2Fart.39491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lundberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yucel-Lindberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, P. J.</span><span> </span><span class="NLM_article-title">Periodontitis in RA-the citrullinated enolase connection</span> <span class="citation_source-journal">Nat. Rev. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1038/nrrheum.2010.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1038%2Fnrrheum.2010.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=20820197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=727-730&author=K.+Lundbergauthor=N.+Wegnerauthor=T.+Yucel-Lindbergauthor=P.+J.+Venables&title=Periodontitis+in+RA-the+citrullinated+enolase+connection&doi=10.1038%2Fnrrheum.2010.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Periodontitis in RA-the citrullinated enolase connection</span></div><div class="casAuthors">Lundberg, Karin; Wegner, Natalia; Yucel-Lindberg, Tulay; Venables, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">727-730</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibodies to citrullinated enolase define a subset of rheumatoid arthritis (RA) assocd. with smoking and DR4 alleles.  In this Perspectives article, the authors review epidemiol. and genetic links between periodontitis (a disease in which Porphyromonas gingivalis is a major pathogen) and RA and propose that that the assocn. might be causal, due to mol. mimicry between epitopes on host and P. gingivalis citrullinated enolases driving the autoimmune response.  Autoimmunity in rheumatoid arthritis (RA) is characterized by an antibody response to citrullinated proteins.  Two of the risk factors for RA-HLA-DRB1 shared epitope alleles and smoking-are also assocd. with periodontitis, which is largely, but not exclusively, caused by Porphyromonas gingivalis infection.  Furthermore, RA and periodontitis have a similar pathophysiol., characterized by destructive inflammation.  The citrullination of proteins by P. gingivalis and the subsequent generation of autoantigens that drive autoimmunity in RA represents a possible causative link between these two diseases.  Antibodies directed towards the immunodominant epitope of human citrullinated α-enolase cross-react with a conserved sequence on citrullinated P. gingivalis enolase.  On the basis of this cross-reactivity, in this Perspectives article we explore the hypothesis of mol. mimicry in the etiol. of RA, with citrullinated enolase as the specific antigen involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAuxMkj0Tgk7Vg90H21EOLACvtfcHk0liQ1tXXIdDmbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLzI&md5=adae31402135be903bbc4d710422188d</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2010.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2010.139%26sid%3Dliteratum%253Aachs%26aulast%3DLundberg%26aufirst%3DK.%26aulast%3DWegner%26aufirst%3DN.%26aulast%3DYucel-Lindberg%26aufirst%3DT.%26aulast%3DVenables%26aufirst%3DP.%2BJ.%26atitle%3DPeriodontitis%2520in%2520RA-the%2520citrullinated%2520enolase%2520connection%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2010%26volume%3D6%26spage%3D727%26epage%3D730%26doi%3D10.1038%2Fnrrheum.2010.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Koziel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mydel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potempa, J.</span><span> </span><span class="NLM_article-title">The link between periodontal disease and rheumatoid arthritis: an updated review</span> <span class="citation_source-journal">Curr. Rheumatol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="refDoi"> DOI: 10.1007/s11926-014-0408-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1007%2Fs11926-014-0408-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=24458478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC2czovFGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=408&author=J.+Kozielauthor=P.+Mydelauthor=J.+Potempa&title=The+link+between+periodontal+disease+and+rheumatoid+arthritis%3A+an+updated+review&doi=10.1007%2Fs11926-014-0408-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">The link between periodontal disease and rheumatoid arthritis: an updated review</span></div><div class="casAuthors">Koziel Joanna; Mydel Piotr; Potempa Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current rheumatology reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">408</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Porphyromonas gingivalis is a leading pathogen in chronic periodontitis, a disease process involving progressive destruction of the tissues that support the teeth.  Recently, the organism has been reported to produce a unique bacterial enzyme, P. gingivalis peptidyl-arginine deiminase (PPAD), which has the ability to convert arginine residues in proteins to citrulline.  Protein citrullination alters protein structure and function; hence, PPAD may be involved in deregulation of the host's signalling network and immune evasion.  Further, accumulating evidence suggests a role for autoimmunity against citrullinated proteins in the development of rheumatoid arthritis (RA).  As inflammatory conditions in the lungs of cigarette smokers contribute to the breakdown of immune tolerance to citrullinated epitopes, chronic exposure to citrullinated proteins at periodontitis sites may also predispose susceptible individuals to the development of autoantibodies and the initiation of RA.  In this review, we discuss evidence that PPAD may represent a mechanistic link between periodontitis and RA, diseases that are known to be significantly associated at the epidemiological level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRec_aWYOizrNj_Vg2vObihfW6udTcc2ea8IclsVmnKgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czovFGmsQ%253D%253D&md5=9fe703574164ad0b5dd9b69e0e8f204f</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1007%2Fs11926-014-0408-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-014-0408-9%26sid%3Dliteratum%253Aachs%26aulast%3DKoziel%26aufirst%3DJ.%26aulast%3DMydel%26aufirst%3DP.%26aulast%3DPotempa%26aufirst%3DJ.%26atitle%3DThe%2520link%2520between%2520periodontal%2520disease%2520and%2520rheumatoid%2520arthritis%253A%2520an%2520updated%2520review%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2014%26volume%3D16%26spage%3D408%26doi%3D10.1007%2Fs11926-014-0408-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Trabocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimmelbein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guarna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span> </span><span class="NLM_article-title">Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.3109/14756366.2014.947976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2014.947976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=25198885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=466-471&author=A.+Trabocchiauthor=N.+Palaauthor=I.+Krimmelbeinauthor=G.+Menchiauthor=A.+Guarnaauthor=M.+Sechiauthor=T.+Drekerauthor=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Peptidomimetics+as+protein+arginine+deiminase+4+%28PAD4%29+inhibitors&doi=10.3109%2F14756366.2014.947976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors</span></div><div class="casAuthors">Trabocchi, Andrea; Pala, Nicolino; Krimmelbein, Ilga; Menchi, Gloria; Guarna, Antonio; Sechi, Mario; Dreker, Tobias; Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The protein arginine deiminase 4 (PAD4) is a calcium-dependent enzyme, which catalyzes the irreversible conversion of peptidyl-arginines into peptidyl-citrullines and plays an important role in several diseases such as in the rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, Creutzfeldt-Jacob's disease and cancer.  In this study, the authors report the inhibition profiles and computational docking toward the PAD4 enzyme of a series of 1,2,3-triazole peptidomimetic-based derivs. incorporating the β-phenylalanine and guanidine scaffolds.  Several effective, low micromolar PAD4 inhibitors are reported in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgnjqFPrxaT7Vg90H21EOLACvtfcHk0lhijmgEpCNsXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbvE&md5=3524acfe15eeb79049a7bceb6dd1b6e7</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.3109%2F14756366.2014.947976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2014.947976%26sid%3Dliteratum%253Aachs%26aulast%3DTrabocchi%26aufirst%3DA.%26aulast%3DPala%26aufirst%3DN.%26aulast%3DKrimmelbein%26aufirst%3DI.%26aulast%3DMenchi%26aufirst%3DG.%26aulast%3DGuarna%26aufirst%3DA.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DDreker%26aufirst%3DT.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DPeptidomimetics%2520as%2520protein%2520arginine%2520deiminase%25204%2520%2528PAD4%2529%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2015%26volume%3D30%26spage%3D466%26epage%3D471%26doi%3D10.3109%2F14756366.2014.947976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Witalison, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofseth, L. J.</span><span> </span><span class="NLM_article-title">Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.2174/1389450116666150202160954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.2174%2F1389450116666150202160954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=25642720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSht7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=700-710&author=E.+E.+Witalisonauthor=P.+R.+Thompsonauthor=L.+J.+Hofseth&title=Protein+arginine+deiminases+and+associated+citrullination%3A+physiological+functions+and+diseases+associated+with+dysregulation&doi=10.2174%2F1389450116666150202160954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation</span></div><div class="casAuthors">Witalison, Erin E.; Thompson, Paul R.; Hofseth, Lorne J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">700-710</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Human proteins are subjected to more than 200 known post-translational modifications (PTMs) (e.g., phosphorylation, glycosylation, ubiquitination, S-nitrosylation, methylation, Nacetylation, and citrullination) and these PTMs can alter protein structure and function with consequent effects on the multitude of pathways necessary for maintaining the physiol. homeostasis.  When dysregulated, however, the enzymes that catalyze these PTMs can impact the genesis of countless diseases.  In this review, we will focus on protein citrullination, a PTM catalyzed by the Protein Arginine Deiminase (PAD) family of enzymes.  Specifically, we will describe the roles of the PADs in both normal human physiol. and disease.  The development of PAD inhibitors and their efficacy in a variety of autoimmune disorders and cancer will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdv_o7-kOsurVg90H21EOLACvtfcHk0lhijmgEpCNsXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSht7vJ&md5=9d0072b3b5e23308858bb4cd4ed0cab7</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.2174%2F1389450116666150202160954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450116666150202160954%26sid%3Dliteratum%253Aachs%26aulast%3DWitalison%26aufirst%3DE.%2BE.%26aulast%3DThompson%26aufirst%3DP.%2BR.%26aulast%3DHofseth%26aufirst%3DL.%2BJ.%26atitle%3DProtein%2520arginine%2520deiminases%2520and%2520associated%2520citrullination%253A%2520physiological%2520functions%2520and%2520diseases%2520associated%2520with%2520dysregulation%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2015%26volume%3D16%26spage%3D700%26epage%3D710%26doi%3D10.2174%2F1389450116666150202160954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maddur, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miossec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaveri, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayry, J.</span><span> </span><span class="NLM_article-title">Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">181</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2012.03.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.ajpath.2012.03.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=22640807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOitbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2012&pages=8-18&author=M.+S.+Maddurauthor=P.+Miossecauthor=S.+V.+Kaveriauthor=J.+Bayry&title=Th17+cells%3A+biology%2C+pathogenesis+of+autoimmune+and+inflammatory+diseases%2C+and+therapeutic+strategies&doi=10.1016%2Fj.ajpath.2012.03.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Th 17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies</span></div><div class="casAuthors">Maddur, Mohan S.; Miossec, Pierre; Kaveri, Srini V.; Bayry, Jagadeesh</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-18</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Th17 cells that secrete the cytokines IL-17A and IL-17F and express lineage-specific transcription factor RORC (RORγt in mice) represent a distinct lineage of CD4+ T cells.  Transforming growth factor-β and inflammatory cytokines, such as IL-6, IL-21, IL-1β, and IL-23, play central roles in the generation of Th17 cells.  Th17 cells are crit. for the clearance of extracellular pathogens, including Candida and Klebsiella.  However, under certain conditions, these cells and their effector mols., such as IL-17, IL-21, IL-22, GM-CSF, and CCL20, are assocd. with the pathogenesis of several autoimmune and inflammatory diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, inflammatory bowel disease, and allergy and asthma.  This review discusses these disease states and the various therapeutic strategies under investigation to target Th17 cells, which include blocking the differentiation and amplification of Th17 cells, inhibiting or neutralizing the cytokines of Th17 cells, and suppressing the transcription factors specific for Th17 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8EspukaEizbVg90H21EOLACvtfcHk0lhijmgEpCNsXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOitbbF&md5=15b79f41578ef7eaef6798a93e175c16</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.03.044%26sid%3Dliteratum%253Aachs%26aulast%3DMaddur%26aufirst%3DM.%2BS.%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKaveri%26aufirst%3DS.%2BV.%26aulast%3DBayry%26aufirst%3DJ.%26atitle%3DTh17%2520cells%253A%2520biology%252C%2520pathogenesis%2520of%2520autoimmune%2520and%2520inflammatory%2520diseases%252C%2520and%2520therapeutic%2520strategies%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D181%26spage%3D8%26epage%3D18%26doi%3D10.1016%2Fj.ajpath.2012.03.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Skapenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipsky, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Koops, H.</span><span> </span><span class="NLM_article-title">The role of the T cell in autoimmune inflammation</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">S4</span><span class="NLM_x">–</span> <span class="NLM_lpage">S14</span><span class="refDoi"> DOI: 10.1186/ar1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1186%2Far1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=15833146" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=S4-S14&author=A.+Skapenkoauthor=J.+Leipeauthor=P.+E.+Lipskyauthor=H.+Schulze-Koops&title=The+role+of+the+T+cell+in+autoimmune+inflammation&doi=10.1186%2Far1703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1186%2Far1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far1703%26sid%3Dliteratum%253Aachs%26aulast%3DSkapenko%26aufirst%3DA.%26aulast%3DLeipe%26aufirst%3DJ.%26aulast%3DLipsky%26aufirst%3DP.%2BE.%26aulast%3DSchulze-Koops%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520the%2520T%2520cell%2520in%2520autoimmune%2520inflammation%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2005%26volume%3D7%26spage%3DS4%26epage%3DS14%26doi%3D10.1186%2Far1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kanda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimura, T.</span><span> </span><span class="NLM_article-title">Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios</span> <span class="citation_source-journal">Mod. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.3109/s10165-007-0589-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2Fs10165-007-0589-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=17929126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGgs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=364-368&author=H.+Kandaauthor=K.+Yokotaauthor=C.+Kohnoauthor=T.+Sawadaauthor=K.+Satoauthor=M.+Yamaguchiauthor=Y.+Komagataauthor=K.+Shimadaauthor=K.+Yamamotoauthor=T.+Mimura&title=Effects+of+low-dosage+simvastatin+on+rheumatoid+arthritis+through+reduction+of+Th1%2FTh2+and+CD4%2FCD8+ratios&doi=10.3109%2Fs10165-007-0589-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios</span></div><div class="casAuthors">Kanda, Hiroko; Yokota, Kazuhiro; Kohno, Chieko; Sawada, Tetsuji; Sato, Kojiro; Yamaguchi, Masao; Komagata, Yoshinori; Shimada, Kota; Yamamoto, Kazuhiko; Mimura, Toshihide</div><div class="citationInfo"><span class="NLM_cas:title">Modern Rheumatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">364-368</span>CODEN:
                <span class="NLM_cas:coden">MROHA4</span>;
        ISSN:<span class="NLM_cas:issn">1439-7595</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">The objective of this study was to assess both the anti-inflammatory and immunomodulatory effects of low-dosage simvastatin on rheumatoid arthritis (RA).  In each patient, simvastatin at 10 mg/day was administered for 12 wk.  The other treatments were unchanged at least 3 mo before simvastatin administration to the end of the study.  Patients were assessed for the improvement in clin., lab., and immunol. parameters of RA and for adverse events.  Twenty-four patients with RA were enrolled.  Clin. symptoms, including patient's assessment of pain and disease activity on visual analog scale (VAS), the swollen joint and tender joint counts, and handgrip strength significantly improved.  Physician's assessment of disease activity on VAS, a period of morning stiffness and modified health assessment questionnaire showed a tendency of improving after administration of low-dosage of simvastatin.  Of special interest was that the median levels of erythrocytes sedimentation rate, C-reactive protein, and rheumatoid factor were significantly decreased from 54.0 mm/h to 45.5 mm/h, from 1.50 mg/dL to 0.85 mg/dL, and from 57.0 IU/mL to 28.0 IU/mL, resp., after administration of simvastatin.  ACR20 and ACR50 responses were achieved in 62% and 38%, resp., of simvastatin-treated patients for 12 wk.  Immunol. assessment in peripheral blood revealed that the Th1/Th2 and CD4/CD8 ratios were significantly reduced by simvastatin.  No adverse events were reported during simvastatin treatment.  Immunomodulation through the alteration of Th1/Th2 and CD4/CD8 ratios may be a pharmacol. mechanism in the anti-rheumatic effect of low-dosage simvastatin.  Although it is necessary to evaluate the long-term effects of statins, low-dosage statins appear to be good as addnl. therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo71tTjmt1TOLVg90H21EOLACvtfcHk0lgQd8bvN_XaNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGgs7rL&md5=d2d8b418160109620bb7ec906003c2b9</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.3109%2Fs10165-007-0589-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252Fs10165-007-0589-4%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DH.%26aulast%3DYokota%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DC.%26aulast%3DSawada%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DKomagata%26aufirst%3DY.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DMimura%26aufirst%3DT.%26atitle%3DEffects%2520of%2520low-dosage%2520simvastatin%2520on%2520rheumatoid%2520arthritis%2520through%2520reduction%2520of%2520Th1%252FTh2%2520and%2520CD4%252FCD8%2520ratios%26jtitle%3DMod.%2520Rheumatol.%26date%3D2007%26volume%3D17%26spage%3D364%26epage%3D368%26doi%3D10.3109%2Fs10165-007-0589-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Leipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerzendorf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Koops, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skapenko, A.</span><span> </span><span class="NLM_article-title">Role of Th17 cells in human autoimmune arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">2876</span><span class="NLM_x">–</span> <span class="NLM_lpage">2885</span><span class="refDoi"> DOI: 10.1002/art.27622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.27622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=20583102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=2876-2885&author=J.+Leipeauthor=M.+Grunkeauthor=C.+Dechantauthor=C.+Reindlauthor=U.+Kerzendorfauthor=H.+Schulze-Koopsauthor=A.+Skapenko&title=Role+of+Th17+cells+in+human+autoimmune+arthritis&doi=10.1002%2Fart.27622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Th17 cells in human autoimmune arthritis</span></div><div class="casAuthors">Leipe, Jan; Grunke, Mathias; Dechant, Claudia; Reindl, Christiane; Kerzendorf, Ulrike; Schulze-Koops, Hendrik; Skapenko, Alla</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2876-2885</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To delineate the role of Th17 cells in the pathogenesis of autoimmune arthritides.  Th17 cells were analyzed in well-defined homogeneous cohorts of patients with the prototypical autoimmune arthritides rheumatoid arthritis (RA) and psoriatic arthritis (PsA), grouped according to patients who had very early active RA (n = 36; mean disease duration 2.8 mo, Disease Activity Score in 28 joints 5.0) and those who had very early active PsA (n = 20; mean disease duration 2.3 mo), none of whom had received treatment with glucocorticoids or disease-modifying antirheumatic drugs, as well as patients with established RA (n = 21; mean disease duration 68 mo) who were considered either responders or nonresponders to therapy.  Groups of healthy individuals and patients with osteoarthritis (a noninflammatory arthritis) were used as control cohorts.  Expression of T lineage-specific transcription factors (RORC, T-bet, GATA-3, and FoxP3) and the response of CD4 T cells to Th17 cell-inducing conditions were analyzed in vitro.  The frequencies of Th17 cells and levels of interleukin-17 strongly correlated with systemic disease activity at both the onset and the progression of RA or PsA.  The values were reduced to control levels in patients with treatment-controlled disease activity.  Th17 cells were enriched in the joints, and increased frequencies of synovial Th17 cells expressed CCR4 and CCR6, indicative of selective migration of Th17 cells to the joints.  The intrinsically elevated expression of RORC, accompanied by biased Th17 cell development, and the resistance of Th17 cells to a natural cytokine antagonist in patients with RA and patients with PsA were suggestive of the underlying mol. mechanisms of uncontrolled Th17 activity in these patients.  Th17 cells play an important role in inflammation in human autoimmune arthritides, both at the onset and in established disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp62F0RUDGaUrVg90H21EOLACvtfcHk0lgQd8bvN_XaNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrrK&md5=922bf3cabf3d6ad57ebeb90c07def4c2</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1002%2Fart.27622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27622%26sid%3Dliteratum%253Aachs%26aulast%3DLeipe%26aufirst%3DJ.%26aulast%3DGrunke%26aufirst%3DM.%26aulast%3DDechant%26aufirst%3DC.%26aulast%3DReindl%26aufirst%3DC.%26aulast%3DKerzendorf%26aufirst%3DU.%26aulast%3DSchulze-Koops%26aufirst%3DH.%26aulast%3DSkapenko%26aufirst%3DA.%26atitle%3DRole%2520of%2520Th17%2520cells%2520in%2520human%2520autoimmune%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D2876%26epage%3D2885%26doi%3D10.1002%2Fart.27622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Souza-Moreira, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos-Salinas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Rey, E.</span><span> </span><span class="NLM_article-title">Neuropeptides as pleiotropic modulators of the immune response</span> <span class="citation_source-journal">Neuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1159/000328636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1159%2F000328636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21734355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yltbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2011&pages=89-100&author=L.+Souza-Moreiraauthor=J.+Campos-Salinasauthor=M.+Caroauthor=E.+Gonzalez-Rey&title=Neuropeptides+as+pleiotropic+modulators+of+the+immune+response&doi=10.1159%2F000328636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptides as pleiotropic modulators of the immune response</span></div><div class="casAuthors">Souza-Moreira, Luciana; Campos-Salinas, Jenny; Caro, Marta; Gonzalez-Rey, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Neuroendocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">NUNDAJ</span>;
        ISSN:<span class="NLM_cas:issn">0028-3835</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Although necessary to eliminate pathogens, inflammation can lead to serious deleterious effects in the host if left unchecked.  During the inflammatory response, further damage may arise from potential autoimmune responses occurring when the immune cells and mols. that respond to pathogen-derived antigens also react to self-antigens.  In this sense, the identification of endogenous factors that control exacerbated immune responses is a key goal for the development of new therapeutic approaches for inflammatory and autoimmune diseases.  Some neuropeptides that are produced during the ongoing inflammatory response have emerged as endogenous anti-inflammatory agents that could collaborate in tuning the balanced steady state of the immune system.  These neuropeptides participate in maintaining immune tolerance through two distinct mechanisms: by regulating the balance between pro-inflammatory and anti-inflammatory factors, and by inducing the emergence of regulatory T cells with suppressive activity against autoreactive T cell effectors.  Indeed, a functioning neuropeptide system contributes to general health, and alterations in the levels of these neuropeptides and/or their receptors lead to changes in susceptibility to inflammatory and autoimmune diseases.  Recently, we found that some neuropeptides also have antimicrobial and antiparasitic actions, suggesting that they could act as primary mediators of innate defense, even in the most primitive organisms.  In this review, we use the vasoactive intestinal peptide as example of an immunomodulatory neuropeptide to summarize the most relevant data found for other neuropeptides with similar characteristics, including adrenomedullin, urocortin, cortistatin and ghrelin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroOMkNxl3ofbVg90H21EOLACvtfcHk0lgQd8bvN_XaNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yltbzJ&md5=948602015c5ab1cda2af2c4b6f7c2ea8</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1159%2F000328636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000328636%26sid%3Dliteratum%253Aachs%26aulast%3DSouza-Moreira%26aufirst%3DL.%26aulast%3DCampos-Salinas%26aufirst%3DJ.%26aulast%3DCaro%26aufirst%3DM.%26aulast%3DGonzalez-Rey%26aufirst%3DE.%26atitle%3DNeuropeptides%2520as%2520pleiotropic%2520modulators%2520of%2520the%2520immune%2520response%26jtitle%3DNeuroendocrinology%26date%3D2011%26volume%3D94%26spage%3D89%26epage%3D100%26doi%3D10.1159%2F000328636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Delgado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganea, D.</span><span> </span><span class="NLM_article-title">Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents</span> <span class="citation_source-journal">Brain, Behav., Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span><span class="refDoi"> DOI: 10.1016/j.bbi.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bbi.2008.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1146-1151&author=M.+Delgadoauthor=D.+Ganea&title=Anti-inflammatory+neuropeptides%3A+a+new+class+of+endogenous+immunoregulatory+agents&doi=10.1016%2Fj.bbi.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DGanea%26aufirst%3DD.%26atitle%3DAnti-inflammatory%2520neuropeptides%253A%2520a%2520new%2520class%2520of%2520endogenous%2520immunoregulatory%2520agents%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2008%26volume%3D22%26spage%3D1146%26epage%3D1151%26doi%3D10.1016%2Fj.bbi.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Margheri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceruso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurenzana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzeri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annunziato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rosso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimaz, R.</span><span> </span><span class="NLM_article-title">Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1080/14756366.2016.1217857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1080%2F14756366.2016.1217857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=27539792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOmt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=60-63&author=F.+Margheriauthor=M.+Cerusoauthor=F.+Cartaauthor=A.+Laurenzanaauthor=L.+Maggiauthor=S.+Lazzeriauthor=G.+Simoniniauthor=F.+Annunziatoauthor=M.+Del+Rossoauthor=C.+T.+Supuranauthor=R.+Cimaz&title=Overexpression+of+the+transmembrane+carbonic+anhydrase+isoforms+IX+and+XII+in+the+inflamed+synovium&doi=10.1080%2F14756366.2016.1217857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium</span></div><div class="casAuthors">Margheri, Francesca; Ceruso, Mariangela; Carta, Fabrizio; Laurenzana, Anna; Maggi, Laura; Lazzeri, Simone; Simonini, Gabriele; Annunziato, Francesco; Del Rosso, Mario; Supuran, Claudiu T.; Cimaz, Rolando</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup4</span>),
    <span class="NLM_cas:pages">60-63</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Juvenile idiopathic arthritis (JIA) is the most common form of chronic rheumatic disease affecting children worldwide, with some features similar to adult rheumatoid arthritis (RA).  In the present study, we aim at investigating novel markers that will allow in the future for tailored, more personalized treatment strategies.  Hence, taking notice of several reports proving the role of local acidosis as a causal link between inflammatory diseases and related pain, and the involvement of several carbonic anhydrases (CA, EC 4.2.1.1) isoforms in articular diseases, we evaluated in JIA patients the expression of these metalloenzymes.  We identified that JIA patients show high levels of active CA IX and XII isoforms.  Our results represent the first evidence of the identification of these enzymes as potential therapeutic targets and development of novel innovative therapies for arthritis, also considering that the two isoforms are validated antitumor targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HZAqJSLZZLVg90H21EOLACvtfcHk0lgZlC47JM3uzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOmt7%252FI&md5=780b2ae6f9d02050c0c167e8cec91c8c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1217857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1217857%26sid%3Dliteratum%253Aachs%26aulast%3DMargheri%26aufirst%3DF.%26aulast%3DCeruso%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DLaurenzana%26aufirst%3DA.%26aulast%3DMaggi%26aufirst%3DL.%26aulast%3DLazzeri%26aufirst%3DS.%26aulast%3DSimonini%26aufirst%3DG.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DDel%2BRosso%26aufirst%3DM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCimaz%26aufirst%3DR.%26atitle%3DOverexpression%2520of%2520the%2520transmembrane%2520carbonic%2520anhydrase%2520isoforms%2520IX%2520and%2520XII%2520in%2520the%2520inflamed%2520synovium%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D60%26epage%3D63%26doi%3D10.1080%2F14756366.2016.1217857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Chang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span> </span><span class="NLM_article-title">Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis</span> <span class="citation_source-journal">BMC Musculoskeletal Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span><span class="refDoi"> DOI: 10.1186/1471-2474-11-279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1186%2F1471-2474-11-279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21143847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=279-290&author=X.+Changauthor=J.+Hanauthor=Y.+Zhaoauthor=X.+Yanauthor=S.+Sunauthor=Y.+Cui&title=Increased+expression+of+carbonic+anhydrase+I+in+the+synovium+of+patients+with+ankylosing+spondylitis&doi=10.1186%2F1471-2474-11-279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis</span></div><div class="casAuthors">Chang, Xiaotian; Han, Jinxiang; Zhao, Yan; Yan, Xinfeng; Shun, Shui; Cui, Yazhou</div><div class="citationInfo"><span class="NLM_cas:title">BMC Musculoskeletal Disorders</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279</span>CODEN:
                <span class="NLM_cas:coden">BMDMCE</span>;
        ISSN:<span class="NLM_cas:issn">1471-2474</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: One of the most distinctive features of ankylosing spondylitis (AS) is new bone formation and bone resorption at sites of chronic inflammation.  Previous studies have indicated that the hyperplasia and inflammation of synovial tissues are significantly related to the pathogenic process of AS.  The present study used a proteomic approach to identify novel AS-specific proteins by simultaneously comparing the expression profiles of synovial membranes from patients with AS, rheumatoid arthritis (RA) and osteoarthritis (OA).  Methods: Synovial tissues were collected from the hip joints of patients with AS and knee joints of patients with RA or OA (n = 10 for each disease) during joint replacement surgery.  Proteins extd. from the synovial tissues were sepd. by 2-D electrophoresis (2-DE), and the proteins with significantly increased expression in the AS samples were subjected to MALDI-TOF/TOF-MS anal.  The results were verified using western blotting and immunohistochem.  Levels of the candidate proteins in synovial fluids from knee joints (n = 40 for each disease) were measured using ELISA.  Results: The proteomic approach revealed significantly increased expression of carbonic anhydrase I (CA1) in the synovial membrane of patients with AS as compared with the RA and OA tissue samples.  Immunohistochem. and western blotting anal. confirmed the findings described above.  The ELISA detected a higher level of CA1 in synovial fluids from patients with AS than those with OA.  The mean value of the CA1 level was also higher in AS patients as compared with RA patients.  This study also detected increased expression of alpha-1-antitrypsin in the synovial tissues from AS patients, which is in agreement with other reports.  Conclusion: In vitro expts. by other groups indicated that CA1 catalyzes the generation of HCO3- through the hydration of CO2, which then combines with Ca2+ to form a CaCO3 ppt.  Calcification is an essential step of bone formation.  Substantial evidence indicates that carbonic anhydrase also stimulates bone resorption.  Hence, overexpression of CA1 in the synovial tissues of AS patients may promote improper calcification and bone resorption in AS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCHbyoabCvlrVg90H21EOLACvtfcHk0lgZlC47JM3uzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrjK&md5=3fe0aded3642803229d61d98ea2471d0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2F1471-2474-11-279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2474-11-279%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DY.%26atitle%3DIncreased%2520expression%2520of%2520carbonic%2520anhydrase%2520I%2520in%2520the%2520synovium%2520of%2520patients%2520with%2520ankylosing%2520spondylitis%26jtitle%3DBMC%2520Musculoskeletal%2520Disord.%26date%3D2010%26volume%3D11%26spage%3D279%26epage%3D290%26doi%3D10.1186%2F1471-2474-11-279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X.</span><span> </span><span class="NLM_article-title">Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction</span> <span class="citation_source-journal">BMC Musculoskeletal Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1186/1471-2474-13-256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1186%2F1471-2474-13-256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23256642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Oqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=256-265&author=Y.+Zhengauthor=L.+Wangauthor=W.+Zhangauthor=H.+Xuauthor=X.+Chang&title=Transgenic+mice+over-expressing+carbonic+anhydrase+I+showed+aggravated+joint+inflammation+and+tissue+destruction&doi=10.1186%2F1471-2474-13-256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction</span></div><div class="casAuthors">Zheng, Yabing; Wang, Lin; Zhang, Wei; Xu, Hengwei; Chang, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">BMC Musculoskeletal Disorders</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">256</span>CODEN:
                <span class="NLM_cas:coden">BMDMCE</span>;
        ISSN:<span class="NLM_cas:issn">1471-2474</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Studies have demonstrated that carbonic anhydrase I (CA1) stimulates calcium salt pptn. and cell calcification, which is an essential step in new bone formation.  Our study had reported that CA1 encoding gene has a strong assocn. with rheumatoid arthritis (RA) and ankylosing spondylitis (AS), two rheumatic diseases with abnormal new bone formation and bone resorption in joints.  This study investigated the effect of CA1 on joint inflammation and tissue destruction in transgenic mice that over-express CA1 (CA1-Tg).  Methods: CA1-Tg was generated with C57BL/6J mice by conventional methods.  CA1-Tg was treated with collagen-II to induce arthritis (CIA).  Wild-type mice, CA1-Tg treated with bovine serum albumin (BSA) and transgenic mice over-expressing PADI4 (PADI4-Tg), a gene known to be involved in rheumatoid arthritis, were used as controls.  Histochem. and X-ray radiog. assay were used to examine joint destruction.  Western blotting and real time-PCR were used to examine CA1 expression.  Results: CIA was obsd. in 60% of CA1-Tg, 20% of PADI4-Tg and 20% of wild-type mice after collagen injections.  No CIA was found in CA1-Tg mice that received injections of BSA.  The arthritic score was 5.5 ± 0.84 in the CA1-Tgs but the score was less than 2 in the injected wild-type mice and the PADI4-Tgs.  The thickness of the hind paws in the CA1-Tgs was 3.46 ± 0.11 mm, which was thicker than that of PADI4-Tgs (2.23 ± 0.08 mm), wild-type mice (2.08 ± 0.06 mm) and BSA-treated CA1-Tgs (2.04 ± 0.07 mm).  Histochem. showed obvious inflammation, synovial hyperplasia and bone destruction in the joints of CA1-Tg that was not detected in PADI4-Tgs or wild-type mice.  X-ray assays showed bone fusion in the paws and spines of CA1-Tg mice.  Conclusion: Over-expression of CA1 may aggravate joint inflammation and tissue destruction in the transgenic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBgR7O5Re0G7Vg90H21EOLACvtfcHk0lgZlC47JM3uzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Oqtrw%253D&md5=ccd41a8452b65cf7e8d510302ca8f44d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1471-2474-13-256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2474-13-256%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DX.%26atitle%3DTransgenic%2520mice%2520over-expressing%2520carbonic%2520anhydrase%2520I%2520showed%2520aggravated%2520joint%2520inflammation%2520and%2520tissue%2520destruction%26jtitle%3DBMC%2520Musculoskeletal%2520Disord.%26date%3D2012%26volume%3D13%26spage%3D256%26epage%3D265%26doi%3D10.1186%2F1471-2474-13-256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Deutsch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krief, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konttinen, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaks, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aframian, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmon, A.</span><span> </span><span class="NLM_article-title">Identification of Sjögren’s syndrome oral fluid biomarker candidates following high-abundance protein depletion</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1093/rheumatology/keu405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1093%2Frheumatology%2Fkeu405" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=884-890&author=O.+Deutschauthor=G.+Kriefauthor=Y.+T.+Konttinenauthor=B.+Zaksauthor=D.+T.+Wongauthor=D.+J.+Aframianauthor=A.+Palmon&title=Identification+of+Sj%C3%B6gren%E2%80%99s+syndrome+oral+fluid+biomarker+candidates+following+high-abundance+protein+depletion&doi=10.1093%2Frheumatology%2Fkeu405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkeu405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkeu405%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DO.%26aulast%3DKrief%26aufirst%3DG.%26aulast%3DKonttinen%26aufirst%3DY.%2BT.%26aulast%3DZaks%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DAframian%26aufirst%3DD.%2BJ.%26aulast%3DPalmon%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520Sj%25C3%25B6gren%25E2%2580%2599s%2520syndrome%2520oral%2520fluid%2520biomarker%2520candidates%2520following%2520high-abundance%2520protein%2520depletion%26jtitle%3DRheumatology%26date%3D2015%26volume%3D54%26spage%3D884%26epage%3D890%26doi%3D10.1093%2Frheumatology%2Fkeu405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span> </span><span class="NLM_article-title">Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure</span> <span class="citation_source-journal">Clin. Dev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">354594</span><span class="refDoi"> DOI: 10.1155/2012/354594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1155%2F2012%2F354594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23049597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FjslSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=354594&author=C.+Liuauthor=Y.+Weiauthor=J.+Wangauthor=L.+Piauthor=J.+Huangauthor=P.+Wang&title=Carbonic+anhydrases+III+and+IV+autoantibodies+in+rheumatoid+arthritis%2C+systemic+lupus+erythematosus%2C+diabetes%2C+hypertensive+renal+disease%2C+and+heart+failure&doi=10.1155%2F2012%2F354594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure</span></div><div class="casAuthors">Liu Chengeng; Wei Yue; Wang Jianmin; Pi Langan; Huang Jianjun; Wang Peichang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & developmental immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">354594</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In the present study, the CA III and IV autoantibodies, CA activity, antioxidant enzymes and cytokines in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), diabetes, hypertensive renal disease, and heart failure were investigated.  The anti-CA III antibody titers in patients with RA, SLE, and type 1 diabetes (T1D) were significantly higher than that in control groups (P < 0.05).  The anti-CA IV antibody titers in patients with RA, SLE, type 1 diabetic nephropathy (T1DN), and heart failure were significantly higher than that in control groups (P < 0.05) while anti-CA IV antibody could suppress the total CA activity.  The SOD and GPx levels in patients with RA, SLE, and T1DN were significantly lower than that in control groups (P < 0.05).  IL-6, IL-17, IFN-γ, and TNF-α levels were significantly higher in SLE group compared with the control group (P < 0.05).  Weak but significant correlations were found between anti-CA III antibodies and ESR in RA (r = 0.403, P = 0.013) and SLE patients (r = 0.397, P = 0.007).  These results suggested that the generation of CA III and IV autoantibodies, antioxidant enzymes, and cytokines might influence each other and CA autoantibodies might affect the normal physiology function of CA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMwJt9ij_06p6KlWarZTAzfW6udTcc2eZIOktuRndeMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FjslSksQ%253D%253D&md5=7b1a21e831746b620169ecc4b4b16211</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1155%2F2012%2F354594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F354594%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPi%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DCarbonic%2520anhydrases%2520III%2520and%2520IV%2520autoantibodies%2520in%2520rheumatoid%2520arthritis%252C%2520systemic%2520lupus%2520erythematosus%252C%2520diabetes%252C%2520hypertensive%2520renal%2520disease%252C%2520and%2520heart%2520failure%26jtitle%3DClin.%2520Dev.%2520Immunol.%26date%3D2012%26volume%3D2012%26spage%3D354594%26doi%3D10.1155%2F2012%2F354594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1038/nrd2467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1038%2Fnrd2467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=18167490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Khsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=168-181&author=C.+T.+Supuran&title=Carbonic+anhydrases%3A+novel+therapeutic+applications+for+inhibitors+and+activators&doi=10.1038%2Fnrd2467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-181</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are involved in numerous physiol. and pathol. processes, including gluconeogenesis, lipogenesis, ureagenesis, tumorigenicity and the growth and virulence of various pathogens.  In addn. to the established role of CA inhibitors (CAIs) as diuretics and antiglaucoma drugs, it has recently emerged that CAIs could have potential as novel antiobesity, anticancer and anti-infective drugs.  Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer's disease.  This article discusses the biol. rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases, and highlights progress in the development of specific modulators of the relevant CA isoforms, some of which are now being evaluated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8lavoPtcpPrVg90H21EOLACvtfcHk0lhEiERVn5qAlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Khsr0%253D&md5=f00fe348bbcf38048727c1283496cdfa</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2467%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrases%253A%2520novel%2520therapeutic%2520applications%2520for%2520inhibitors%2520and%2520activators%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D168%26epage%3D181%26doi%3D10.1038%2Fnrd2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">α-Carbonic anhydrases possess thioesterase activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span><span class="refDoi"> DOI: 10.1021/ml500470b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500470b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=292-295&author=M.+Tancauthor=F.+Cartaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=%CE%B1-Carbonic+anhydrases+possess+thioesterase+activity&doi=10.1021%2Fml500470b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fml500470b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500470b%26sid%3Dliteratum%253Aachs%26aulast%3DTanc%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3D%25CE%25B1-Carbonic%2520anhydrases%2520possess%2520thioesterase%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D292%26epage%3D295%26doi%3D10.1021%2Fml500470b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">How many carbonic anhydrase inhibition mechanisms exist?</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.3109/14756366.2015.1122001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2015.1122001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=26619898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=345-360&author=C.+T.+Supuran&title=How+many+carbonic+anhydrase+inhibition+mechanisms+exist%3F&doi=10.3109%2F14756366.2015.1122001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">How many carbonic anhydrase inhibition mechanisms exist?</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-360</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Six genetic families of the enzyme carbonic anhydrase (CA, EC 4.2.1.1) were described to date.  Inhibition of CAs has pharmacol. applications in the field of antiglaucoma, anticonvulsant, anticancer, and anti-infective agents.  New classes of CA inhibitors (CAIs) were described in the last decade with enzyme inhibition mechanisms differing considerably from the classical inhibitors of the sulfonamide or anion type.  Five different CA inhibition mechanisms are known: (i) the zinc binders coordinate to the catalytically crucial Zn(II) ion from the enzyme active site, with the metal in tetrahedral or trigonal bipyramidal geometries.  Sulfonamides and their isosters, most anions, dithiocarbamates and their isosters, carboxylates, and hydroxamates bind in this way; (ii) inhibitors that anchor to the zinc-coordinated water mol./hydroxide ion (phenols, carboxylates, polyamines, 2-thioxocoumarins, sulfocoumarins); (iii) inhibitors which occlude the entrance to the active site cavity (coumarins and their isosters), this binding site coinciding with that where CA activators bind; (iv) compds. which bind out of the active site cavity (a carboxylic acid deriv. was seen to inhibit CA in this manner), and (v) compds. for which the inhibition mechanism is not known, among which the secondary/tertiary sulfonamides as well as imatinib/nilotinib are the most investigated examples.  As CAIs are used clin. in many pathologies, with a sulfonamide inhibitor (SLC-0111) in Phase I clin. trials for the management of metastatic solid tumors, this review updates the recent findings in the field which may be useful for a structure-based drug design approach of more selective/potent modulators of the activity of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh8n13uOvB17Vg90H21EOLACvtfcHk0lhEiERVn5qAlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bE&md5=3f7f8071c39c4fbf59a8b71205ae973d</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.3109%2F14756366.2015.1122001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2015.1122001%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DHow%2520many%2520carbonic%2520anhydrase%2520inhibition%2520mechanisms%2520exist%253F%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D345%26epage%3D360%26doi%3D10.3109%2F14756366.2015.1122001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vullo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2182</span><span class="NLM_x">–</span> <span class="NLM_lpage">2185</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2012.01.129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2182-2185&author=F.+Cartaauthor=D.+Vulloauthor=A.+Marescaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=New+chemotypes+acting+as+isozyme-selective+carbonic+anhydrase+inhibitors+with+low+affinity+for+the+offtarget+cytosolic+isoform+II&doi=10.1016%2Fj.bmcl.2012.01.129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.129%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNew%2520chemotypes%2520acting%2520as%2520isozyme-selective%2520carbonic%2520anhydrase%2520inhibitors%2520with%2520low%2520affinity%2520for%2520the%2520offtarget%2520cytosolic%2520isoform%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2182%26epage%3D2185%26doi%3D10.1016%2Fj.bmcl.2012.01.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span> </span><span class="NLM_article-title">Antiobesity carbonic anhydrase inhibitors: a literature and patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span><span class="refDoi"> DOI: 10.1517/13543776.2013.790957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1517%2F13543776.2013.790957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23607332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=725-735&author=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Antiobesity+carbonic+anhydrase+inhibitors%3A+a+literature+and+patent+review&doi=10.1517%2F13543776.2013.790957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12eR"><div class="casContent"><span class="casTitleNuber">12e</span><div class="casTitle"><span class="NLM_cas:atitle">Antiobesity carbonic anhydrase inhibitors: a literature and patent review</span></div><div class="casAuthors">Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">725-735</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Obesity is ranked as one of the top 10 global health problems and the major concern deriving from it is the exposure of the population to a vast array of chronic pathologies such as cardiovascular and musculoskeletal disorders, type 2 diabetes, cancer, such as colon, breast and endometrial cancer, together with psychol. disorders derived from this condition.  The discovery that the clin. used anticonvulsants topiramate (TPM) and zonisamide (ZNS) induced wt. loss in obese, epileptic patients, afforded the validation of the mitochondrial carbonic anhydrases (CAs, EC 4.2.1.1) VA and VB as targets for the development of antiobesity drugs.Areas covered: This review deals with the scientific and patent literature regarding obesity or obesity-related pathologies, being particularly focused on the use of carbonic anhydrase inhibitors (CAI) such as TPM and ZNS which inhibit the de novo lipogenesis. Expert opinion: There is an urgent need of new drugs for the treatment of obesity.  The identification that the mitochondrial CAs are implicated in the de novo lipogenesis allowed to consider selective inhibitors of such enzymes as useful for the development of new antiobesity drugs.  Actually TPM was approved 1 yr ago for this therapy, whereas ZNS is also an effective such agent.  These compds. are the lead mols. in this field and an intense research is on the way in order to develop new compds. based on the selective inhibition of mitochondrial CA isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpV5LUSX76OrVg90H21EOLACvtfcHk0lhdWKeZlIOBMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtL4%253D&md5=52482234cea242b5564460a01575053f</span></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.790957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.790957%26sid%3Dliteratum%253Aachs%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DAntiobesity%2520carbonic%2520anhydrase%2520inhibitors%253A%2520a%2520literature%2520and%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D725%26epage%3D735%26doi%3D10.1517%2F13543776.2013.790957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Alterio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambrosio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span> </span><span class="NLM_article-title">Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">4421</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span><span class="refDoi"> DOI: 10.1021/cr200176r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200176r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=4421-4468&author=V.+Alterioauthor=A.+Di+Fioreauthor=K.+D%E2%80%99Ambrosioauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Multiple+binding+modes+of+inhibitors+to+carbonic+anhydrases%3A+how+to+design+specific+drugs+targeting+15+different+isoforms%3F&doi=10.1021%2Fcr200176r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12fR"><div class="casContent"><span class="casTitleNuber">12f</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?</span></div><div class="casAuthors">Alterio, Vincenzo; Di Fiore, Anna; D'Ambrosio, Katia; Supuran, Claudiu T.; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4421-4468</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this review is to provide an exhaustive description of the structural studies on α-CAs (carbonic anhydrases) so far reported.  In particular, the main structural features of the catalytically active α-CA isoenzymes characterized to date will be described and the current state of the art on complexes of hCA II with the principal classes of inhibitors will be summarized.  A comparison with the corresponding adducts of other isoforms, when available, will be also performed, in order to find for each isoform the key residues responsible for enzyme/inhibitor interaction.  Finally, recent advances in the field of drug design of selective CAIs will be illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA0GdtMHwlZ7Vg90H21EOLACvtfcHk0lhdWKeZlIOBMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D&md5=eb45ffb5efe07980f1388d99bf51406a</span></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1021%2Fcr200176r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200176r%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520inhibitors%2520to%2520carbonic%2520anhydrases%253A%2520how%2520to%2520design%2520specific%2520drugs%2520targeting%252015%2520different%2520isoforms%253F%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D4421%26epage%3D4468%26doi%3D10.1021%2Fcr200176r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Structure-based drug discovery of carbonic anhydrase inhibitors</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span><span class="refDoi"> DOI: 10.3109/14756366.2012.672983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2012.672983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=22468747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=759-772&author=C.+T.+Supuran&title=Structure-based+drug+discovery+of+carbonic+anhydrase+inhibitors&doi=10.3109%2F14756366.2012.672983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12gR"><div class="casContent"><span class="casTitleNuber">12g</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug discovery of carbonic anhydrase inhibitors</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">759-772</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibition of the metalloenzyme carbonic anhydrase (CA; EC 4.2.1.1) has pharmacol. applications in the field of anti-glaucoma, anti-convulsant and anti-cancer agents.  But recently, it has also emerged that these enzymes have the potential for designing anti-infective drugs (anti-fungal and anti-bacterial agents) with a novel mechanism of action.  Sulfonamides and their isosteres (sulfamates/sulfamides) constitute the main class of CA inhibitors (CAIs), which bind to the metal ion from the enzyme active site.  Recently, the dithiocarbamates (DTCs), possessing a similar mechanism of action, were reported as a new class of inhibitors.  These types of CAIs will be discussed in detail in this review.  Novel drug design strategies have been reported ultimately based on the tail approach for obtaining sulfonamides/DTCs, which exploit more external binding regions within the enzyme active site (in addn. to coordination to the metal ion), leading thus to isoform-selective compds.  Most of the promising data have been obtained by combining x-ray crystallog. of enzyme-inhibitor adducts with novel synthetic approaches for generating chem. diversity.  Whereas sulfonamide - NO donating hybrid drugs were reported as effective anti-glaucoma agents, most of the interesting new inhibitors were designed for inhibiting specifically the tumor-assocd. isoforms CA IX and XII, validated targets for imaging and treatment of hypoxic tumors.  Promising compds. that inhibit CAs from bacterial and fungal pathogens, of the DTC and carboxylate types, will be also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsmAtcxdWfHbVg90H21EOLACvtfcHk0li0NqycNV9Cqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgtL7N&md5=55a993be904b13c63eb52b9d0229e187</span></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=10.3109%2F14756366.2012.672983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2012.672983%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DStructure-based%2520drug%2520discovery%2520of%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2012%26volume%3D27%26spage%3D759%26epage%3D772%26doi%3D10.3109%2F14756366.2012.672983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Farr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, P. A.</span><span> </span><span class="NLM_article-title">Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis</span> <span class="citation_source-journal">Clin. Exp. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=4017318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADyaL2M3lsFOgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=99-104&author=M.+Farrauthor=K.+Garveyauthor=A.+M.+Boldauthor=M.+J.+Kendallauthor=P.+A.+Bacon&title=Significance+of+the+hydrogen+ion+concentration+in+synovial+fluid+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis</span></div><div class="casAuthors">Farr M; Garvey K; Bold A M; Kendall M J; Bacon P A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental rheumatology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-104</span>
        ISSN:<span class="NLM_cas:issn">0392-856X</span>.
    </div><div class="casAbstract">The hydrogen ion (H+) concentration and pCO2 were measured in the synovial fluid (SF) from the knee joints of 130 patients with arthritis by an acid-base analyser (ABL2 Acid-Base Laboratory), using a simple technique which prevented contact with air.  H+ concentration was significantly higher in SF from 60 RA patients (mean 64.4 n mol/l; range 38-142 n mol/l) compared with patients with OA (mean 44 n mol/l; range 29-56 n mol/l), and 40 with other arthritides (mean 52 n mol/l).  The H+ concentration in the SF showed a significant association with other variables of local inflammation-platelet, total leucocyte and polymorph counts, 5-nucleotidase, acid phosphatase and IgA levels in the SF and the clinical knee score, but not with the volume of the effusion.  A similar relationship between these variables of inflammatory activity and SF pCO2 was also established.  A higher SF H+ concentration was also found in systemically active disease, but no difference in SF pH between seropositive and seronegative patients.  Whilst the pH of SF approximated to that of the blood in OA, it was significantly lower in the SF in RA.  SF pH is a useful marker of local inflammatory activity, and its measurement is simple, reliable and rapid.  It is relevant because changes in pH influence many of the processes involved in inflammation and the pH difference between SF and blood influences the transfer of drugs into the joint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWQDsjjJW6DkQ0lWbKiCflfW6udTcc2ebxOVUEJpjvRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3lsFOgsQ%253D%253D&md5=85e9c6f8a2d7772871e0368759fcadb5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarr%26aufirst%3DM.%26aulast%3DGarvey%26aufirst%3DK.%26aulast%3DBold%26aufirst%3DA.%2BM.%26aulast%3DKendall%26aufirst%3DM.%2BJ.%26aulast%3DBacon%26aufirst%3DP.%2BA.%26atitle%3DSignificance%2520of%2520the%2520hydrogen%2520ion%2520concentration%2520in%2520synovial%2520fluid%2520in%2520rheumatoid%2520arthritis%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D1985%26volume%3D3%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Steen, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeh, P. W.</span><span> </span><span class="NLM_article-title">A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1523%2FJNEUROSCI.15-05-03982.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=7751959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADyaK2MXls1aisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=3982-3989&author=K.+H.+Steenauthor=A.+E.+Steenauthor=P.+W.+Reeh&title=A+dominant+role+of+acid+pH+in+inflammatory+excitation+and+sensitization+of+nociceptors+in+rat+skin%2C+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro</span></div><div class="casAuthors">Steen, Kay H.; Steen, Astrid E.; Reeh, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5, Pt. 2</span>),
    <span class="NLM_cas:pages">3982-9</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A major role of local acidosis in long lasting excitation and sensitization of cutaneous nociceptors has recently been demonstrated.  In inflamed tissue, acid pH meets with a mixt. of inflammatory mediators which, by themselves, stimulate nociceptors though being subject to profound tachyphylaxis.  We have mimicked this condition in a rat skin-saphenous nerve prepn. in vitro which allows direct application of chems. to the isolated receptive fields at the corium side.  Stimulant solns. used were CO2-satd. "synthetic interstitial fluid" (CO2-SIF, pH 6.1), an "inflammatory soup" (IS) in submaximal concn. contg. bradykinin, 5-HT, histamine, prostaglandin E2 (all 10-6M in SIF at 38.5° and pH 7.0), and a combination made of CO2-satd. IS (CO2-IS, pH 6.1).  Identified mechano-heat sensitive ("polymodal") C-fiber terminals (n = 36) were treated with these solns. for 5 min at 10 min intervals or for 30 min of sustained stimulation: 20 units responded to CO2-SIF, 12 to IS, whereas 27 units (75%) were excited by CO2-IS.  Thus, 6 out of 15 units insensitive to either of the two basic solns. were stimulated by their combination.  This enhanced effect of CO2-IS was also expressed in shorter latencies (than with CO2-SIF) and in a significantly larger mean response magnitude of the fiber population: 152 spikes with the combination vs. 45 spikes evoked by IS and 93 spikes by CO2-SIF (n = 25; p < 0.002 and < 0.02, resp., Wilcoxon test).  The synergistic interaction between CO2 and IS also showed up during sustained nociceptor stimulation (30 min) by either CO2SIF (n = 7) or IS (n = 1) when, during the middle 10 min, CO2-IS was applied which significantly increased the discharge.  There is a strong, potentially algogenic, interaction between acid pH and inflammatory mediators in terms of prevalence and magnitude of nociceptor excitation.  At equal and pathophysiol. relevant concn., however, hydrogen ions play a dominant role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8eLXfegRJPLVg90H21EOLACvtfcHk0li0NqycNV9Cqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls1aisbs%253D&md5=35d850f5272831214c9af2aa43859320</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.15-05-03982.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.15-05-03982.1995%26sid%3Dliteratum%253Aachs%26aulast%3DSteen%26aufirst%3DK.%2BH.%26aulast%3DSteen%26aufirst%3DA.%2BE.%26aulast%3DReeh%26aufirst%3DP.%2BW.%26atitle%3DA%2520dominant%2520role%2520of%2520acid%2520pH%2520in%2520inflammatory%2520excitation%2520and%2520sensitization%2520of%2520nociceptors%2520in%2520rat%2520skin%252C%2520in%2520vitro%26jtitle%3DJ.%2520Neurosci.%26date%3D1995%26volume%3D15%26spage%3D3982%26epage%3D3989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Lardner, A.</span><span> </span><span class="NLM_article-title">The effects of extracellular pH on immune function</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=11310837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=522-530&author=A.+Lardner&title=The+effects+of+extracellular+pH+on+immune+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of extracellular pH on immune function</span></div><div class="casAuthors">Lardner, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">522-530</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 80 refs.  The effect of alterations in extracellular pH on cellular and humoral immune function is reviewed.  Because acidic pH predominates at inflammatory loci and other sites of immune activity, most studies to date focus on the effect of acidic rather than alk. pH.  Investigations on polymorphonuclear leukocytes demonstrate mainly inhibition of chemotaxis, respiratory activity, and bactericidal capacity at reduced pH.  Evidence of impaired lymphocyte cytotoxicity and proliferation at acidic pH is also beginning to emerge.  Many of the clin. acidosis are accompanied similarly by immunodeficiency.  Studies on macrophages and eosinophils are few and inconclusive.  A small no. of studies demonstrate acid-induced activation of complement proteins and the alternative complement pathway, plus increased antibody-binding to leukocytes at lowered pH.  A differential effect of acidic pH on humoral and cellular immunity may, therefore, exist.  Increasing recognition of the significance of extracellular pH in relation to immune function warrants further studies in this presently incomplete but rewarding field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi8Hr7d3nZXbVg90H21EOLACvtfcHk0li0NqycNV9Cqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVagurs%253D&md5=86f05548986270622e403e359f0f2422</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLardner%26aufirst%3DA.%26atitle%3DThe%2520effects%2520of%2520extracellular%2520pH%2520on%2520immune%2520function%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2001%26volume%3D69%26spage%3D522%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Crofford, L. J.</span><span> </span><span class="NLM_article-title">Use of NSAIDs in treating patients with arthritis</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S2</span><span class="refDoi"> DOI: 10.1186/ar4174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1186%2Far4174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=24267197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=S2&issue=Suppl.+3&author=L.+J.+Crofford&title=Use+of+NSAIDs+in+treating+patients+with+arthritis&doi=10.1186%2Far4174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Use of NSAIDs in treating patients with arthritis</span></div><div class="casAuthors">Crofford, Leslie J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S2/1-S2/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Patients with rheumatic diseases, including rheumatoid arthritis and osteoarthritis, almost universally describe pain and stiffness as important contributors to reduced health-related quality of life.  Of the treatment options available, NSAIDs are the most widely used agents for symptomatic treatment.  NSAIDs are effective anti-inflammatory and analgesic drugs by virtue of their ability to inhibit biosynthesis of prostaglandins at the level of the cyclooxygenase enzyme.  However, many of the adverse effects of NSAIDs are also related to inhibition of prostaglandin prodn., making their use problematic in some patient populations.  For the clinician, understanding the biol. of prostaglandin as it relates to gastrointestinal, renal and cardiovascular physiol. and the pharmacol. properties of specific NSAIDs is key to using these drugs safely.  Of particular importance is the recognition of co-morbid conditions and concomitant drugs that may increase the risk of NSAIDs in particular patients.  In patients with risk factors for NSAID toxicity, using the lowest dose of a drug with a short half-life only when it is needed is likely to be the safest treatment option.  For those patients whose symptoms cannot be managed with intermittent treatment, using protective strategies is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5mE_VnWwGBbVg90H21EOLACvtfcHk0lhPxKjrOpWIlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWiuro%253D&md5=b4bc116857f63677befd0520c9c9d400</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Far4174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far4174%26sid%3Dliteratum%253Aachs%26aulast%3DCrofford%26aufirst%3DL.%2BJ.%26atitle%3DUse%2520of%2520NSAIDs%2520in%2520treating%2520patients%2520with%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2013%26volume%3D15%26issue%3DSuppl.%25203%26spage%3DS2%26doi%3D10.1186%2Far4174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">3057</span><span class="NLM_x">–</span> <span class="NLM_lpage">3062</span><span class="refDoi"> DOI: 10.1021/ja809683v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja809683v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=3057-3062&author=A.+Marescaauthor=C.+Temperiniauthor=H.+Vuauthor=N.+B.+Phamauthor=S.+A.+Poulsenauthor=A.+Scozzafavaauthor=R.+J.+Quinnauthor=C.+T.+Supuran&title=Non-zinc+mediated+inhibition+of+carbonic+anhydrases%3A+coumarins+are+a+new+class+of+suicide+inhibitors&doi=10.1021%2Fja809683v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors</span></div><div class="casAuthors">Maresca, Alfonso; Temperini, Claudia; Vu, Hoan; Pham, Ngoc B.; Poulsen, Sally-Ann; Scozzafava, Andrea; Quinn, Ronald J.; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3057-3062</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The x-ray crystal structure of the adduct between the zinc metalloenzyme carbonic anhydrase II (CA, E.C. 4.2.1.1) with the recently discovered natural product coumarin deriv. 6-(1S-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one showed the coumarin hydrolysis product, a cis-2-hydroxy-cinnamic acid deriv., and not the parent coumarin, bound within the enzyme active site.  The bound inhibitor exhibits an extended, two-arm conformation that effectively plugs the entrance to the enzyme active site with no interactions with the catalytically crucial zinc ion.  The inhibitor is sandwiched between Phe131, with which it makes an edge-to-face stacking, and Asn67/Glu238sym, with which it makes several polar and hydrogen bonding interactions.  This unusual binding mode, with no interactions between the inhibitor mol. and the active site metal ion is previously unobserved for this enzyme class and presents a new opportunity for future drug design campaigns to target a mode of inhibition that differs substantially from classical inhibitors such as the clin. used sulfonamides and sulfamates.  Several structurally simple coumarin scaffolds were also shown to inhibit all 13 catalytically active mammalian CA isoforms, with inhibition consts. ranging from nanomolar to millimolar.  The inhibition is time dependent, with max. inhibition being obsd. after 6 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jUFnGCNktbVg90H21EOLACvtfcHk0lhPxKjrOpWIlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCgtrc%253D&md5=dfec471d2bade2177549dedebfd33808</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fja809683v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja809683v%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DTemperini%26aufirst%3DC.%26aulast%3DVu%26aufirst%3DH.%26aulast%3DPham%26aufirst%3DN.%2BB.%26aulast%3DPoulsen%26aufirst%3DS.%2BA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNon-zinc%2520mediated%2520inhibition%2520of%2520carbonic%2520anhydrases%253A%2520coumarins%2520are%2520a%2520new%2520class%2520of%2520suicide%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D3057%26epage%3D3062%26doi%3D10.1021%2Fja809683v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pochet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1021/jm901287j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901287j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWhtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=335-344&author=A.+Marescaauthor=C.+Temperiniauthor=L.+Pochetauthor=B.+Masereelauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Deciphering+the+mechanism+of+carbonic+anhydrase+inhibition+with+coumarins+and+thiocoumarins&doi=10.1021%2Fjm901287j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins</span></div><div class="casAuthors">Maresca, Alfonso; Temperini, Claudia; Pochet, Lionel; Masereel, Bernard; Scozzafava, Andrea; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">335-344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coumarin derivs. were recently shown to constitute a totally new class of inhibitors of the zinc metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1), being hydrolyzed within the CA active site to 2-hydroxycinnamic acids.  We explore here a new series of variously substituted coumarins and a thiocoumarin for their interaction with 13 mammalian CA isoforms, detecting low nanomolar and isoform selective inhibitors.  The mechanism of action of this class of inhibitors is delineated in detail by resolving the X-ray crystal structure of CA II in complex with trans-2-hydroxy-cinnamic acid, the in situ hydrolysis product of simple coumarin.  Thiocoumarins also act as efficient CAIs, similarly to coumarins.  The versatility of the (thio)coumarin chem., the cis-trans isomerization evidenced here, and easy derivatization of the (thio)coumarin rings, coupled with the nanomolar inhibition range of several isoenzymes, afford isoform-selective CAIs with various biomedical applications, which render these classes of compds. superior to the clin. used sulfonamides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFIEKoRM8VErVg90H21EOLACvtfcHk0lhPxKjrOpWIlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWhtrrP&md5=10282540175101bb94a3fc7d841055a1</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm901287j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901287j%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DTemperini%26aufirst%3DC.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DDeciphering%2520the%2520mechanism%2520of%2520carbonic%2520anhydrase%2520inhibition%2520with%2520coumarins%2520and%2520thiocoumarins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D335%26epage%3D344%26doi%3D10.1021%2Fjm901287j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ferraroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01720</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01720" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=462-473&author=M.+Ferraroniauthor=F.+Cartaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Thioxocoumarins+show+an+alternative+carbonic+anhydrase+inhibition+mechanism+compared+to+coumarins&doi=10.1021%2Facs.jmedchem.5b01720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins</span></div><div class="casAuthors">Ferraroni, Marta; Carta, Fabrizio; Scozzafava, Andrea; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">462-473</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of coumarins and the corresponding 2-thioxocoumarines were prepd. and tested for their inhibition profiles against four physiol. relevant human carbonic anhydrases (hCAs, EC 4.2.1.1), isoforms hCA I, II, IX, and XII.  The X-ray crystal structure of 6-hydroxy-2-thioxocoumarin bound to hCA II revealed an unprecedented and unexpected inhibition mechanism for this new class of inhibitors when compared to isostructural coumarins.  Unlike coumarins which are hydrolyzed by the esterase CA activity to the corresponding 2-hydroxy-cinnamic acid derivs., the 2-thioxocoumarin was obsd. intact when bound to hCA II, with its exo-sulfur atom anchored to the zinc-coordinated water mol., whereas the scaffold establishing favorable contacts with amino acid residues from the active site.  This inhibition mechanism is very different from the one obsd. for hydrolyzed coumarins, which occlude the entrance of the active site cavity.  This versatility in the binding mode of coumarins/thioxocoumarins has important consequences for the design of isoform-selective CA inhibitors, some of which are in clin. use or clin. development for various pathologies, among which glaucoma, edema, epilepsy, neuropathic pain, and hypoxic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplbMRXrFgfp7Vg90H21EOLACvtfcHk0lg_3U6G8w2Q0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7rE&md5=dade9ac32a35bfe4a7f640dac26c9f03</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01720%26sid%3Dliteratum%253Aachs%26aulast%3DFerraroni%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DThioxocoumarins%2520show%2520an%2520alternative%2520carbonic%2520anhydrase%2520inhibition%2520mechanism%2520compared%2520to%2520coumarins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D462%26epage%3D473%26doi%3D10.1021%2Facs.jmedchem.5b01720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Touisni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Glycosylcumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8271</span><span class="NLM_x">–</span> <span class="NLM_lpage">8277</span><span class="refDoi"> DOI: 10.1021/jm200983e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200983e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8271-8277&author=N.+Touisniauthor=A.+Marescaauthor=P.+C.+McDonaldauthor=Y.+Louauthor=A.+Scozzafavaauthor=S.+Dedharauthor=J.-Y.+Winumauthor=C.+T.+Supuran&title=Glycosylcumarin+carbonic+anhydrase+IX+and+XII+inhibitors+strongly+attenuate+the+growth+of+primary+breast+tumors&doi=10.1021%2Fjm200983e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Fjm200983e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200983e%26sid%3Dliteratum%253Aachs%26aulast%3DTouisni%26aufirst%3DN.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DP.%2BC.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DDedhar%26aufirst%3DS.%26aulast%3DWinum%26aufirst%3DJ.-Y.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DGlycosylcumarin%2520carbonic%2520anhydrase%2520IX%2520and%2520XII%2520inhibitors%2520strongly%2520attenuate%2520the%2520growth%2520of%2520primary%2520breast%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8271%26epage%3D8277%26doi%3D10.1021%2Fjm200983e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bonneau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.3109/14756366.2011.650692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2011.650692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=22299576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC38vhvVWmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=397-401&author=A.+Bonneauauthor=A.+Marescaauthor=J.+Y.+Winumauthor=C.+T.+Supuran&title=Metronidazole-coumarin+conjugates+and+3-cyano-7-hydroxy-coumarin+act+as+isoform-selective+carbonic+anhydrase+inhibitors&doi=10.3109%2F14756366.2011.650692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors</span></div><div class="casAuthors">Bonneau Adeline; Maresca Alfonso; Winum Jean-Yves; Supuran Claudiu T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of enzyme inhibition and medicinal chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">397-401</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reaction of 6-/7-hydroxycoumarin with metronidazole afforded conjugates which incorporate two interesting chemotypes which may inhibit carbonic anhydrases (CAs, EC 4.2.1.1) due to the presence of the coumarin moiety and possess radiosensitizing effects due to the presence of the nitroazole.  Another dual action compound, which may act both as CA inhibitor as well as monocarboxylate transporter inhibitor, is 3-cyano-7-hydroxy-coumarin.  These compounds have been investigated as inhibitors of 11 human CA isoforms.  Submicromolar inhibition was observed against hCA VA, hCA VB, hCA VI, hCA VII, hCA IX, hCA XII and hCA XIV, whereas isoforms hCA I, II and XIII were not inhibited by these compounds.  These coumarins thus act as isoform-selective CA inhibitors with the possibility to target isoforms involved in pathologies such as obesity (CA VA/VB) or cancer (CA IX and XII) without inhibiting the physiologically dominant, highly abundant hCA I and II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6507i8s2belUIs6wFK5xJfW6udTcc2ebIuuJkl856ubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vhvVWmtg%253D%253D&md5=b33d67e750820e963bed42c987fa4738</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.3109%2F14756366.2011.650692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2011.650692%26sid%3Dliteratum%253Aachs%26aulast%3DBonneau%26aufirst%3DA.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DMetronidazole-coumarin%2520conjugates%2520and%25203-cyano-7-hydroxy-coumarin%2520act%2520as%2520isoform-selective%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26spage%3D397%26epage%3D401%26doi%3D10.3109%2F14756366.2011.650692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Sharma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.3109/14756366.2013.777334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2013.777334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23488741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVSmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=292-296&author=A.+Sharmaauthor=M.+Tiwariauthor=C.+T.+Supuran&title=Novel+coumarins+and+benzocoumarins+acting+as+isoform-selective+inhibitors+against+the+tumor-associated+carbonic+anhydrase+IX&doi=10.3109%2F14756366.2013.777334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17fR"><div class="casContent"><span class="casTitleNuber">17f</span><div class="casTitle"><span class="NLM_cas:atitle">Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX</span></div><div class="casAuthors">Sharma, Aditi; Tiwari, Meena; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">292-296</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of coumarins and benzocoumarins incorporating Me and hydroxyl moieties in the heterocyclic ring were investigated for the inhibition of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1).  These coumarins were very weak or ineffective as inhibitors of the house-keeping, offtarget isoforms CA I and II, but showed effective, submicromolar inhibition of the transmembrane, tumor-assocd. isoforms CA IX and to a slightly less extent, CA XII.  The nature and position of the groups substituting the coumarin ring influenced CA inhibitory properties. 4-Methyl-5,7-dihydroydroxycoumarin showed KIs >200 μM against CA I and II, of 0.19 μM against CA IX and of 6.4 μM against CA XII, being thus a selective, efficient inhibitor for the tumor-assocd. over cytosolic CA isoforms.  These compds. are interesting leads for designing isoform-selective enzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8OlpnmvNMKrVg90H21EOLACvtfcHk0lg_3U6G8w2Q0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVSmtb4%253D&md5=9994867a241b31b5c5fe9e63f5e13eb0</span></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=10.3109%2F14756366.2013.777334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2013.777334%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DTiwari%26aufirst%3DM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNovel%2520coumarins%2520and%2520benzocoumarins%2520acting%2520as%2520isoform-selective%2520inhibitors%2520against%2520the%2520tumor-associated%2520carbonic%2520anhydrase%2520IX%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2014%26volume%3D29%26spage%3D292%26epage%3D296%26doi%3D10.3109%2F14756366.2013.777334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7258</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2010.10.094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7255-7258&author=A.+Marescaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=7%2C8-Disubstituted-+but+not+6%2C7-disubstituted+coumarins+selectively+inhibit+the+transmembrane%2C+tumor-associated+carbonic+anhydrase+isoforms+IX+and+XII+over+the+cytosolic+ones&doi=10.1016%2Fj.bmcl.2010.10.094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.094%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3D7%252C8-Disubstituted-%2520but%2520not%25206%252C7-disubstituted%2520coumarins%2520selectively%2520inhibit%2520the%2520transmembrane%252C%2520tumor-associated%2520carbonic%2520anhydrase%2520isoforms%2520IX%2520and%2520XII%2520over%2520the%2520cytosolic%2520ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7255%26epage%3D7258%26doi%3D10.1016%2Fj.bmcl.2010.10.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4511</span><span class="NLM_x">–</span> <span class="NLM_lpage">4514</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2010.06.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4511-4514&author=A.+Marescaauthor=C.+T.+Supuran&title=Coumarins+incorporating+hydroxy-+and+chloro-moieties+selectively+inhibit+the+transmembrane%2C+tumor-associated+carbonic+anhydrase+isoforms+IX+and+XII+over+the+cytosolic+ones+I+and+II&doi=10.1016%2Fj.bmcl.2010.06.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.040%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCoumarins%2520incorporating%2520hydroxy-%2520and%2520chloro-moieties%2520selectively%2520inhibit%2520the%2520transmembrane%252C%2520tumor-associated%2520carbonic%2520anhydrase%2520isoforms%2520IX%2520and%2520XII%2520over%2520the%2520cytosolic%2520ones%2520I%2520and%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4511%26epage%3D4514%26doi%3D10.1016%2Fj.bmcl.2010.06.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bozdag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alafeefy, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamimi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vullo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.11.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmc.2016.11.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=677-683&issue=2&author=M.+Bozdagauthor=A.+M.+Alafeefyauthor=A.+M.+Altamimiauthor=D.+Vulloauthor=F.+Cartaauthor=C.+T.+Supuran&title=Coumarins+and+other+fused+bicyclic+heterocycles+with+selective+tumor-associated+carbonic+anhydrase+isoforms+inhibitory+activity&doi=10.1016%2Fj.bmc.2016.11.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.11.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.11.039%26sid%3Dliteratum%253Aachs%26aulast%3DBozdag%26aufirst%3DM.%26aulast%3DAlafeefy%26aufirst%3DA.%2BM.%26aulast%3DAltamimi%26aufirst%3DA.%2BM.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCoumarins%2520and%2520other%2520fused%2520bicyclic%2520heterocycles%2520with%2520selective%2520tumor-associated%2520carbonic%2520anhydrase%2520isoforms%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D2%26spage%3D677%26epage%3D683%26doi%3D10.1016%2Fj.bmc.2016.11.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastrolorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span> </span><span class="NLM_article-title">COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span><span class="refDoi"> DOI: 10.2174/1389557043403792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.2174%2F1389557043403792" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=625-632&author=C.+T.+Supuranauthor=A.+Casiniauthor=A.+Mastrolorenzoauthor=A.+Scozzafava&title=COX-2+selective+inhibitors%2C+carbonic+anhydrase+inhibition+and+anticancer+properties+of+sulfonamides+belonging+to+this+class+of+pharmacological+agents&doi=10.2174%2F1389557043403792"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.2174%2F1389557043403792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557043403792%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DMastrolorenzo%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26atitle%3DCOX-2%2520selective%2520inhibitors%252C%2520carbonic%2520anhydrase%2520inhibition%2520and%2520anticancer%2520properties%2520of%2520sulfonamides%2520belonging%2520to%2520this%2520class%2520of%2520pharmacological%2520agents%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D625%26epage%3D632%26doi%3D10.2174%2F1389557043403792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Khalifah, R. G.</span><span> </span><span class="NLM_article-title">The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">2561</span><span class="NLM_x">–</span> <span class="NLM_lpage">2573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2FS0021-9258%2818%2962326-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=4994926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1971&pages=2561-2573&author=R.+G.+Khalifah&title=The+carbon+dioxide+hydration+activity+of+carbonic+anhydrase.+I.+Stop-flow+kinetic+studies+on+the+native+human+isoenzymes+B+and+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon dioxide hydration activity of carbonic anhydrase.  I.  Stop-flow kinetic studies on the native human isoenzymes B and C</span></div><div class="casAuthors">Khalifah, Raja G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2561-73</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The kinetics of catalysis of carbon dioxide hydration by human carbonic anhydrases B and C (EC 4.2.1.1) has been reinvestigated with the use of an improved pH indicator stop-flow approach that was checked by studying the uncatalyzed rate of hydration, with Michaelis-Menten parameters being detd. between pH 5.8 and 8.8 in noninhibitory buffers.  For both isoenzymes, Km was independent of pH, whereas Vmax increased with increasing pH with results being similar to the finding of others on bovine carbonic anhydrase, but differing from earlier reports of Gibbons and Edsall (1964) in the finding that Km was pH-independent.  Despite the differences between the low and high activity forms of the enzyme, there were close kinetic similarities between them that indicated underlying similarities in active site structure.  Imidazole (I) (0.22-1.32M) inhibited the B enzyme, apparently competitively, and had no effect on the C enzyme.  N-Methyl substitution of I abolished its inhibitory effect.  Nitrous oxide (11-45mM) did not inhibit catalysis of carbon dioxide hydration by either of the 2 human isoenzymes, or by bovine carbonic anhydrase.  The enzyme-catalyzed hydration of carbon dioxide probably requires not only water activation by a basic group, but also charge neutralization in the transition state by an electron acceptor function.  The zinc-bound water in carbonic anhydrase could be involved in both donor and acceptor roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri57EkpgPMx7Vg90H21EOLACvtfcHk0liQi49MwqNFJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D&md5=2764970fcd4f08250b28b9e8e9474681</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2962326-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252962326-9%26sid%3Dliteratum%253Aachs%26aulast%3DKhalifah%26aufirst%3DR.%2BG.%26atitle%3DThe%2520carbon%2520dioxide%2520hydration%2520activity%2520of%2520carbonic%2520anhydrase.%2520I.%2520Stop-flow%2520kinetic%2520studies%2520on%2520the%2520native%2520human%2520isoenzymes%2520B%2520and%2520C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1971%26volume%3D246%26spage%3D2561%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Di Cesare Mannelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calosi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carossino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtancoli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Failli, P.</span><span> </span><span class="NLM_article-title">Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats</span> <span class="citation_source-journal">Mediators Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">905360</span><span class="refDoi"> DOI: 10.1155/2013/905360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1155%2F2013%2F905360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23861563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3sfhtleltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=905360&author=L.+Di+Cesare+Mannelliauthor=D.+Baniauthor=A.+Benciniauthor=M.+L.+Brandiauthor=L.+Calosiauthor=M.+Cantoreauthor=A.+M.+Carossinoauthor=C.+Ghelardiniauthor=B.+Valtancoliauthor=P.+Failli&title=Therapeutic+effects+of+the+superoxide+dismutase+mimetic+compound+MnIIMe2DO2A+on+experimental+articular+pain+in+rats&doi=10.1155%2F2013%2F905360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats</span></div><div class="casAuthors">Di Cesare Mannelli Lorenzo; Bani Daniele; Bencini Andrea; Brandi Maria Luisa; Calosi Laura; Cantore Miriam; Carossino Anna Maria; Ghelardini Carla; Valtancoli Barbara; Failli Paola</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">905360</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Superoxide anion (O(2) (•-)) is overproduced in joint inflammation, rheumatoid arthritis, and osteoarthritis.  Increased O(2) (•-) production leads to tissue damage, articular degeneration, and pain.  In these conditions, the physiological defense against O(2) (•-), superoxide dismutases (SOD) are decreased.  The Mn(II) complex MnL4 is a potent SOD mimetic, and in this study it was tested in inflammatory and osteoarticular rat pain models.  In vivo protocols were approved by the animal Ethical Committee of the University of Florence.  Pain was measured by paw pressure and hind limb weight bearing alterations tests.  MnL4 (15 mg kg(-1)) acutely administered, significantly reduced pain induced by carrageenan, complete Freund's adjuvant (CFA), and sodium monoiodoacetate (MIA).  In CFA and MIA protocols, it ameliorated the alteration of postural equilibrium.  When administered by osmotic pump in the MIA osteoarthritis, MnL4 reduced pain, articular derangement, plasma TNF alpha levels, and protein carbonylation.  The scaffold ring was ineffective.  MnL4 (10(-7) M) prevented the lipid peroxidation of isolated human chondrocytes when O(2) (•-) was produced by RAW 264.7.  MnL4 behaves as a potent pain reliever in acute inflammatory and chronic articular pain, being its efficacy related to antioxidant property.  Therefore MnL4 appears as a novel protective compound potentially suitable for the treatment of joint diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRcle_nAtSdN4McDoIzZtNkfW6udTcc2ea5Nb-J3Zdi67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfhtleltQ%253D%253D&md5=27844eb625538d174767e71a08a6f4ac</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1155%2F2013%2F905360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F905360%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DBani%26aufirst%3DD.%26aulast%3DBencini%26aufirst%3DA.%26aulast%3DBrandi%26aufirst%3DM.%2BL.%26aulast%3DCalosi%26aufirst%3DL.%26aulast%3DCantore%26aufirst%3DM.%26aulast%3DCarossino%26aufirst%3DA.%2BM.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DValtancoli%26aufirst%3DB.%26aulast%3DFailli%26aufirst%3DP.%26atitle%3DTherapeutic%2520effects%2520of%2520the%2520superoxide%2520dismutase%2520mimetic%2520compound%2520MnIIMe2DO2A%2520on%2520experimental%2520articular%2520pain%2520in%2520rats%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D905360%26doi%3D10.1155%2F2013%2F905360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mishra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazari, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, A. K.</span><span> </span><span class="NLM_article-title">In vitro and in vivo evaluation of 99mTc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors</span> <span class="citation_source-journal">J. Drug Target.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span><span class="refDoi"> DOI: 10.3109/1061186X.2011.561857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F1061186X.2011.561857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21425922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaisLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=761-769&author=G.+Mishraauthor=P.+P.+Hazariauthor=N.+Kumarauthor=A.+K.+Mishra&title=In+vitro+and+in+vivo+evaluation+of+99mTc-DO3A-EA-Folate+for+receptor-mediated+targeting+of+folate+positive+tumors&doi=10.3109%2F1061186X.2011.561857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluation of 99mTc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors</span></div><div class="casAuthors">Mishra, Gauri; Hazari, Puja Panwar; Kumar, Nitin; Mishra, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">761-769</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Background: The cell membrane folate receptor is a potential mol. target for tumor selective drug delivery via receptor-mediated endocytosis, including delivery of radiolabeled folate-chelate conjugates for diagnostic imaging.  Method: A new radiopharmaceutical, 99mTc-1,4,7-tris (carboxymethyl)-10-(4-aminoethyl)-1,4,7,10-tetraazacyclododecane (DO3A-EA)-Folate has been synthesized introducing DO3A-EA to the γ-carboxyl group of folic acid and was characterized by different spectroscopic techniques.  Cytotoxicity was detd. by macrocolony and MTT assay on three different cell lines.  Cell uptake studies and receptor binding assay were performed using 99mTc-DO3A-EA-Folate.  Tumor imaging was performed in KB cell line implanted tumor bearing nude mice, and uptake of the radiotracer was estd.  Results: The synthesized conjugate binds with 99mTc at high efficiency at ambient temp.  The resulting conjugate is stable under physiol. conditions for 24 h after radiocomplexation.  Using an in vitro receptor binding assay, the conjugate showed Kd in μM range on human tumor cell lines (KB, U-87MG and OAW).  The pharmacokinetic data revealed rapid wash out of the more than 75% activity within 5 min from the circulation with hepato-biliary clearance.  Data from γ scintigraphic and biodistribution studies performed in KB tumor bearing nude mice revealed major accumulation of radiotracer at tumor site.  High tumor uptake was shown in the tumor bearing mice; tumor to blood ratios reached 2.27 ± 0.32 and 6.05 ± 1.02 at 1 and 4 h after post injection, resp.  Conclusion: These results suggest that 99mTc-DO3A-EA-Folate may be clin. useful as a noninvasive radiodiagnostic imaging agent for the detection of FR-pos. human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovryu6U4RRdbVg90H21EOLACvtfcHk0lgBKCDTuHJldA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaisLrJ&md5=dcbd8d2b893d67a6f241825ea849f260</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3109%2F1061186X.2011.561857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1061186X.2011.561857%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DG.%26aulast%3DHazari%26aufirst%3DP.%2BP.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DMishra%26aufirst%3DA.%2BK.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%252099mTc-DO3A-EA-Folate%2520for%2520receptor-mediated%2520targeting%2520of%2520folate%2520positive%2520tumors%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2011%26volume%3D19%26spage%3D761%26epage%3D769%26doi%3D10.3109%2F1061186X.2011.561857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innocenti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5511</span><span class="NLM_x">–</span> <span class="NLM_lpage">5522</span><span class="refDoi"> DOI: 10.1021/jm1003667</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1003667" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5511-5522&author=F.+Cartaauthor=C.+Temperiniauthor=A.+Innocentiauthor=A.+Scozzafavaauthor=K.+Kailaauthor=C.+T.+Supuran&title=Polyamines+inhibit+carbonic+anhydrases+by+anchoring+to+the+zinc-coordinated+water+molecule&doi=10.1021%2Fjm1003667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm1003667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1003667%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DTemperini%26aufirst%3DC.%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DKaila%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DPolyamines%2520inhibit%2520carbonic%2520anhydrases%2520by%2520anchoring%2520to%2520the%2520zinc-coordinated%2520water%2520molecule%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5511%26epage%3D5522%26doi%3D10.1021%2Fjm1003667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Innocenti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1857</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2009.02.088" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1855-1857&author=A.+Innocentiauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+Inhibition+of+cytosolic+isoforms+I%2C+II%2C+III%2C+VII+and+XIII+with+less+investigated+inorganic+anions&doi=10.1016%2Fj.bmcl.2009.02.088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.088%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520Inhibition%2520of%2520cytosolic%2520isoforms%2520I%252C%2520II%252C%2520III%252C%2520VII%2520and%2520XIII%2520with%2520less%2520investigated%2520inorganic%2520anions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1855%26epage%3D1857%26doi%3D10.1016%2Fj.bmcl.2009.02.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Innocenti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII and XIV with less investigated inorganic anions</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1548</span><span class="NLM_x">–</span> <span class="NLM_lpage">1550</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2010.01.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1548-1550&author=A.+Innocentiauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+Inhibition+of+transmembrane+isoforms+IX%2C+XII+and+XIV+with+less+investigated+inorganic+anions&doi=10.1016%2Fj.bmcl.2010.01.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.081%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520Inhibition%2520of%2520transmembrane%2520isoforms%2520IX%252C%2520XII%2520and%2520XIV%2520with%2520less%2520investigated%2520inorganic%2520anions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1548%26epage%3D1550%26doi%3D10.1016%2Fj.bmcl.2010.01.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Temperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. X-Ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct. An inhibitor mimicking the sulfonamide and urea binding to the enzyme</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2009.11.124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=474-478&author=C.+Temperiniauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+X-Ray+crystal+studies+of+the+carbonic+anhydrase+II-trithiocarbonate+adduct.+An+inhibitor+mimicking+the+sulfonamide+and+urea+binding+to+the+enzyme&doi=10.1016%2Fj.bmcl.2009.11.124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.124%26sid%3Dliteratum%253Aachs%26aulast%3DTemperini%26aufirst%3DC.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520X-Ray%2520crystal%2520studies%2520of%2520the%2520carbonic%2520anhydrase%2520II-trithiocarbonate%2520adduct.%2520An%2520inhibitor%2520mimicking%2520the%2520sulfonamide%2520and%2520urea%2520binding%2520to%2520the%2520enzyme%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D474%26epage%3D478%26doi%3D10.1016%2Fj.bmcl.2009.11.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1868</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span><span class="refDoi"> DOI: 10.1039/c2cc16395k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1039%2Fc2cc16395k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=1868-1870&author=F.+Cartaauthor=M.+Aggarwalauthor=A.+Marescaauthor=A.+Scozzafavaauthor=R.+McKennaauthor=C.+T.+Supuran&title=Dithiocarbamates%3A+a+new+class+of+carbonic+anhydrase+inhibitors.+Crystallographic+and+kinetic+investigations&doi=10.1039%2Fc2cc16395k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1039%2Fc2cc16395k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc16395k%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DAggarwal%26aufirst%3DM.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DDithiocarbamates%253A%2520a%2520new%2520class%2520of%2520carbonic%2520anhydrase%2520inhibitors.%2520Crystallographic%2520and%2520kinetic%2520investigations%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26spage%3D1868%26epage%3D1870%26doi%3D10.1039%2Fc2cc16395k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Avram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milac, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">More effective dithiocarbamate derivatives inhibiting carbonic anhydrases, generated by QSAR and computational design</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span><span class="refDoi"> DOI: 10.3109/14756366.2012.727410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2012.727410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23116520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FpvFClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=350-359&author=S.+Avramauthor=A.+L.+Milacauthor=F.+Cartaauthor=C.+T.+Supuran&title=More+effective+dithiocarbamate+derivatives+inhibiting+carbonic+anhydrases%2C+generated+by+QSAR+and+computational+design&doi=10.3109%2F14756366.2012.727410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">More effective dithiocarbamate derivatives inhibiting carbonic anhydrases, generated by QSAR and computational design</span></div><div class="casAuthors">Avram Speranta; Milac Adina Luminita; Carta Fabrizio; Supuran Claudiu T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of enzyme inhibition and medicinal chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">350-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dithiocarbamates (DTC) are promising compounds with potential applications in antitumoral and glaucoma therapy.  Our aim is to understand molecular features affecting DTC interaction with carbonic anhydrases (CAs), zinc-containing enzymes maintaining acid-base balance in blood and other tissues.  To this end, we generate QSAR models based on a compound series containing 25 DTC, inhibitors of four human (h) CAs isoforms: hCA I, II, IX and XII.  We establish that critical physicochemical parameters for DTC inhibitory activity are: hydrophobic, electronic, steric, topological and shape.  The predictive power of our QSAR models is indicated by significant values of statistical coefficients: cross-validated correlation q(2) (0.55-0.73), fitted correlation r(2) (0.75-0.84) and standard error of prediction (0.47-0.23).  Based on the established QSAR equations, we analyse 22 new DTC derivatives and identify DTC dicarboxilic acids derivatives and their esters as potentially improved inhibitors of CA I, II, IX and XII.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-IK0lC_yKw6x48Rj5GnGofW6udTcc2eZ-f0xsL5Copbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FpvFClsQ%253D%253D&md5=f16f7d2f862ecb0b04ab6ffaff7963d8</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.3109%2F14756366.2012.727410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2012.727410%26sid%3Dliteratum%253Aachs%26aulast%3DAvram%26aufirst%3DS.%26aulast%3DMilac%26aufirst%3DA.%2BL.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DMore%2520effective%2520dithiocarbamate%2520derivatives%2520inhibiting%2520carbonic%2520anhydrases%252C%2520generated%2520by%2520QSAR%2520and%2520computational%2520design%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26spage%3D350%26epage%3D359%26doi%3D10.3109%2F14756366.2012.727410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akdemir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4691</span><span class="NLM_x">–</span> <span class="NLM_lpage">4700</span><span class="refDoi"> DOI: 10.1021/jm400414j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400414j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4691-4700&author=F.+Cartaauthor=A.+Akdemirauthor=A.+Scozzafavaauthor=E.+Masiniauthor=C.+T.+Supuran&title=Xanthates+and+trithiocarbonates+strongly+inhibit+carbonic+anhydrases+and+show+antiglaucoma+effects+in+vivo&doi=10.1021%2Fjm400414j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Xanthates and Trithiocarbonates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Effects in Vivo</span></div><div class="casAuthors">Carta, Fabrizio; Akdemir, Atilla; Scozzafava, Andrea; Masini, Emanuela; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4691-4700</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dithiocarbamates (DTCs ) were recently discovered as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors.  A series of xanthates and a trithiocarbonate, structurally related to the DTCs, were prepd. by reaction of alcs./thiols with carbon disulfide in the presence of bases.  These compds. were tested for the inhibition of four human (h) isoforms, hCA I, II, IX, and XII, involved in pathologies such as glaucoma (CA II and XII) or cancer (CA IX).  Several low nanomolar xanthate/trithiocarbonate inhibitors targeting these CAs were detected.  A docking study of some xanthates within the CA II active site showed that these compds. bind in a similar manner with the dithiocarbamates, coordinating monodentately to the Zn(II) ion from the enzyme active site.  Several xanthates showed potent intraocular pressure lowering activity in two animal models of glaucoma via the topical administration.  Xanthates and thioxanthates represent two novel, promising classes of CA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV6dqMR8Qxe7Vg90H21EOLACvtfcHk0liqZIIGGjVAmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtbc%253D&md5=25eee80ff4504abc86442850af883eaa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm400414j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400414j%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DAkdemir%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMasini%26aufirst%3DE.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DXanthates%2520and%2520trithiocarbonates%2520strongly%2520inhibit%2520carbonic%2520anhydrases%2520and%2520show%2520antiglaucoma%2520effects%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4691%26epage%3D4700%26doi%3D10.1021%2Fjm400414j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kilkenny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuthill, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, D. G.</span><span> </span><span class="NLM_article-title">Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research</span> <span class="citation_source-journal">J. Pharmacol. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.4103/0976-500X.72351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.4103%2F0976-500X.72351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21350617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3M3hvVyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=94-99&author=C.+Kilkennyauthor=W.+J.+Browneauthor=I.+C.+Cuthillauthor=M.+Emersonauthor=D.+G.+Altman&title=Improving+bioscience+research+reporting%3A+the+ARRIVE+guidelines+for+reporting+animal+research&doi=10.4103%2F0976-500X.72351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research</span></div><div class="casAuthors">Kilkenny Carol; Browne William J; Cuthill Innes C; Emerson Michael; Altman Douglas G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacology & pharmacotherapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">94-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFwcJ9W7T-OWyYR5VtavbzfW6udTcc2eZ-f0xsL5Copbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3hvVyksg%253D%253D&md5=adb67f1d88a6f9cf879d5b5bab56dd40</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.4103%2F0976-500X.72351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0976-500X.72351%26sid%3Dliteratum%253Aachs%26aulast%3DKilkenny%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DW.%2BJ.%26aulast%3DCuthill%26aufirst%3DI.%2BC.%26aulast%3DEmerson%26aufirst%3DM.%26aulast%3DAltman%26aufirst%3DD.%2BG.%26atitle%3DImproving%2520bioscience%2520research%2520reporting%253A%2520the%2520ARRIVE%2520guidelines%2520for%2520reporting%2520animal%2520research%26jtitle%3DJ.%2520Pharmacol.%2520Pharmacother.%26date%3D2010%26volume%3D1%26spage%3D94%26epage%3D99%26doi%3D10.4103%2F0976-500X.72351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Butler, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godefroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weil-Fugazza, J.</span><span> </span><span class="NLM_article-title">A limited arthritic model for chronic pain studies in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/0304-3959(92)90133-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2F0304-3959%2892%2990133-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1738577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADyaK387ltVSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1992&pages=73-81&author=S.+H.+Butlerauthor=F.+Godefroyauthor=J.+M.+Bessonauthor=J.+Weil-Fugazza&title=A+limited+arthritic+model+for+chronic+pain+studies+in+the+rat&doi=10.1016%2F0304-3959%2892%2990133-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A limited arthritic model for chronic pain studies in the rat</span></div><div class="casAuthors">Butler S H; Godefroy F; Besson J M; Weil-Fugazza J</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-81</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">Freund's adjuvant induced polyarthritis in rats has been used extensively to study pain processes of long duration.  There are limitations of this model for chronic studies of pain/arthritis since the severe systemic changes provoke ethical concerns and also affect behaviour, physiology and biochemistry.  Attempts to limit adjuvant-induced arthritis by plantar injection of the inoculum have been made.  In this model, however, the process evolved to produce widespread polyarthritis if followed for the 6-plus-weeks necessary for chronic studies.  Therefore, although it offers the researcher a reliable limited model of inflammation and nociception at the outset, for longer studies it may have all the disadvantages of the polyarthritic rat.  The purpose of the present study was to produce a limited arthritic process in rats, stable over 6 weeks and suitable for behavioural and neurochemical studies of various chronic pain treatment methods.  Injection (0.05 ml) of complete adjuvant containing 300 micrograms Mycobacterium butyricum in the tibio-tarsal joint produces a predictable monoarthritis, stable clinically and behaviourly from weeks 2 through 6 post injection.  As revealed by clinical observations and X-ray examinations, the arthritis produced was limited anatomically, pronounced, prolonged and stable.  A marked increase in sensitivity to paw pressure was seen in the affected limb.  Animals gained weight and remained active, indicating little systemic disturbance as opposed to polyarthritic rats.  We propose this limited model of arthritis as a suitable alternative to the polyarthritic rat for prolonged studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8JqpNUe2Bd9XdcedVHT5tfW6udTcc2eYGwjNoT10QwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387ltVSqug%253D%253D&md5=3e5b40828514fb38a83a8ca180f889b3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990133-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990133-V%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DS.%2BH.%26aulast%3DGodefroy%26aufirst%3DF.%26aulast%3DBesson%26aufirst%3DJ.%2BM.%26aulast%3DWeil-Fugazza%26aufirst%3DJ.%26atitle%3DA%2520limited%2520arthritic%2520model%2520for%2520chronic%2520pain%2520studies%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D1992%26volume%3D48%26spage%3D73%26epage%3D81%26doi%3D10.1016%2F0304-3959%2892%2990133-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Di Cesare Mannelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelardini, C.</span><span> </span><span class="NLM_article-title">Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1294</span><span class="refDoi"> DOI: 10.1093/rheumatology/kew055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1093%2Frheumatology%2Fkew055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=27032424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotF2i" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=1285-1294&author=L.+Di+Cesare+Mannelliauthor=L.+Micheliauthor=L.+Cinciauthor=M.+Marescaauthor=C.+Vergelliauthor=A.+Paciniauthor=M.+T.+Quinnauthor=M.+P.+Giovannoniauthor=C.+Ghelardini&title=Effects+of+the+neutrophil+elastase+inhibitor+EL-17+in+rat+adjuvant-induced+arthritis&doi=10.1093%2Frheumatology%2Fkew055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis</span></div><div class="casAuthors">Di Cesare Mannelli, Lorenzo; Micheli, Laura; Cinci, Lorenzo; Maresca, Mario; Vergelli, Claudia; Pacini, Alessandra; Quinn, Mark T.; Giovannoni, Maria Paola; Ghelardini, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1285-1294</span>CODEN:
                <span class="NLM_cas:coden">RUMAFK</span>;
        ISSN:<span class="NLM_cas:issn">1462-0324</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Neutrophil elastase (NE), a granule-assocd. enzyme, participates in connective tissue breakdown and promotes cytokine release and specific receptor activation during various inflammatory diseases like RA.  NE is increased in the SF and cartilage of RA patients and represents a target for the development of new therapeutic possibilities.  The present research aimed to evaluate the preclin. pharmacol. profile of the N -benzoylpyrazole deriv. EL-17, a potent and selective NE inhibitor, in a rat model of RA.  Complete Freund's Adjuvant (CFA) was injected in the tibiotarsal joint and the effect of acute or repeated treatments with EL-17 (1-30 mg/kg by mouth) were evaluated.  On day 14 after CFA injection, a single administration of EL-17 significantly reduced CFA-dependent hypersensitivity to mech. noxious stimuli and the postural unbalance related to spontaneous pain.  To evaluate the preventive efficacy, EL-17 was administered daily starting from the day of CFA treatment.  Behavioral measurements performed on days 7 and 14 showed a progressive efficacy of EL-17 against hypersensitivity to mech. noxious and non-noxious stimuli, as well as a decrease of hind limb wt.-bearing alterations.  Histol. evaluation of the tibiotarsal joint (day 14) demonstrated significant prevention of articular derangement after EL-17 (30 mg/kg) treatment.  The protective effects of EL-17 directly correlated with a complete reversion of the plasma NE activity increase induced by CFA.  The NE inhibitor EL-17 relieved articular pain after acute administration.  Furthermore, repeated treatment reduced the development of hypersensitivity and protected joint tissue, revealing a disease-modifying profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsXPV9foauHLVg90H21EOLACvtfcHk0lh5T3JgS4BH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotF2i&md5=eb0ca4a2f5b4d3aede873ffcd1069ad5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkew055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkew055%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DMicheli%26aufirst%3DL.%26aulast%3DCinci%26aufirst%3DL.%26aulast%3DMaresca%26aufirst%3DM.%26aulast%3DVergelli%26aufirst%3DC.%26aulast%3DPacini%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DM.%2BT.%26aulast%3DGiovannoni%26aufirst%3DM.%2BP.%26aulast%3DGhelardini%26aufirst%3DC.%26atitle%3DEffects%2520of%2520the%2520neutrophil%2520elastase%2520inhibitor%2520EL-17%2520in%2520rat%2520adjuvant-induced%2520arthritis%26jtitle%3DRheumatology%26date%3D2016%26volume%3D55%26spage%3D1285%26epage%3D1294%26doi%3D10.1093%2Frheumatology%2Fkew055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Leighton, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, J.</span><span> </span><span class="NLM_article-title">κ-Opioid agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1988.tb10310.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1111%2Fj.1476-5381.1988.tb10310.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=2836010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVSjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1988&pages=553-560&author=G.+E.+Leightonauthor=R.+E.+Rodriguezauthor=R.+G.+Hillauthor=J.+Hughes&title=%CE%BA-Opioid+agonist+produce+antinociception+after+i.v.+and+i.c.v.+but+not+intrathecal+administration+in+the+rat&doi=10.1111%2Fj.1476-5381.1988.tb10310.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">κ-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat</span></div><div class="casAuthors">Leighton, G. E.; Rodriguez, R. E.; Hill, R. G.; Hughes, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">553-60</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Following i.v. administration to rats, PD117302, U50488, U69593, and morphine produced steep parallel dose-response curves indicating antinociceptive activity when evaluated in the paw-pressure test.  When U50488 and U69593 were tested at a single dose of 3.3 mg/kg no effect was seen in the tail-flick test.  When given by the intrathecal route, only morphine was effective at increasing the nociceptive threshold.  PD117302, U50488 and U69593 were without effect in either the paw-pressure or tail-flick tests at ≤100 μg per rat.  PD117302 caused flaccid paralysis of the hindlimbs following intrathecal administration at the top dose tested.  This effect was not reversible by naloxone.  All 3 κ-opioid receptor agonists produced naloxone-reversible antinociception in the paw-pressure test, and to a lesser extent in the tail-flick test, when injected directly into the 3rd cerebral ventricle with the max. effect occurring between 5 and 10 min after administration and declining back to control levels by 60 min.  Morphine had a much slower onset of action with the peak effect being obsd. 30 min after dosing.  The antinociceptive effects of κ-agonists are likely to operate via an action at a supraspinal rather than a spinal site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRnCwR2n4YdLVg90H21EOLACvtfcHk0lh5T3JgS4BH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVSjtLo%253D&md5=a07f811b47c181c8d06a9abf42fbf83e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1988.tb10310.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1988.tb10310.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeighton%26aufirst%3DG.%2BE.%26aulast%3DRodriguez%26aufirst%3DR.%2BE.%26aulast%3DHill%26aufirst%3DR.%2BG.%26aulast%3DHughes%26aufirst%3DJ.%26atitle%3D%25CE%25BA-Opioid%2520agonist%2520produce%2520antinociception%2520after%2520i.v.%2520and%2520i.c.v.%2520but%2520not%2520intrathecal%2520administration%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D93%26spage%3D553%26epage%3D560%26doi%3D10.1111%2Fj.1476-5381.1988.tb10310.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bove, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calcaterra, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juneau, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgore, K. S.</span><span> </span><span class="NLM_article-title">Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis</span> <span class="citation_source-journal">Osteoarthr. Cartil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1016/S1063-4584(03)00163-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2FS1063-4584%2803%2900163-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=14609535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BD3srjt1KitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=821-830&author=S.+E.+Boveauthor=S.+L.+Calcaterraauthor=R.+M.+Brookerauthor=C.+M.+Huberauthor=R.+E.+Guzmanauthor=P.+L.+Juneauauthor=D.+J.+Schrierauthor=K.+S.+Kilgore&title=Weight+bearing+as+a+measure+of+disease+progression+and+efficacy+of+anti-inflammatory+compounds+in+a+model+of+monosodium+iodoacetate-induced+osteoarthritis&doi=10.1016%2FS1063-4584%2803%2900163-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis</span></div><div class="casAuthors">Bove S E; Calcaterra S L; Brooker R M; Huber C M; Guzman R E; Juneau P L; Schrier D J; Kilgore K S</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">821-30</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To describe an in vivo model in the rat in which change in weight distribution is used as a measure of disease progression and efficacy of acetaminophen and two nonsteroidal anti-inflammatory drugs (NSAIDs) in a model of monosodium iodoacetate (MIA)-induced osteoarthritis (OA).  METHODS:  Intra-articular injections of MIA and saline were administered to male Wistar rats (175-200 g) into the right and left knee joints, respectively.  Changes in hind paw weight distribution between the right (osteoarthritic) and left (contralateral control) limbs were utilized as an index of joint discomfort.  Acetaminophen and two archetypal, orally administered NSAIDs, naproxen and rofecoxib, were examined for their ability to decrease MIA-induced change in weight distribution.  RESULTS:  A concentration-dependent increase in change in hind paw weight distribution was noted after intra-articular injection of MIA.  Both naproxen and rofecoxib demonstrated the capacity to significantly (P<0.05) decrease hind paw weight distribution in a dose-dependent fashion, indicating that the change in weight distribution associated with MIA injection is susceptible to pharmacological intervention.  CONCLUSION:  The determination of differences in hind paw weight distribution in the rat MIA model of OA is a technically straightforward, reproducible method that is predictive of the effects of anti-inflammatory and analgesic agents.  This system may be useful for the discovery of novel pharmacologic agents in human OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXM-0hOfBxH_6xYuD7tu2XfW6udTcc2eYFp2p82f7xwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srjt1KitA%253D%253D&md5=12ee3d4de4609d794d4e4f4b176f25a3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS1063-4584%2803%2900163-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1063-4584%252803%252900163-8%26sid%3Dliteratum%253Aachs%26aulast%3DBove%26aufirst%3DS.%2BE.%26aulast%3DCalcaterra%26aufirst%3DS.%2BL.%26aulast%3DBrooker%26aufirst%3DR.%2BM.%26aulast%3DHuber%26aufirst%3DC.%2BM.%26aulast%3DGuzman%26aufirst%3DR.%2BE.%26aulast%3DJuneau%26aufirst%3DP.%2BL.%26aulast%3DSchrier%26aufirst%3DD.%2BJ.%26aulast%3DKilgore%26aufirst%3DK.%2BS.%26atitle%3DWeight%2520bearing%2520as%2520a%2520measure%2520of%2520disease%2520progression%2520and%2520efficacy%2520of%2520anti-inflammatory%2520compounds%2520in%2520a%2520model%2520of%2520monosodium%2520iodoacetate-induced%2520osteoarthritis%26jtitle%3DOsteoarthr.%2520Cartil.%26date%3D2003%26volume%3D11%26spage%3D821%26epage%3D830%26doi%3D10.1016%2FS1063-4584%2803%2900163-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Neri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Interfering with pH regulation in tumours as a therapeutic strategy</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span><span class="refDoi"> DOI: 10.1038/nrd3554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1038%2Fnrd3554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21921921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOlsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=767-777&author=D.+Neriauthor=C.+T.+Supuran&title=Interfering+with+pH+regulation+in+tumours+as+a+therapeutic+strategy&doi=10.1038%2Fnrd3554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Interfering with pH regulation in tumours as a therapeutic strategy</span></div><div class="casAuthors">Neri, Dario; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">767-777</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The high metabolic rate of tumors often leads to acidosis and hypoxia in poorly perfused regions.  Tumor cells have thus evolved the ability to function in a more acidic environment than normal cells.  Key pH regulators in tumor cells include: isoforms 2, 9 and 12 of carbonic anhydrase, isoforms of anion exchangers, Na+/HCO3- co-transporters, Na+/H+ exchangers, monocarboxylate transporters and the vacuolar ATPase.  Both small mols. and antibodies targeting these pH regulators are currently at various stages of clin. development.  These antitumor mechanisms are not exploited by the classical cancer drugs and therefore represent a new anticancer drug discovery strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl7enRfSHzprVg90H21EOLACvtfcHk0lgOE_1PYnnz-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOlsL7L&md5=7a1e1b7badcf7d2e26bd70da2bfe0925</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd3554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3554%26sid%3Dliteratum%253Aachs%26aulast%3DNeri%26aufirst%3DD.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DInterfering%2520with%2520pH%2520regulation%2520in%2520tumours%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D767%26epage%3D777%26doi%3D10.1038%2Fnrd3554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c','cit12d','cit12e','cit12f','cit12g'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c','cit17d','cit17e','cit17f'],'ref18':['cit18a','cit18b','cit18c','cit18d'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':['cit25a','cit25b'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 62 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chao Wang, Yu-Chao Liu, Meng-Yu Xu, <span class="NLM_string-name hlFld-ContribAuthor">Bin Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Dialkyl-Substituted Monofluoroalkenes via Palladium-Catalyzed Cross-Coupling of Alkyl Carbagermatranes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (12)
                                     , 4593-4597. <a href="https://doi.org/10.1021/acs.orglett.1c01289" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01289%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BDialkyl-Substituted%252BMonofluoroalkenes%252Bvia%252BPalladium-Catalyzed%252BCross-Coupling%252Bof%252BAlkyl%252BCarbagermatranes%26aulast%3DWang%26aufirst%3DChao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15042021%26date%3D01062021%26volume%3D23%26issue%3D12%26spage%3D4593%26epage%3D4597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Silvia Bua, Laura Lucarini, Laura Micheli, Marta Menicatti, Gianluca Bartolucci, Silvia Selleri, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Emanuela Masini, Fabrizio Carta, Paola Gratteri, Alessio Nocentini, <span class="NLM_string-name hlFld-ContribAuthor">Claudiu T. Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug–Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2325-2342. <a href="https://doi.org/10.1021/acs.jmedchem.9b01130" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01130%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBioisosteric%252BDevelopment%252Bof%252BMultitarget%252BNonsteroidal%252BAnti-Inflammatory%252BDrug%2525E2%252580%252593Carbonic%252BAnhydrases%252BInhibitor%252BHybrids%252Bfor%252Bthe%252BManagement%252Bof%252BRheumatoid%252BArthritis%26aulast%3DBua%26aufirst%3DSilvia%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D12072019%26date%3D15112019%26date%3D05112019%26volume%3D63%26issue%3D5%26spage%3D2325%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Emanuela Berrino, Lisa Milazzo, Laura Micheli, Daniela Vullo, Andrea Angeli, Murat Bozdag, Alessio Nocentini, Marta Menicatti, Gianluca Bartolucci, Lorenzo di Cesare Mannelli, Carla Ghelardini, Claudiu T. Supuran, <span class="NLM_string-name hlFld-ContribAuthor">Fabrizio Carta</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Carbonic Anhydrase Inhibitors with Carbon Monoxide Releasing Properties for the Management of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 7233-7249. <a href="https://doi.org/10.1021/acs.jmedchem.9b00845" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00845%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BCarbonic%252BAnhydrase%252BInhibitors%252Bwith%252BCarbon%252BMonoxide%252BReleasing%252BProperties%252Bfor%252Bthe%252BManagement%252Bof%252BRheumatoid%252BArthritis%26aulast%3DBerrino%26aufirst%3DEmanuela%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24052019%26date%3D23072019%26date%3D09072019%26volume%3D62%26issue%3D15%26spage%3D7233%26epage%3D7249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rita Meleddu, Simona Distinto, Filippo Cottiglia, Rossella Angius, Marco Gaspari, Domenico Taverna, Claudia Melis, Andrea Angeli, Giulia Bianco, Serenella Deplano, Benedetta Fois, Sonia Del Prete, Clemente Capasso, Stefano Alcaro, Francesco Ortuso, Matilde Yanez, Claudiu T. Supuran, <span class="NLM_string-name hlFld-ContribAuthor">Elias Maccioni</span>. </span><span class="cited-content_cbyCitation_article-title">Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (10)
                                     , 1045-1050. <a href="https://doi.org/10.1021/acsmedchemlett.8b00352" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00352%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTuning%252Bthe%252BDual%252BInhibition%252Bof%252BCarbonic%252BAnhydrase%252Band%252BCyclooxygenase%252Bby%252BDihydrothiazole%252BBenzensulfonamides%26aulast%3DMeleddu%26aufirst%3DRita%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02082018%26date%3D17092018%26date%3D19092018%26date%3D17092018%26volume%3D9%26issue%3D10%26spage%3D1045%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ozlem Akgul, Lorenzo Di Cesare Mannelli, Daniela Vullo, Andrea Angeli, Carla Ghelardini, Gianluca Bartolucci, Abdulmalik Saleh Alfawaz Altamimi, Andrea Scozzafava, Claudiu T. Supuran, <span class="NLM_string-name hlFld-ContribAuthor">Fabrizio Carta</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs–CAIs) for the Management of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (11)
                                     , 4961-4977. <a href="https://doi.org/10.1021/acs.jmedchem.8b00420" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00420%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BNonsteroidal%252BAnti-Inflammatory%252BDrugs%252Band%252BCarbonic%252BAnhydrase%252BInhibitors%252BHybrids%252B%252528NSAIDs%2525E2%252580%252593CAIs%252529%252Bfor%252Bthe%252BManagement%252Bof%252BRheumatoid%252BArthritis%26aulast%3DAkgul%26aufirst%3DOzlem%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D14032018%26date%3D21052018%26date%3D10052018%26volume%3D61%26issue%3D11%26spage%3D4961%26epage%3D4977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdul  Sadiq</span>, <span class="hlFld-ContribAuthor ">Mater H.  Mahnashi</span>, <span class="hlFld-ContribAuthor ">Bandar A.  Alyami</span>, <span class="hlFld-ContribAuthor ">Yahya S.  Alqahtani</span>, <span class="hlFld-ContribAuthor ">Ali O.  Alqarni</span>, <span class="hlFld-ContribAuthor ">Umer  Rashid</span>. </span><span class="cited-content_cbyCitation_article-title">Tailoring the substitution pattern of Pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>112 </em>, 104969. <a href="https://doi.org/10.1016/j.bioorg.2021.104969" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104969%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DTailoring%252Bthe%252Bsubstitution%252Bpattern%252Bof%252BPyrrolidine-2%25252C5-dione%252Bfor%252Bdiscovery%252Bof%252Bnew%252Bstructural%252Btemplate%252Bfor%252Bdual%252BCOX%25252FLOX%252Binhibition%26aulast%3DSadiq%26aufirst%3DAbdul%26date%3D2021%26volume%3D112%26spage%3D104969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging role of carbonic anhydrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Clinical Science</span><span> <strong>2021,</strong> <em>135 </em>
                                    (10)
                                     , 1233-1249. <a href="https://doi.org/10.1042/CS20210040" title="DOI URL">https://doi.org/10.1042/CS20210040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/CS20210040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FCS20210040%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Science%26atitle%3DEmerging%252Brole%252Bof%252Bcarbonic%252Banhydrase%252Binhibitors%26aulast%3DSupuran%26aufirst%3DClaudiu%25C2%25A0T.%26date%3D2021%26date%3D2021%26volume%3D135%26issue%3D10%26spage%3D1233%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md. Meraj  Ansari</span>, <span class="hlFld-ContribAuthor ">Anas  Ahmad</span>, <span class="hlFld-ContribAuthor ">Ajay  Kumar</span>, <span class="hlFld-ContribAuthor ">Pravej  Alam</span>, <span class="hlFld-ContribAuthor ">Tajdar Husain  Khan</span>, <span class="hlFld-ContribAuthor ">Govindasamy  Jayamurugan</span>, <span class="hlFld-ContribAuthor ">Syed Shadab  Raza</span>, <span class="hlFld-ContribAuthor ">Rehan  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Aminocellulose-grafted-polycaprolactone coated gelatin nanoparticles alleviate inflammation in rheumatoid arthritis: A combinational therapeutic approach. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Polymers</span><span> <strong>2021,</strong> <em>258 </em>, 117600. <a href="https://doi.org/10.1016/j.carbpol.2020.117600" title="DOI URL">https://doi.org/10.1016/j.carbpol.2020.117600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carbpol.2020.117600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carbpol.2020.117600%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Polymers%26atitle%3DAminocellulose-grafted-polycaprolactone%252Bcoated%252Bgelatin%252Bnanoparticles%252Balleviate%252Binflammation%252Bin%252Brheumatoid%252Barthritis%25253A%252BA%252Bcombinational%252Btherapeutic%252Bapproach%26aulast%3DAnsari%26aufirst%3DMd.%2BMeraj%26date%3D2021%26volume%3D258%26spage%3D117600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Peng</span>, <span class="hlFld-ContribAuthor ">Fei  Yan</span>, <span class="hlFld-ContribAuthor ">Chunguang  Li</span>, <span class="hlFld-ContribAuthor ">Yiqiang  He</span>, <span class="hlFld-ContribAuthor ">Yue  Lou</span>, <span class="hlFld-ContribAuthor ">Dingxuan  Ma</span>, <span class="hlFld-ContribAuthor ">Yi  Li</span>, <span class="hlFld-ContribAuthor ">Zhan  Shi</span>, <span class="hlFld-ContribAuthor ">Shouhua  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">A cage-based covalent organic framework for drug delivery. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (6)
                                     , 3343-3348. <a href="https://doi.org/10.1039/D0NJ04941G" title="DOI URL">https://doi.org/10.1039/D0NJ04941G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ04941G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ04941G%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DA%252Bcage-based%252Bcovalent%252Borganic%252Bframework%252Bfor%252Bdrug%252Bdelivery%26aulast%3DLi%26aufirst%3DMing%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D6%26spage%3D3343%26epage%3D3348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuhang  Miao</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Yinling  Yun</span>, <span class="hlFld-ContribAuthor ">Jie  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anti-rheumatoid arthritis activities of 3-(4-aminophenyl)-coumarin derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 450-461. <a href="https://doi.org/10.1080/14756366.2021.1873978" title="DOI URL">https://doi.org/10.1080/14756366.2021.1873978</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1873978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1873978%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banti-rheumatoid%252Barthritis%252Bactivities%252Bof%252B3-%2525284-aminophenyl%252529-coumarin%252Bderivatives%26aulast%3DMiao%26aufirst%3DYuhang%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D450%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">A Story on Carbon Dioxide and Its Hydration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 115-131. <a href="https://doi.org/10.1007/978-3-030-57456-7_6" title="DOI URL">https://doi.org/10.1007/978-3-030-57456-7_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-57456-7_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-57456-7_6%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BStory%252Bon%252BCarbon%252BDioxide%252Band%252BIts%252BHydration%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2021%26date%3D2021%26spage%3D115%26epage%3D131%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNew%252BTrends%252Bin%252BMacromolecular%252Band%252BSupramolecular%252BChemistry%252Bfor%252BBiological%252BApplications%26aulast%3DJ.M.%2BAbadie%26aufirst%3DMarc%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Jianyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingtao  Ao</span>, <span class="hlFld-ContribAuthor ">Fengming  He</span>, <span class="hlFld-ContribAuthor ">Weizhu  Chen</span>, <span class="hlFld-ContribAuthor ">Yuqing  Qian</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Meijuan  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and discovery of ω-3 polyunsaturated fatty acid- alkanolamine (PUFA-AA) derivatives as anti-inflammatory agents targeting Nur77. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104456. <a href="https://doi.org/10.1016/j.bioorg.2020.104456" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104456%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bdiscovery%252Bof%252B%2525CF%252589-3%252Bpolyunsaturated%252Bfatty%252Bacid-%252Balkanolamine%252B%252528PUFA-AA%252529%252Bderivatives%252Bas%252Banti-inflammatory%252Bagents%252Btargeting%252BNur77%26aulast%3DFang%26aufirst%3DHua%26date%3D2020%26volume%3D105%26spage%3D104456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ghada S.  Masaret</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Docking and Antihypertensive Activity of Pyridone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (44)
                                     , 13995-14003. <a href="https://doi.org/10.1002/slct.202003959" title="DOI URL">https://doi.org/10.1002/slct.202003959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202003959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202003959%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%25252C%252BDocking%252Band%252BAntihypertensive%252BActivity%252Bof%252BPyridone%252BDerivatives%26aulast%3DMasaret%26aufirst%3DGhada%2BS.%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D44%26spage%3D13995%26epage%3D14003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandra B.  Mishra</span>, <span class="hlFld-ContribAuthor ">Manisha  Tiwari</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (6)
                                     , 2485-2565. <a href="https://doi.org/10.1002/med.21713" title="DOI URL">https://doi.org/10.1002/med.21713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21713%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DProgress%252Bin%252Bthe%252Bdevelopment%252Bof%252Bhuman%252Bcarbonic%252Banhydrase%2525C2%2525A0inhibitors%252Band%252Btheir%252Bpharmacological%252Bapplications%25253A%252BWhere%252Bare%252Bwe%252Btoday%25253F%26aulast%3DMishra%26aufirst%3DChandra%2BB.%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D6%26spage%3D2485%26epage%3D2565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ghita  Ghislat</span>, <span class="hlFld-ContribAuthor ">Taufiq  Rahman</span>, <span class="hlFld-ContribAuthor ">Pedro J.  Ballester</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (11)
                                     , 1570. <a href="https://doi.org/10.3390/biom10111570" title="DOI URL">https://doi.org/10.3390/biom10111570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10111570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10111570%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DIdentification%252Band%252BValidation%252Bof%252BCarbonic%252BAnhydrase%252BII%252Bas%252Bthe%252BFirst%252BTarget%252Bof%252Bthe%252BAnti-Inflammatory%252BDrug%252BActarit%26aulast%3DGhislat%26aufirst%3DGhita%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D11%26spage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Winum</span>, <span class="hlFld-ContribAuthor ">Raivis  Zalubovskis</span>, <span class="hlFld-ContribAuthor ">Atilla  Akdemir</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>, <span class="hlFld-ContribAuthor ">Wagdy M.  Eldehna</span>, <span class="hlFld-ContribAuthor ">Clemente  Capasso</span>, <span class="hlFld-ContribAuthor ">Giuseppina De  Simone</span>, <span class="hlFld-ContribAuthor ">Simona Maria  Monti</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">William A.  Donald</span>, <span class="hlFld-ContribAuthor ">Shoukat  Dedhar</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Metabolites</span><span> <strong>2020,</strong> <em>10 </em>
                                    (10)
                                     , 412. <a href="https://doi.org/10.3390/metabo10100412" title="DOI URL">https://doi.org/10.3390/metabo10100412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/metabo10100412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmetabo10100412%26sid%3Dliteratum%253Aachs%26jtitle%3DMetabolites%26atitle%3DCarbonic%252BAnhydrase%252BInhibitors%252BTargeting%252BMetabolism%252Band%252BTumor%252BMicroenvironment%26aulast%3DAngeli%26aufirst%3DAndrea%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D10%26spage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Lucarini</span>, <span class="hlFld-ContribAuthor ">Mariaconcetta  Durante</span>, <span class="hlFld-ContribAuthor ">Silvia  Sgambellone</span>, <span class="hlFld-ContribAuthor ">Cecilia  Lanzi</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Bigagli</span>, <span class="hlFld-ContribAuthor ">Ozlem  Akgul</span>, <span class="hlFld-ContribAuthor ">Emanuela  Masini</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 1307. <a href="https://doi.org/10.3390/biom10091307" title="DOI URL">https://doi.org/10.3390/biom10091307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10091307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10091307%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DEffects%252Bof%252BNew%252BNSAID-CAI%252BHybrid%252BCompounds%252Bin%252BInflammation%252Band%252BLung%252BFibrosis%26aulast%3DLucarini%26aufirst%3DLaura%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (6)
                                     , 671-686. <a href="https://doi.org/10.1080/17460441.2020.1743676" title="DOI URL">https://doi.org/10.1080/17460441.2020.1743676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1743676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1743676%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DExploring%252Bthe%252Bmultiple%252Bbinding%252Bmodes%252Bof%252Binhibitors%252Bto%252Bcarbonic%252Banhydrases%252Bfor%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D6%26spage%3D671%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Linrong  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Yue</span>, <span class="hlFld-ContribAuthor ">Yingguang  Li</span>, <span class="hlFld-ContribAuthor ">Hanfang  Liu</span>, <span class="hlFld-ContribAuthor ">Peng George  Wang</span>, <span class="hlFld-ContribAuthor ">Chaojie  Wang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Wang</span>, <span class="hlFld-ContribAuthor ">Wen  Luo</span>, <span class="hlFld-ContribAuthor ">Songqiang  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103768. <a href="https://doi.org/10.1016/j.bioorg.2020.103768" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103768</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103768%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DBromocoumarinplatin%25252C%252Btargeting%252Bsimultaneously%252Bmitochondria%252Band%252Bnuclei%252Bwith%252Bp53%252Bapoptosis%252Bpathway%252Bto%252Bovercome%252Bcisplatin%252Bresistance%26aulast%3DMa%26aufirst%3DJing%26date%3D2020%26volume%3D99%26spage%3D103768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (4)
                                     , 297-307. <a href="https://doi.org/10.1080/17425255.2020.1743679" title="DOI URL">https://doi.org/10.1080/17425255.2020.1743679</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425255.2020.1743679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425255.2020.1743679%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DAn%252Bupdate%252Bon%252Bdrug%252Binteraction%252Bconsiderations%252Bin%252Bthe%252Btherapeutic%252Buse%252Bof%252Bcarbonic%252Banhydrase%252Binhibitors%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D4%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Franco</span>, <span class="hlFld-ContribAuthor ">Iolanda  De Marco</span>. </span><span class="cited-content_cbyCitation_article-title">Supercritical CO2 adsorption of non-steroidal anti-inflammatory drugs into biopolymer aerogels. </span><span class="cited-content_cbyCitation_journal-name">Journal of CO2 Utilization</span><span> <strong>2020,</strong> <em>36 </em>, 40-53. <a href="https://doi.org/10.1016/j.jcou.2019.11.001" title="DOI URL">https://doi.org/10.1016/j.jcou.2019.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jcou.2019.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jcou.2019.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520CO2%2520Utilization%26atitle%3DSupercritical%252BCO2%252Badsorption%252Bof%252Bnon-steroidal%252Banti-inflammatory%252Bdrugs%252Binto%252Bbiopolymer%252Baerogels%26aulast%3DFranco%26aufirst%3DPaola%26date%3D2020%26volume%3D36%26spage%3D40%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priti  Kumari</span>, <span class="hlFld-ContribAuthor ">Chintam  Narayana</span>, <span class="hlFld-ContribAuthor ">Ghanshyam  Tiwari</span>, <span class="hlFld-ContribAuthor ">Ram  Sagar</span>. </span><span class="cited-content_cbyCitation_article-title">Glycohybrid molecules in medicinal chemistry: Present status and future prospective. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 451-479. <a href="https://doi.org/10.1016/B978-0-12-816675-8.00011-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-816675-8.00011-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816675-8.00011-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816675-8.00011-7%26sid%3Dliteratum%253Aachs%26atitle%3DGlycohybrid%252Bmolecules%252Bin%252Bmedicinal%252Bchemistry%25253A%252BPresent%252Bstatus%252Band%252Bfuture%252Bprospective%26aulast%3DKumari%26aufirst%3DPriti%26date%3D2020%26spage%3D451%26epage%3D479%26pub%3DElsevier%26atitle%3DCarbohydrates%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashok  Aspatwar</span>, <span class="hlFld-ContribAuthor ">Emanuela  Berrino</span>, <span class="hlFld-ContribAuthor ">Silvia  Bua</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Clemente  Capasso</span>, <span class="hlFld-ContribAuthor ">Seppo  Parkkila</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1765-1772. <a href="https://doi.org/10.1080/14756366.2020.1822829" title="DOI URL">https://doi.org/10.1080/14756366.2020.1822829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1822829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1822829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DToxicity%252Bevaluation%252Bof%252Bsulfamides%252Band%252Bcoumarins%252Bthat%252Befficiently%252Binhibit%252Bhuman%252Bcarbonic%252Banhydrases%26aulast%3DAspatwar%26aufirst%3DAshok%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1765%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors</p>. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Pharmacology</span><span> <strong>2020,</strong> <em>Volume 12 </em>, 603-617. <a href="https://doi.org/10.2147/JEP.S265620" title="DOI URL">https://doi.org/10.2147/JEP.S265620</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/JEP.S265620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FJEP.S265620%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Pharmacology%26atitle%3D%25253Cp%25253EExperimental%252BCarbonic%252BAnhydrase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BHypoxic%252BTumors%25253C%25252Fp%25253E%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT%26date%3D2020%26date%3D2020%26volume%3DVolume%252012%26spage%3D603%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (11)
                                     , 1175-1197. <a href="https://doi.org/10.1080/17460441.2019.1651289" title="DOI URL">https://doi.org/10.1080/17460441.2019.1651289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1651289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1651289%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAdvances%252Bin%252Bthe%252Bstructural%252Bannotation%252Bof%252Bhuman%252Bcarbonic%252Banhydrases%252Band%252Bimpact%252Bon%252Bfuture%252Bdrug%252Bdiscovery%26aulast%3DNocentini%26aufirst%3DAlessio%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D11%26spage%3D1175%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Murat  Bozdag</span>, <span class="hlFld-ContribAuthor ">Marta  Ferraroni</span>, <span class="hlFld-ContribAuthor ">Carol  Ward</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Silvia  Bua</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Simon P.  Langdon</span>, <span class="hlFld-ContribAuthor ">Ian H.  Kunkler</span>, <span class="hlFld-ContribAuthor ">Abdul-Malek S.  Al-Tamimi</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111600. <a href="https://doi.org/10.1016/j.ejmech.2019.111600" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111600%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCarbonic%252Banhydrase%252Binhibitors%252Bbased%252Bon%252Bsorafenib%252Bscaffold%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bcrystallographic%252Binvestigation%252Band%252Beffects%252Bon%252Bprimary%252Bbreast%252Bcancer%252Bcells%26aulast%3DBozdag%26aufirst%3DMurat%26date%3D2019%26volume%3D182%26spage%3D111600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria P.  Paramonova</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Ozerov</span>, <span class="hlFld-ContribAuthor ">Alexander O.  Chizhov</span>, <span class="hlFld-ContribAuthor ">Robert  Snoeck</span>, <span class="hlFld-ContribAuthor ">Graciela  Andrei</span>, <span class="hlFld-ContribAuthor ">Anastasia L.  Khandazhinskaya</span>, <span class="hlFld-ContribAuthor ">Mikhail S.  Novikov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of uracil–coumarin conjugates as potential inhibitors of virus replication. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 638-639. <a href="https://doi.org/10.1016/j.mencom.2019.11.010" title="DOI URL">https://doi.org/10.1016/j.mencom.2019.11.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2019.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2019.11.010%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DSynthesis%252Bof%252Buracil%2525E2%252580%252593coumarin%252Bconjugates%252Bas%252Bpotential%252Binhibitors%252Bof%252Bvirus%252Breplication%26aulast%3DParamonova%26aufirst%3DMaria%2BP.%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D638%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Huiying  Zou</span>, <span class="hlFld-ContribAuthor ">Guangying  Chen</span>, <span class="hlFld-ContribAuthor ">Gangliang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Activities of Chemical Drugs for the Treatment of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2019,</strong> <em>377 </em>
                                    (5)
                                     <a href="https://doi.org/10.1007/s41061-019-0252-5" title="DOI URL">https://doi.org/10.1007/s41061-019-0252-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-019-0252-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-019-0252-5%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BActivities%252Bof%252BChemical%252BDrugs%252Bfor%252Bthe%252BTreatment%252Bof%252BRheumatoid%252BArthritis%26aulast%3DZhou%26aufirst%3DShiyang%26date%3D2019%26date%3D2019%26volume%3D377%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ghulam  Mustafa</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Muhammad  Zia-ur-Rehman</span>, <span class="hlFld-ContribAuthor ">Nosheen  Akbar</span>, <span class="hlFld-ContribAuthor ">Saiqa  Ishtiaq</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient method for the synthesis of novel derivatives 4-{5-[4-(4-amino-5-mercapto-4H-[1,2,4]triazol-3-yl)-phenyl]-3-trifluoromethyl-pyrazol-1-yl}-benzenesulfonamide and their anti-inflammatory potential. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>91 </em>, 103110. <a href="https://doi.org/10.1016/j.bioorg.2019.103110" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103110%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAn%252Befficient%252Bmethod%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bnovel%252Bderivatives%252B4-%25257B5-%25255B4-%2525284-amino-5-mercapto-4H-%25255B1%25252C2%25252C4%25255Dtriazol-3-yl%252529-phenyl%25255D-3-trifluoromethyl-pyrazol-1-yl%25257D-benzenesulfonamide%252Band%252Btheir%252Banti-inflammatory%252Bpotential%26aulast%3DMustafa%26aufirst%3DGhulam%26date%3D2019%26volume%3D91%26spage%3D103110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuan  Yang</span>, <span class="hlFld-ContribAuthor ">Knut Husø  Lauritzen</span>, <span class="hlFld-ContribAuthor ">Maria Belland  Olsen</span>, <span class="hlFld-ContribAuthor ">Tuva Børresdatter  Dahl</span>, <span class="hlFld-ContribAuthor ">Trine  Ranheim</span>, <span class="hlFld-ContribAuthor ">Mohammed Shakil  Ahmed</span>, <span class="hlFld-ContribAuthor ">Håvard  Attramadal</span>, <span class="hlFld-ContribAuthor ">Pål  Aukrust</span>, <span class="hlFld-ContribAuthor ">Bente  Halvorsen</span>, <span class="hlFld-ContribAuthor ">Tuula Anneli  Nyman</span>, <span class="hlFld-ContribAuthor ">Øystein  Sandanger</span>, <span class="hlFld-ContribAuthor ">Arne  Yndestad</span>. </span><span class="cited-content_cbyCitation_article-title">Low Cellular NAD
              +
              Compromises Lipopolysaccharide-Induced Inflammatory Responses via Inhibiting TLR4 Signal Transduction in Human Monocytes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Immunology</span><span> <strong>2019,</strong> <em>203 </em>
                                    (6)
                                     , 1598-1608. <a href="https://doi.org/10.4049/jimmunol.1801382" title="DOI URL">https://doi.org/10.4049/jimmunol.1801382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4049/jimmunol.1801382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4049%2Fjimmunol.1801382%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Immunology%26atitle%3DLow%252BCellular%252BNAD%252B%25252B%252BCompromises%252BLipopolysaccharide-Induced%252BInflammatory%252BResponses%252Bvia%252BInhibiting%252BTLR4%252BSignal%252BTransduction%252Bin%252BHuman%252BMonocytes%26aulast%3DYang%26aufirst%3DKuan%26date%3D2019%26date%3D2019%26volume%3D203%26issue%3D6%26spage%3D1598%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Murat  Bozdag</span>, <span class="hlFld-ContribAuthor ">Giulio  Poli</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Elena  Lucarini</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Di Cesare Mannelli</span>, <span class="hlFld-ContribAuthor ">Silvia  Selleri</span>, <span class="hlFld-ContribAuthor ">Carla  Ghelardini</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Winum</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">N-aryl-N’-ureido-O-sulfamates: Potent and selective inhibitors of the human Carbonic Anhydrase VII isoform with neuropathic pain relieving properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>89 </em>, 103033. <a href="https://doi.org/10.1016/j.bioorg.2019.103033" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DN-aryl-N%2525E2%252580%252599-ureido-O-sulfamates%25253A%252BPotent%252Band%252Bselective%252Binhibitors%252Bof%252Bthe%252Bhuman%252BCarbonic%252BAnhydrase%252BVII%252Bisoform%252Bwith%252Bneuropathic%252Bpain%252Brelieving%252Bproperties%26aulast%3DBozdag%26aufirst%3DMurat%26date%3D2019%26volume%3D89%26spage%3D103033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Murat  Bozdag</span>, <span class="hlFld-ContribAuthor ">Abdulmalik Saleh Alfawaz  Altamimi</span>, <span class="hlFld-ContribAuthor ">Daniela  Vullo</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>. </span><span class="cited-content_cbyCitation_article-title">State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (15)
                                     , 2558-2573. <a href="https://doi.org/10.2174/0929867325666180622120625" title="DOI URL">https://doi.org/10.2174/0929867325666180622120625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180622120625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180622120625%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DState%252Bof%252Bthe%252BArt%252Bon%252BCarbonic%252BAnhydrase%252BModulators%252Bfor%252BBiomedical%252BPurposes%26aulast%3DBozdag%26aufirst%3DMurat%26date%3D2019%26volume%3D26%26issue%3D15%26spage%3D2558%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanadi A.  Katouah</span>, <span class="hlFld-ContribAuthor ">Hatem. E.  Gaffer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Docking Study of Pyrimidine Derivatives Scaffold for Anti‐Hypertension Application. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (20)
                                     , 6250-6255. <a href="https://doi.org/10.1002/slct.201900799" title="DOI URL">https://doi.org/10.1002/slct.201900799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201900799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201900799%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BDocking%252BStudy%252Bof%252BPyrimidine%252BDerivatives%252BScaffold%252Bfor%252BAnti%2525E2%252580%252590Hypertension%252BApplication%26aulast%3DKatouah%26aufirst%3DHanadi%2BA.%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D20%26spage%3D6250%26epage%3D6255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Micheli</span>, <span class="hlFld-ContribAuthor ">Bozdag</span>, <span class="hlFld-ContribAuthor ">Akgul</span>, <span class="hlFld-ContribAuthor ">Carta</span>, <span class="hlFld-ContribAuthor ">Guccione</span>, <span class="hlFld-ContribAuthor ">Bergonzi</span>, <span class="hlFld-ContribAuthor ">Bilia</span>, <span class="hlFld-ContribAuthor ">Cinci</span>, <span class="hlFld-ContribAuthor ">Lucarini</span>, <span class="hlFld-ContribAuthor ">Parisio</span>, <span class="hlFld-ContribAuthor ">Supuran</span>, <span class="hlFld-ContribAuthor ">Ghelardini</span>, <span class="hlFld-ContribAuthor ">Di Cesare Mannelli</span>. </span><span class="cited-content_cbyCitation_article-title">Pain Relieving Effect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (8)
                                     , 1923. <a href="https://doi.org/10.3390/ijms20081923" title="DOI URL">https://doi.org/10.3390/ijms20081923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20081923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20081923%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPain%252BRelieving%252BEffect%252Bof-NSAIDs-CAIs%252BHybrid%252BMolecules%25253A%252BSystemic%252Band%252BIntra-Articular%252BTreatments%252Bagainst%252BRheumatoid%252BArthritis%26aulast%3DMicheli%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D8%26spage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaa A.-M.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Adel S.  El-Azab</span>, <span class="hlFld-ContribAuthor ">Mohammed E.A.  Hammouda</span>, <span class="hlFld-ContribAuthor ">Magda A.  El-Sherbeny</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: Dual cyclooxygenase/carbonic anhydrase inhibitory actions. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>, 260-268. <a href="https://doi.org/10.1016/j.bioorg.2018.11.033" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.11.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.11.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Banti-inflammatory%252Bactivity%252Bof%252Bsulfonamides%252Band%252Bcarboxylates%252Bincorporating%252Btrimellitimides%25253A%252BDual%252Bcyclooxygenase%25252Fcarbonic%252Banhydrase%252Binhibitory%252Bactions%26aulast%3DAbdel-Aziz%26aufirst%3DAlaa%2BA.-M.%26date%3D2019%26volume%3D84%26spage%3D260%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peteris  Trapencieris</span>, <span class="hlFld-ContribAuthor ">Anete  Parkova</span>, <span class="hlFld-ContribAuthor ">Ineta  Vendina-Birzniece</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic Anhydrase Inhibitors with Dual Targeting. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 163-178. <a href="https://doi.org/10.1007/978-3-030-12780-0_12" title="DOI URL">https://doi.org/10.1007/978-3-030-12780-0_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-12780-0_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-12780-0_12%26sid%3Dliteratum%253Aachs%26atitle%3DCarbonic%252BAnhydrase%252BInhibitors%252Bwith%252BDual%252BTargeting%26aulast%3DTrapencieris%26aufirst%3DPeteris%26date%3D2019%26date%3D2019%26spage%3D163%26epage%3D178%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCarbonic%252BAnhydrase%252Bas%252BDrug%252BTarget%26aulast%3DMatulis%26aufirst%3DDaumantas%26date%3D2019%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic anhydrase inhibitors for the treatment of neuropathic pain and arthritis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 367-386. <a href="https://doi.org/10.1016/B978-0-12-816476-1.00017-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-816476-1.00017-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816476-1.00017-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816476-1.00017-4%26sid%3Dliteratum%253Aachs%26atitle%3DCarbonic%252Banhydrase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bneuropathic%252Bpain%252Band%252Barthritis%26aulast%3DNocentini%26aufirst%3DAlessio%26date%3D2019%26spage%3D367%26epage%3D386%26pub%3DElsevier%26atitle%3DCarbonic%252BAnhydrases%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrizio  Blandina</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic anhydrase activators and their potential in the pharmaceutical field. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 477-492. <a href="https://doi.org/10.1016/B978-0-12-816476-1.00021-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-816476-1.00021-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816476-1.00021-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816476-1.00021-6%26sid%3Dliteratum%253Aachs%26atitle%3DCarbonic%252Banhydrase%252Bactivators%252Band%252Btheir%252Bpotential%252Bin%252Bthe%252Bpharmaceutical%252Bfield%26aulast%3DBlandina%26aufirst%3DPatrizio%26date%3D2019%26spage%3D477%26epage%3D492%26pub%3DElsevier%26atitle%3DCarbonic%252BAnhydrases%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic Anhydrase Inhibitor—NO Donor Hybrids and Their Pharmacological Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 229-242. <a href="https://doi.org/10.1016/B978-0-12-816545-4.00012-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816545-4.00012-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816545-4.00012-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816545-4.00012-8%26sid%3Dliteratum%253Aachs%26atitle%3DCarbonic%252BAnhydrase%252BInhibitor%2525E2%252580%252594NO%252BDonor%252BHybrids%252Band%252BTheir%252BPharmacological%252BApplications%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2019%26spage%3D229%26epage%3D242%26pub%3DElsevier%26atitle%3DTherapeutic%252BApplication%252Bof%252BNitric%252BOxide%252Bin%252BCancer%252Band%252BInflammatory%252BDisorders%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2018,</strong> <em>27 </em>
                                    (12)
                                     , 963-970. <a href="https://doi.org/10.1080/13543784.2018.1548608" title="DOI URL">https://doi.org/10.1080/13543784.2018.1548608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2018.1548608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2018.1548608%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DCarbonic%252Banhydrase%252Binhibitors%252Bas%252Bemerging%252Bagents%252Bfor%252Bthe%252Btreatment%252Band%252Bimaging%252Bof%252Bhypoxic%252Btumors%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2018%26date%3D2018%26volume%3D27%26issue%3D12%26spage%3D963%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Komal  Rao</span>, <span class="hlFld-ContribAuthor ">Sabahat  Aziz</span>, <span class="hlFld-ContribAuthor ">Talat  Roome</span>, <span class="hlFld-ContribAuthor ">Anam  Razzak</span>, <span class="hlFld-ContribAuthor ">Bushra  Sikandar</span>, <span class="hlFld-ContribAuthor ">Khawar Saeed  Jamali</span>, <span class="hlFld-ContribAuthor ">Muhammad  Imran</span>, <span class="hlFld-ContribAuthor ">Tooba  Jabri</span>, <span class="hlFld-ContribAuthor ">Muhammad Raza  Shah</span>. </span><span class="cited-content_cbyCitation_article-title">Gum acacia stabilized silver nanoparticles based nano-cargo for enhanced anti-arthritic potentials of hesperidin in adjuvant induced arthritic rats. </span><span class="cited-content_cbyCitation_journal-name">Artificial Cells, Nanomedicine, and Biotechnology</span><span> <strong>2018,</strong> <em>46 </em>
                                    (sup1)
                                     , 597-607. <a href="https://doi.org/10.1080/21691401.2018.1431653" title="DOI URL">https://doi.org/10.1080/21691401.2018.1431653</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/21691401.2018.1431653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F21691401.2018.1431653%26sid%3Dliteratum%253Aachs%26jtitle%3DArtificial%2520Cells%252C%2520Nanomedicine%252C%2520and%2520Biotechnology%26atitle%3DGum%252Bacacia%252Bstabilized%252Bsilver%252Bnanoparticles%252Bbased%252Bnano-cargo%252Bfor%252Benhanced%252Banti-arthritic%252Bpotentials%252Bof%252Bhesperidin%252Bin%252Badjuvant%252Binduced%252Barthritic%252Brats%26aulast%3DRao%26aufirst%3DKomal%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3Dsup1%26spage%3D597%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 729-740. <a href="https://doi.org/10.1080/13543776.2018.1508453" title="DOI URL">https://doi.org/10.1080/13543776.2018.1508453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1508453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1508453%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DCarbonic%252Banhydrase%252Binhibitors%252Bas%252Bantitumor%25252Fantimetastatic%252Bagents%25253A%252Ba%252Bpatent%252Breview%252B%2525282008%2525E2%252580%2525932018%252529%26aulast%3DNocentini%26aufirst%3DAlessio%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D729%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 713-721. <a href="https://doi.org/10.1080/13543776.2018.1519023" title="DOI URL">https://doi.org/10.1080/13543776.2018.1519023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1519023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1519023%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DApplications%252Bof%252Bcarbonic%252Banhydrases%252Binhibitors%252Bin%252Brenal%252Band%252Bcentral%252Bnervous%252Bsystem%252Bdiseases%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D713%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Sonia  Del Prete</span>, <span class="hlFld-ContribAuthor ">Fatmah A.S.  Alasmary</span>, <span class="hlFld-ContribAuthor ">Linah S.  Alqahtani</span>, <span class="hlFld-ContribAuthor ">Zeid  AlOthman</span>, <span class="hlFld-ContribAuthor ">William A.  Donald</span>, <span class="hlFld-ContribAuthor ">Clemente  Capasso</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">The first activation studies of the η-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>80 </em>, 94-98. <a href="https://doi.org/10.1016/j.bioorg.2018.06.002" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bfirst%252Bactivation%252Bstudies%252Bof%252Bthe%252B%2525CE%2525B7-carbonic%252Banhydrase%252Bfrom%252Bthe%252Bmalaria%252Bparasite%252BPlasmodium%252Bfalciparum%252Bwith%252Bamines%252Band%252Bamino%252Bacids%26aulast%3DAngeli%26aufirst%3DAndrea%26date%3D2018%26volume%3D80%26spage%3D94%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sourav  Thakur</span>, <span class="hlFld-ContribAuthor ">Bushra  Riyaz</span>, <span class="hlFld-ContribAuthor ">Akshay  Patil</span>, <span class="hlFld-ContribAuthor ">Amanjot  Kaur</span>, <span class="hlFld-ContribAuthor ">Bhupinder  Kapoor</span>, <span class="hlFld-ContribAuthor ">Vijay  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2018,</strong> <em>106 </em>, 1011-1023. <a href="https://doi.org/10.1016/j.biopha.2018.07.027" title="DOI URL">https://doi.org/10.1016/j.biopha.2018.07.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2018.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2018.07.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DNovel%252Bdrug%252Bdelivery%252Bsystems%252Bfor%252BNSAIDs%252Bin%252Bmanagement%252Bof%252Brheumatoid%252Barthritis%25253A%252BAn%252Boverview%26aulast%3DThakur%26aufirst%3DSourav%26date%3D2018%26volume%3D106%26spage%3D1011%26epage%3D1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Alterio</span>, <span class="hlFld-ContribAuthor ">Anna  Di Fiore</span>, <span class="hlFld-ContribAuthor ">Katia  D’ Ambrosio</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Simona Maria  Monti</span>, <span class="hlFld-ContribAuthor ">Giuseppina  De Simone</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (6)
                                     , 1799-1836. <a href="https://doi.org/10.1002/med.21497" title="DOI URL">https://doi.org/10.1002/med.21497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21497%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DInhibition%252Bof%252Bcarbonic%252Banhydrase%252BIX%252Btargets%252Bprimary%252Btumors%25252C%252Bmetastases%25252C%252Band%252Bcancer%252Bstem%252Bcells%25253A%252BThree%252Bfor%252Bthe%252Bprice%252Bof%252Bone%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT.%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D6%26spage%3D1799%26epage%3D1836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">William A.  Donald</span>, <span class="hlFld-ContribAuthor ">Seppo  Parkkila</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Activation studies with amines and amino acids of the β-carbonic anhydrase from the pathogenic protozoan Leishmania donovani chagasi. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>78 </em>, 406-410. <a href="https://doi.org/10.1016/j.bioorg.2018.04.010" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.04.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.04.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DActivation%252Bstudies%252Bwith%252Bamines%252Band%252Bamino%252Bacids%252Bof%252Bthe%252B%2525CE%2525B2-carbonic%252Banhydrase%252Bfrom%252Bthe%252Bpathogenic%252Bprotozoan%252BLeishmania%252Bdonovani%252Bchagasi%26aulast%3DAngeli%26aufirst%3DAndrea%26date%3D2018%26volume%3D78%26spage%3D406%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Marianne  Kuuslahti</span>, <span class="hlFld-ContribAuthor ">Seppo  Parkkila</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Activation studies with amines and amino acids of the α-carbonic anhydrase from the pathogenic protozoan Trypanosoma cruzi. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (14)
                                     , 4187-4190. <a href="https://doi.org/10.1016/j.bmc.2018.07.011" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DActivation%252Bstudies%252Bwith%252Bamines%252Band%252Bamino%252Bacids%252Bof%252Bthe%252B%2525CE%2525B1-carbonic%252Banhydrase%252Bfrom%252Bthe%252Bpathogenic%252Bprotozoan%252BTrypanosoma%252Bcruzi%26aulast%3DAngeli%26aufirst%3DAndrea%26date%3D2018%26volume%3D26%26issue%3D14%26spage%3D4187%26epage%3D4190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aliya  Ibrar</span>, <span class="hlFld-ContribAuthor ">Syeda Aaliya  Shehzadi</span>, <span class="hlFld-ContribAuthor ">Faiq  Saeed</span>, <span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (13)
                                     , 3731-3762. <a href="https://doi.org/10.1016/j.bmc.2018.05.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.05.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.05.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDeveloping%252Bhybrid%252Bmolecule%252Btherapeutics%252Bfor%252Bdiverse%252Benzyme%252Binhibitory%252Baction%25253A%252BActive%252Brole%252Bof%252Bcoumarin-based%252Bstructural%252Bleads%252Bin%252Bdrug%252Bdiscovery%26aulast%3DIbrar%26aufirst%3DAliya%26date%3D2018%26volume%3D26%26issue%3D13%26spage%3D3731%26epage%3D3762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Wang</span>, <span class="hlFld-ContribAuthor ">Helfried  Neumann</span>, <span class="hlFld-ContribAuthor ">Matthias  Beller</span>. </span><span class="cited-content_cbyCitation_article-title">A General, Activator-Free Palladium-Catalyzed Synthesis of Arylacetic and Benzoic Acids from Formic Acid. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (23)
                                     , 7026-7030. <a href="https://doi.org/10.1002/ange.201802384" title="DOI URL">https://doi.org/10.1002/ange.201802384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201802384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201802384%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DA%252BGeneral%25252C%252BActivator-Free%252BPalladium-Catalyzed%252BSynthesis%252Bof%252BArylacetic%252Band%252BBenzoic%252BAcids%252Bfrom%252BFormic%252BAcid%26aulast%3DWang%26aufirst%3DLin%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D23%26spage%3D7026%26epage%3D7030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Wang</span>, <span class="hlFld-ContribAuthor ">Helfried  Neumann</span>, <span class="hlFld-ContribAuthor ">Matthias  Beller</span>. </span><span class="cited-content_cbyCitation_article-title">A General, Activator-Free Palladium-Catalyzed Synthesis of Arylacetic and Benzoic Acids from Formic Acid. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (23)
                                     , 6910-6914. <a href="https://doi.org/10.1002/anie.201802384" title="DOI URL">https://doi.org/10.1002/anie.201802384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201802384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201802384%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DA%252BGeneral%25252C%252BActivator-Free%252BPalladium-Catalyzed%252BSynthesis%252Bof%252BArylacetic%252Band%252BBenzoic%252BAcids%252Bfrom%252BFormic%252BAcid%26aulast%3DWang%26aufirst%3DLin%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D23%26spage%3D6910%26epage%3D6914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morteza  Abdoli</span>, <span class="hlFld-ContribAuthor ">Murat  Bozdag</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Claudiu  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Benzamide-4-Sulfonamides Are Effective Human Carbonic Anhydrase I, II, VII, and IX Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Metabolites</span><span> <strong>2018,</strong> <em>8 </em>
                                    (2)
                                     , 37. <a href="https://doi.org/10.3390/metabo8020037" title="DOI URL">https://doi.org/10.3390/metabo8020037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/metabo8020037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmetabo8020037%26sid%3Dliteratum%253Aachs%26jtitle%3DMetabolites%26atitle%3DBenzamide-4-Sulfonamides%252BAre%252BEffective%252BHuman%252BCarbonic%252BAnhydrase%252BI%25252C%252BII%25252C%252BVII%25252C%252Band%252BIX%252BInhibitors%26aulast%3DAbdoli%26aufirst%3DMorteza%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D2%26spage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudiu T  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic anhydrase activators. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (5)
                                     , 561-573. <a href="https://doi.org/10.4155/fmc-2017-0223" title="DOI URL">https://doi.org/10.4155/fmc-2017-0223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0223%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DCarbonic%252Banhydrase%252Bactivators%26aulast%3DSupuran%26aufirst%3DClaudiu%2BT%26date%3D2018%26volume%3D10%26issue%3D5%26spage%3D561%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Bonardi</span>, <span class="hlFld-ContribAuthor ">Matteo  Falsini</span>, <span class="hlFld-ContribAuthor ">Daniela  Catarzi</span>, <span class="hlFld-ContribAuthor ">Flavia  Varano</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Di Cesare Mannelli</span>, <span class="hlFld-ContribAuthor ">Barbara  Tenci</span>, <span class="hlFld-ContribAuthor ">Carla  Ghelardini</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Vittoria  Colotta</span>. </span><span class="cited-content_cbyCitation_article-title">Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>146 </em>, 47-59. <a href="https://doi.org/10.1016/j.ejmech.2018.01.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Binvestigations%252Bon%252Bcoumarins%252Bleading%252Bto%252Bchromeno%25255B4%25252C3-c%25255Dpyrazol-4-ones%252Band%252Bpyrano%25255B4%25252C3-c%25255Dpyrazol-4-ones%25253A%252BNew%252Bscaffolds%252Bfor%252Bthe%252Bdesign%252Bof%252Bthe%252Btumor-associated%252Bcarbonic%252Banhydrase%252Bisoforms%252BIX%252Band%252BXII%26aulast%3DBonardi%26aufirst%3DAlessandro%26date%3D2018%26volume%3D146%26spage%3D47%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Ferraroni</span>, <span class="hlFld-ContribAuthor ">Benedetta  Cornelio</span>, <span class="hlFld-ContribAuthor ">Janos  Sapi</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Andrea  Scozzafava</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonamide carbonic anhydrase inhibitors: Zinc coordination and tail effects influence inhibitory efficacy and selectivity for different isoforms. </span><span class="cited-content_cbyCitation_journal-name">Inorganica Chimica Acta</span><span> <strong>2018,</strong> <em>470 </em>, 128-132. <a href="https://doi.org/10.1016/j.ica.2017.03.038" title="DOI URL">https://doi.org/10.1016/j.ica.2017.03.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ica.2017.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ica.2017.03.038%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganica%2520Chimica%2520Acta%26atitle%3DSulfonamide%252Bcarbonic%252Banhydrase%252Binhibitors%25253A%252BZinc%252Bcoordination%252Band%252Btail%252Beffects%252Binfluence%252Binhibitory%252Befficacy%252Band%252Bselectivity%252Bfor%252Bdifferent%252Bisoforms%26aulast%3DFerraroni%26aufirst%3DMarta%26date%3D2018%26volume%3D470%26spage%3D128%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincenzo  Alterio</span>, <span class="hlFld-ContribAuthor ">Davide  Esposito</span>, <span class="hlFld-ContribAuthor ">Simona Maria  Monti</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Giuseppina  De Simone</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 151-157. <a href="https://doi.org/10.1080/14756366.2017.1405263" title="DOI URL">https://doi.org/10.1080/14756366.2017.1405263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2017.1405263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2017.1405263%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DCrystal%252Bstructure%252Bof%252Bthe%252Bhuman%252Bcarbonic%252Banhydrase%252BII%252Badduct%252Bwith%252B1-%2525284-sulfamoylphenyl-ethyl%252529-2%25252C4%25252C6-triphenylpyridinium%252Bperchlorate%25252C%252Ba%252Bmembrane-impermeant%25252C%252Bisoform%252Bselective%252Binhibitor%26aulast%3DAlterio%26aufirst%3DVincenzo%26date%3D2018%26date%3D2017%26volume%3D33%26issue%3D1%26spage%3D151%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Menicatti</span>, <span class="hlFld-ContribAuthor ">Marco  Pallecchi</span>, <span class="hlFld-ContribAuthor ">Silvia  Bua</span>, <span class="hlFld-ContribAuthor ">Daniela  Vullo</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Di Cesare Mannelli</span>, <span class="hlFld-ContribAuthor ">Carla  Ghelardini</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Gianluca  Bartolucci</span>. </span><span class="cited-content_cbyCitation_article-title">Resolution of co-eluting isomers of anti-inflammatory drugs conjugated to carbonic anhydrase inhibitors from plasma in liquid chromatography by energy-resolved tandem mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 671-679. <a href="https://doi.org/10.1080/14756366.2018.1445737" title="DOI URL">https://doi.org/10.1080/14756366.2018.1445737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1445737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1445737%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DResolution%252Bof%252Bco-eluting%252Bisomers%252Bof%252Banti-inflammatory%252Bdrugs%252Bconjugated%252Bto%252Bcarbonic%252Banhydrase%252Binhibitors%252Bfrom%252Bplasma%252Bin%252Bliquid%252Bchromatography%252Bby%252Benergy-resolved%252Btandem%252Bmass%252Bspectrometry%26aulast%3DMenicatti%26aufirst%3DMarta%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D671%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noor ul Amin  MOHSIN</span>, <span class="hlFld-ContribAuthor ">Matloob  AHMAD</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid organic molecules as antiinflammatory agents; a review of structural features and biological activity. </span><span class="cited-content_cbyCitation_journal-name">TURKISH JOURNAL OF CHEMISTRY</span><span> <strong>2018,</strong> <em>42 </em>, 1-20. <a href="https://doi.org/10.3906/kim-1706-58" title="DOI URL">https://doi.org/10.3906/kim-1706-58</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3906/kim-1706-58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3906%2Fkim-1706-58%26sid%3Dliteratum%253Aachs%26jtitle%3DTURKISH%2520JOURNAL%2520OF%2520CHEMISTRY%26atitle%3DHybrid%252Borganic%252Bmolecules%252Bas%252Bantiinflammatory%252Bagents%25253B%252Ba%252Breview%252Bof%252Bstructural%252Bfeatures%252Band%252Bbiological%252Bactivity%26aulast%3DMOHSIN%26aufirst%3DNoor%2Bul%2BAmin%26date%3D2018%26volume%3D42%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jekaterīna  Ivanova</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Daniela  Vullo</span>, <span class="hlFld-ContribAuthor ">Janis  Leitans</span>, <span class="hlFld-ContribAuthor ">Andris  Kazaks</span>, <span class="hlFld-ContribAuthor ">Kaspars  Tars</span>, <span class="hlFld-ContribAuthor ">Raivis  Žalubovskis</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">N -Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (13)
                                     , 3583-3589. <a href="https://doi.org/10.1016/j.bmc.2017.04.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DN%252B-Substituted%252Band%252Bring%252Bopened%252Bsaccharin%252Bderivatives%252Bselectively%252Binhibit%252Btransmembrane%25252C%252Btumor-associated%252Bcarbonic%252Banhydrases%252BIX%252Band%252BXII%26aulast%3DIvanova%26aufirst%3DJekater%25C4%25ABna%26date%3D2017%26volume%3D25%26issue%3D13%26spage%3D3583%26epage%3D3589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yeganeh  Entezari Heravi</span>, <span class="hlFld-ContribAuthor ">Silvia  Bua</span>, <span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Sonia  Del Prete</span>, <span class="hlFld-ContribAuthor ">Ali Akbar  Saboury</span>, <span class="hlFld-ContribAuthor ">Hassan  Sereshti</span>, <span class="hlFld-ContribAuthor ">Clemente  Capasso</span>, <span class="hlFld-ContribAuthor ">Paola  Gratteri</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Malassezia globosa carbonic anhydrase with phenols. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (9)
                                     , 2577-2582. <a href="https://doi.org/10.1016/j.bmc.2017.03.026" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252BMalassezia%252Bglobosa%252Bcarbonic%252Banhydrase%252Bwith%252Bphenols%26aulast%3DEntezari%2BHeravi%26aufirst%3DYeganeh%26date%3D2017%26volume%3D25%26issue%3D9%26spage%3D2577%26epage%3D2582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Daniela  Vullo</span>, <span class="hlFld-ContribAuthor ">Sameh M.  Osman</span>, <span class="hlFld-ContribAuthor ">Zeid  AlOthman</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (9)
                                     , 2569-2576. <a href="https://doi.org/10.1016/j.bmc.2017.03.027" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bcarbonic%252Banhydrase%252Binhibition%252Bof%252Ba%252Bseries%252Bof%252BSLC-0111%252Banalogs%26aulast%3DCarta%26aufirst%3DFabrizio%26date%3D2017%26volume%3D25%26issue%3D9%26spage%3D2569%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Menshawy A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Alaa A.-M.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Helmy M.  Sakr</span>, <span class="hlFld-ContribAuthor ">Adel S.  El-Azab</span>, <span class="hlFld-ContribAuthor ">Silvia  Bua</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and human/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (8)
                                     , 2524-2529. <a href="https://doi.org/10.1016/j.bmc.2017.03.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bhuman%25252Fbacterial%252Bcarbonic%252Banhydrase%252Binhibition%252Bwith%252Ba%252Bseries%252Bof%252Bsulfonamides%252Bincorporating%252Bphthalimido%252Bmoieties%26aulast%3DMohamed%26aufirst%3DMenshawy%2BA.%26date%3D2017%26volume%3D25%26issue%3D8%26spage%3D2524%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Rational design of the hybrids herein reported.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Scheme of Hybrid Compounds <b>4a</b>–<b>h</b> and <b>5a</b>–<b>h</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Key Intermediates <b>3a</b>,<b>b</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of the compounds <b>4a</b>–<b>h</b> and <b>5a</b>–<b>h</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Acute pain relieving effect of <b>4a</b>, <b>5b</b>, <b>5d</b>, <b>5f</b>, <b>5g</b>, and ibuprofen in a rat model of rheumatoid arthritis induced by CFA ia injection. Compounds were administered po at a dose of 10 mg kg<sup>–1</sup>, while ibuprofen was administered (po) at a dose of 100 mg kg<sup>–1</sup>. The paw pressure test was performed to evaluate the hypersensitivity to noxious mechanical stimuli. Measurements were performed on day 14 after CFA intra-articular injection. Compounds were suspended in 1% CMC and orally administered, evaluating the pain threshold over time. Control animals were treated with vehicle. The values represent the mean of eight rats performed in two different experimental sets. (∧∧) <i>P</i> < 0.01 vs vehicle + vehicle treated animals. (∗) <i>P</i> < 0.05 and (∗∗) <i>P</i> < 0.01 vs time 0 min of the same group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/medium/jm-2016-016074_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Acute pain relieving effect of <b>4a</b>, <b>5b</b>, <b>5d</b>, <b>5f</b>, and <b>5g</b> and ibuprofen in a rat model of rheumatoid arthritis induced by CFA ia injection. Compounds were administered po at a dose of 10 mg kg<sup>–1</sup>, while ibuprofen was administered (po) at a dose of 100 mg kg<sup>–1</sup>. The incapacitance test was performed to evaluate the hind limb weight bearing alterations measured as postural imbalance related to pain. Data are expressed as the difference between the weight applied on the contralateral and ipsilateral limb (Δweight). Measurements were performed on day 14 after CFA ia injection. Compounds were suspended in 1% CMC and orally administered, evaluating the postural balance over time. Control animals were treated with vehicle. The values represent the mean of eight rats performed in two different experimental sets. (∧∧) <i>P</i> < 0.01 vs vehicle + vehicle treated animals. (∗) <i>P</i> < 0.05 and (∗∗) <i>P</i> < 0.01 vs time 0 min of the same group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-3/acs.jmedchem.6b01607/20170203/images/large/jm-2016-016074_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01607&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Myasoedova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremers, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therneau, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S. E.</span><span> </span><span class="NLM_article-title">Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955–2007</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1576</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1002/art.27425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.27425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=20191579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3cvps1yqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1576-1582&author=E.+Myasoedovaauthor=C.+S.+Crowsonauthor=H.+M.+Kremersauthor=T.+M.+Therneauauthor=S.+E.+Gabriel&title=Is+the+incidence+of+rheumatoid+arthritis+rising%3F%3A+results+from+Olmsted+County%2C+Minnesota%2C+1955%E2%80%932007&doi=10.1002%2Fart.27425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007</span></div><div class="casAuthors">Myasoedova Elena; Crowson Cynthia S; Kremers Hilal Maradit; Therneau Terry M; Gabriel Sherine E</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1576-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To examine trends in the incidence and prevalence of rheumatoid arthritis (RA) from 1995 to 2007.  METHODS:  To augment our preexisting inception cohort of patients with RA (1955-1994), we assembled a population-based incidence cohort of individuals >or=18 years of age who first fulfilled the American College of Rheumatology 1987 criteria for the classification of RA between January 1, 1995 and December 31, 2007 and a cohort of patients with prevalent RA on January 1, 2005.  Incidence and prevalence rates were estimated and were age-and sex-adjusted to the white population in the US in 2000.  Trends in incidence rates were examined using Poisson regression methods.  RESULTS:  The 1995-2007 incidence cohort comprised 466 patients (mean age 55.6 years), 69% of whom were female and 66% of whom were rheumatoid factor positive.  The overall age- and sex-adjusted annual RA incidence was 40.9/100,000 population.  The age-adjusted incidence in women was 53.1/100,000 population (versus 27.7/100,000 population in men).  During the period of time from 1995 to 2007, the incidence of RA increased moderately in women (P = 0.02) but not in men (P = 0.74).  The increase was similar among all age groups.  The overall age- and sex-adjusted prevalence on January 1, 2005 was 0.72% (95% confidence interval [95% CI] 0.66, 0.77), which is an increase when compared with a prevalence of 0.62% (95% CI 0.55, 0.69) in 1995 (P < 0.001).  Applying the prevalence on January 1, 2005 to the US population in 2005 showed that an estimated 1.5 million US adults were affected by RA.  This is an increase from the previously reported 1.3 million adults with RA in the US.  CONCLUSION:  The incidence of RA in women appears to have increased during the period of time from 1995 to 2007.  The reasons for this recent increase are unknown, but environmental factors may play a role.  A corresponding increase in the prevalence of RA was also observed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQI-35xnnxjhRLDWw4HIq2sfW6udTcc2ebamWhD-P6b5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cvps1yqtw%253D%253D&md5=b2f5693bbfe2f2cdb97b002ed94e975f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fart.27425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27425%26sid%3Dliteratum%253Aachs%26aulast%3DMyasoedova%26aufirst%3DE.%26aulast%3DCrowson%26aufirst%3DC.%2BS.%26aulast%3DKremers%26aufirst%3DH.%2BM.%26aulast%3DTherneau%26aufirst%3DT.%2BM.%26aulast%3DGabriel%26aufirst%3DS.%2BE.%26atitle%3DIs%2520the%2520incidence%2520of%2520rheumatoid%2520arthritis%2520rising%253F%253A%2520results%2520from%2520Olmsted%2520County%252C%2520Minnesota%252C%25201955%25E2%2580%25932007%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D1576%26epage%3D1582%26doi%3D10.1002%2Fart.27425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yelin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, W.</span><span> </span><span class="NLM_article-title">The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=3668977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADyaL1c%252FjsFyksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1987&pages=710-717&author=E.+Yelinauthor=D.+Lubeckauthor=H.+Holmanauthor=W.+Epstein&title=The+impact+of+rheumatoid+arthritis+and+osteoarthritis%3A+the+activities+of+patients+with+rheumatoid+arthritis+and+osteoarthritis+compared+to+controls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls</span></div><div class="casAuthors">Yelin E; Lubeck D; Holman H; Epstein W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of rheumatology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">710-7</span>
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    </div><div class="casAbstract">We measured the impact of rheumatoid arthritis (RA) and osteoarthritis (OA) by comparing the activities of patients with these illnesses to controls matched for age, sex, and community of residence.  Our results indicate that patients with RA experience more losses than controls in every domain of human activity and that patients with OA experience more losses in the performance of household chores, shopping and errands, and leisure activities.  The methods described here provide a simple, reliable way to assess the impacts of illness in the same terms for all dimensions of human activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQI2S3ZhUeOWw5nADWVYHg1fW6udTcc2eZsQTn-flSqJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252FjsFyksw%253D%253D&md5=6f0e79449f64d6cca2b7d928a130941e</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYelin%26aufirst%3DE.%26aulast%3DLubeck%26aufirst%3DD.%26aulast%3DHolman%26aufirst%3DH.%26aulast%3DEpstein%26aufirst%3DW.%26atitle%3DThe%2520impact%2520of%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%253A%2520the%2520activities%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520osteoarthritis%2520compared%2520to%2520controls%26jtitle%3DJ.%2520Rheumatol.%26date%3D1987%26volume%3D14%26spage%3D710%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yelin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, W.</span><span> </span><span class="NLM_article-title">The work dynamics of the person with rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span><span class="refDoi"> DOI: 10.1002/art.1780300504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.1780300504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=3593434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADyaL2s3ktFOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=507-512&author=E.+Yelinauthor=C.+Henkeauthor=W.+Epstein&title=The+work+dynamics+of+the+person+with+rheumatoid+arthritis&doi=10.1002%2Fart.1780300504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The work dynamics of the person with rheumatoid arthritis</span></div><div class="casAuthors">Yelin E; Henke C; Epstein W</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-12</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">This paper traces the work history of patients with rheumatoid arthritis (RA) from the year of diagnosis to 1985.  The paper also describes the risk factors for work loss among patients with RA.  It uses data from a panel of 698 RA patients, observed for 4 years, from the practices of a random sample of northern California rheumatologists.  Of these 698, 353 had worked for pay at some point in their lives.  Three hundred six of the 353 had worked when diagnosed as having RA.  Of these 306, 157 (51%) were no longer working in 1985.  Forty-seven individuals started working after the onset of illness, but of these, approximately one-third had stopped working by 1985.  In all, 50% of RA patients with some work experience stopped working within a decade of diagnosis, 60% within 15 years, and 90% within 30 years.  We found that the probability of work loss is lessened among persons in jobs that have few physical requirements, among those with high levels of discretion over the pace and activities of work, and among those who were able to stay on the job held when the diagnosis was made.  The probability of work loss is increased among service workers.  The findings of this longitudinal study, showing that work characteristics profoundly alter the probability of work loss among persons with RA, are consistent with the findings of our earlier cross-sectional studies of work outcome and RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOCSTunNuI7A20zIbnCCI3fW6udTcc2eZsQTn-flSqJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s3ktFOmsg%253D%253D&md5=139f479967b8d4b6435044c279ca6814</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1002%2Fart.1780300504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.1780300504%26sid%3Dliteratum%253Aachs%26aulast%3DYelin%26aufirst%3DE.%26aulast%3DHenke%26aufirst%3DC.%26aulast%3DEpstein%26aufirst%3DW.%26atitle%3DThe%2520work%2520dynamics%2520of%2520the%2520person%2520with%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D1987%26volume%3D30%26spage%3D507%26epage%3D512%26doi%3D10.1002%2Fart.1780300504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Singh, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saag, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, S. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akl, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannuru, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaysbrot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNaughton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shmerling, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furst, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteson, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schousboe, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drevlow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginsberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grober, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Clair, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tindall, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlindon, T.</span><span> </span><span class="NLM_article-title">2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1002/art.39480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.39480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=26545940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC28zpvVGnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=1-26&author=J.+A.+Singhauthor=K.+G.+Saagauthor=S.+L.+Bridgesauthor=E.+A.+Aklauthor=R.+R.+Bannuruauthor=M.+C.+Sullivanauthor=E.+Vaysbrotauthor=C.+McNaughtonauthor=M.+Osaniauthor=R.+H.+Shmerlingauthor=J.+R.+Curtisauthor=D.+E.+Furstauthor=D.+Parksauthor=A.+Kavanaughauthor=J.+O%E2%80%99Dellauthor=C.+Kingauthor=A.+Leongauthor=E.+L.+Mattesonauthor=J.+T.+Schousboeauthor=B.+Drevlowauthor=S.+Ginsbergauthor=J.+Groberauthor=E.+W.+St.+Clairauthor=E.+Tindallauthor=A.+S.+Millerauthor=T.+McAlindon&title=2015+American+college+of+rheumatology+guideline+for+the+treatment+of+rheumatoid+arthritis&doi=10.1002%2Fart.39480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis</span></div><div class="casAuthors">Singh Jasvinder A; Saag Kenneth G; Bridges S Louis Jr; Curtis Jeffrey R; Akl Elie A; Bannuru Raveendhara R; Sullivan Matthew C; Vaysbrot Elizaveta; McNaughton Christine; Osani Mikala; McAlindon Timothy; Shmerling Robert H; Furst Daniel E; Parks Deborah; Kavanaugh Arthur; O'Dell James; King Charles; Leong Amye; Matteson Eric L; Schousboe John T; Drevlow Barbara; Grober James; Ginsberg Seth; St Clair E William; Tindall Elizabeth; Miller Amy S</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & rheumatology (Hoboken, N.J.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA).  METHODS:  We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options.  We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to rate the quality of evidence.  We employed a group consensus process to grade the strength of recommendations (either strong or conditional).  A strong recommendation indicates that clinicians are certain that the benefits of an intervention far outweigh the harms (or vice versa).  A conditional recommendation denotes uncertainty over the balance of benefits and harms and/or more significant variability in patient values and preferences.  RESULTS:  The guideline covers the use of traditional disease-modifying antirheumatic drugs (DMARDs), biologic agents, tofacitinib, and glucocorticoids in early (<6 months) and established (≥6 months) RA.  In addition, it provides recommendations on using a treat-to-target approach, tapering and discontinuing medications, and the use of biologic agents and DMARDs in patients with hepatitis, congestive heart failure, malignancy, and serious infections.  The guideline addresses the use of vaccines in patients starting/receiving DMARDs or biologic agents, screening for tuberculosis in patients starting/receiving biologic agents or tofacitinib, and laboratory monitoring for traditional DMARDs.  The guideline includes 74 recommendations: 23% are strong and 77% are conditional.  CONCLUSION:  This RA guideline should serve as a tool for clinicians and patients (our two target audiences) for pharmacologic treatment decisions in commonly encountered clinical situations.  These recommendations are not prescriptive, and the treatment decisions should be made by physicians and patients through a shared decision-making process taking into account patients' values, preferences, and comorbidities.  These recommendations should not be used to limit or deny access to therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI9Xng6yKjfjEC-75aqa5AfW6udTcc2eZsQTn-flSqJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zpvVGnsA%253D%253D&md5=b00a30744da179f257667fdb7f40ed2f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fart.39480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39480%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%2BA.%26aulast%3DSaag%26aufirst%3DK.%2BG.%26aulast%3DBridges%26aufirst%3DS.%2BL.%26aulast%3DAkl%26aufirst%3DE.%2BA.%26aulast%3DBannuru%26aufirst%3DR.%2BR.%26aulast%3DSullivan%26aufirst%3DM.%2BC.%26aulast%3DVaysbrot%26aufirst%3DE.%26aulast%3DMcNaughton%26aufirst%3DC.%26aulast%3DOsani%26aufirst%3DM.%26aulast%3DShmerling%26aufirst%3DR.%2BH.%26aulast%3DCurtis%26aufirst%3DJ.%2BR.%26aulast%3DFurst%26aufirst%3DD.%2BE.%26aulast%3DParks%26aufirst%3DD.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DLeong%26aufirst%3DA.%26aulast%3DMatteson%26aufirst%3DE.%2BL.%26aulast%3DSchousboe%26aufirst%3DJ.%2BT.%26aulast%3DDrevlow%26aufirst%3DB.%26aulast%3DGinsberg%26aufirst%3DS.%26aulast%3DGrober%26aufirst%3DJ.%26aulast%3DSt.%2BClair%26aufirst%3DE.%2BW.%26aulast%3DTindall%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DA.%2BS.%26aulast%3DMcAlindon%26aufirst%3DT.%26atitle%3D2015%2520American%2520college%2520of%2520rheumatology%2520guideline%2520for%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D1%26epage%3D26%26doi%3D10.1002%2Fart.39480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Agca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heslinga, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollefstad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heslinga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvien, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atzeni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primdahl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Södergren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallberg Jonsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Rompay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabalan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vlam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Gay, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semb, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitas, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulders, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szekanecz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symmons, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmohamed, M. T.</span><span> </span><span class="NLM_article-title">EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2016-209775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1136%2Fannrheumdis-2016-209775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=27697765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC2svlslWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=17-28&author=R.+Agcaauthor=S.+C.+Heslingaauthor=S.+Rollefstadauthor=M.+Heslingaauthor=I.+B.+McInnesauthor=M.+J.+Petersauthor=T.+K.+Kvienauthor=M.+Dougadosauthor=H.+Radnerauthor=F.+Atzeniauthor=J.+Primdahlauthor=A.+S%C3%B6dergrenauthor=S.+Wallberg+Jonssonauthor=J.+van+Rompayauthor=C.+Zabalanauthor=T.+R.+Pedersenauthor=L.+Jacobssonauthor=K.+de+Vlamauthor=M.+A.+Gonzalez-Gayauthor=A.+G.+Sembauthor=G.+D.+Kitasauthor=Y.+M.+Smuldersauthor=Z.+Szekaneczauthor=N.+Sattarauthor=D.+P.+Symmonsauthor=M.+T.+Nurmohamed&title=EULAR+recommendations+for+cardiovascular+disease+risk+management+in+patients+with+rheumatoid+arthritis+and+other+forms+of+inflammatory+joint+disorders%3A+2015%2F2016+update&doi=10.1136%2Fannrheumdis-2016-209775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update</span></div><div class="casAuthors">Agca R; Heslinga S C; Heslinga M; Rollefstad S; Semb A G; McInnes I B; Peters M J L; Smulders Y M; Kvien T K; Dougados M; Radner H; Atzeni F; Primdahl J; Primdahl J; Primdahl J; Sodergren A; Wallberg Jonsson S; van Rompay J; Zabalan C; Pedersen T R; Jacobsson L; Jacobsson L; de Vlam K; Gonzalez-Gay M A; Kitas G D; Szekanecz Z; Sattar N; Symmons D P M; Nurmohamed M T</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population.  In 2009, the European League Against Rheumatism (EULAR) taskforce recommended screening, identification of CVD risk factors and CVD risk management largely based on expert opinion.  In view of substantial new evidence, an update was conducted with the aim of producing CVD risk management recommendations for patients with IJD that now incorporates an increasing evidence base.  A multidisciplinary steering committee (representing 13 European countries) comprised 26 members including patient representatives, rheumatologists, cardiologists, internists, epidemiologists, a health professional and fellows.  Systematic literature searches were performed and evidence was categorised according to standard guidelines.  The evidence was discussed and summarised by the experts in the course of a consensus finding and voting process.  Three overarching principles were defined.  First, there is a higher risk for CVD in patients with RA, and this may also apply to ankylosing spondylitis and psoriatic arthritis.  Second, the rheumatologist is responsible for CVD risk management in patients with IJD.  Third, the use of non-steroidal anti-inflammatory drugs and corticosteroids should be in accordance with treatment-specific recommendations from EULAR and Assessment of Spondyloarthritis International Society.  Ten recommendations were defined, of which one is new and six were changed compared with the 2009 recommendations.  Each designated an appropriate evidence support level.  The present update extends on the evidence that CVD risk in the whole spectrum of IJD is increased.  This underscores the need for CVD risk management in these patients.  These recommendations are defined to provide assistance in CVD risk management in IJD, based on expert opinion and scientific evidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzCYVs9aAtomHOrQ6qeX-mfW6udTcc2eZ-9hcn3ajoA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svlslWjtQ%253D%253D&md5=a0755bf22a92e5469f33f04a835d4474</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2016-209775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2016-209775%26sid%3Dliteratum%253Aachs%26aulast%3DAgca%26aufirst%3DR.%26aulast%3DHeslinga%26aufirst%3DS.%2BC.%26aulast%3DRollefstad%26aufirst%3DS.%26aulast%3DHeslinga%26aufirst%3DM.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DPeters%26aufirst%3DM.%2BJ.%26aulast%3DKvien%26aufirst%3DT.%2BK.%26aulast%3DDougados%26aufirst%3DM.%26aulast%3DRadner%26aufirst%3DH.%26aulast%3DAtzeni%26aufirst%3DF.%26aulast%3DPrimdahl%26aufirst%3DJ.%26aulast%3DS%25C3%25B6dergren%26aufirst%3DA.%26aulast%3DWallberg%2BJonsson%26aufirst%3DS.%26aulast%3Dvan%2BRompay%26aufirst%3DJ.%26aulast%3DZabalan%26aufirst%3DC.%26aulast%3DPedersen%26aufirst%3DT.%2BR.%26aulast%3DJacobsson%26aufirst%3DL.%26aulast%3Dde%2BVlam%26aufirst%3DK.%26aulast%3DGonzalez-Gay%26aufirst%3DM.%2BA.%26aulast%3DSemb%26aufirst%3DA.%2BG.%26aulast%3DKitas%26aufirst%3DG.%2BD.%26aulast%3DSmulders%26aufirst%3DY.%2BM.%26aulast%3DSzekanecz%26aufirst%3DZ.%26aulast%3DSattar%26aufirst%3DN.%26aulast%3DSymmons%26aufirst%3DD.%2BP.%26aulast%3DNurmohamed%26aufirst%3DM.%2BT.%26atitle%3DEULAR%2520recommendations%2520for%2520cardiovascular%2520disease%2520risk%2520management%2520in%2520patients%2520with%2520rheumatoid%2520arthritis%2520and%2520other%2520forms%2520of%2520inflammatory%2520joint%2520disorders%253A%25202015%252F2016%2520update%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2017%26volume%3D76%26spage%3D17%26epage%3D28%26doi%3D10.1136%2Fannrheumdis-2016-209775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Agarwal, S. K.</span><span> </span><span class="NLM_article-title">Core management principles in rheumatoid arthritis to help guide managed care professionals</span> <span class="citation_source-journal">J. Manag. Care. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S03</span><span class="NLM_x">–</span> <span class="NLM_lpage">S08</span><span class="refDoi"> DOI: 10.18553/jmcp.2011.17.s9-b.S03</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.18553%2Fjmcp.2011.17.s9-b.S03" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=22073933" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=S03-S08&author=S.+K.+Agarwal&title=Core+management+principles+in+rheumatoid+arthritis+to+help+guide+managed+care+professionals&doi=10.18553%2Fjmcp.2011.17.s9-b.S03"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.18553%2Fjmcp.2011.17.s9-b.S03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18553%252Fjmcp.2011.17.s9-b.S03%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%2BK.%26atitle%3DCore%2520management%2520principles%2520in%2520rheumatoid%2520arthritis%2520to%2520help%2520guide%2520managed%2520care%2520professionals%26jtitle%3DJ.%2520Manag.%2520Care.%2520Pharm.%26date%3D2011%26volume%3D17%26spage%3DS03%26epage%3DS08%26doi%3D10.18553%2Fjmcp.2011.17.s9-b.S03" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kharlamova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherina, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potempa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israelsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirke, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yucel-Lindberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potempa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfredsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundberg, K.</span><span> </span><span class="NLM_article-title">Antibodies to porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology</span> <span class="citation_source-journal">Arthritis Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span><span class="refDoi"> DOI: 10.1002/art.39491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.39491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=26554752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFejs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=604-613&author=N.+Kharlamovaauthor=X.+Jiangauthor=N.+Sherinaauthor=B.+Potempaauthor=L.+Israelssonauthor=A.+M.+Quirkeauthor=K.+Erikssonauthor=T.+Yucel-Lindbergauthor=P.+J.+Venablesauthor=J.+Potempaauthor=L.+Alfredssonauthor=K.+Lundberg&title=Antibodies+to+porphyromonas+gingivalis+indicate+interaction+between+oral+infection%2C+smoking%2C+and+risk+genes+in+rheumatoid+arthritis+etiology&doi=10.1002%2Fart.39491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology</span></div><div class="casAuthors">Kharlamova, Nastya; Jiang, Xia; Sherina, Natalia; Potempa, Barbara; Israelsson, Lena; Quirke, Anne-Marie; Eriksson, Kaja; Yucel-Lindberg, Tuelay; Venables, Patrick J.; Potempa, Jan; Alfredsson, Lars; Lundberg, Karin</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">604-613</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To investigate the role of the periodontal pathogen Porphyromonas gingivalis in the etiol. of rheumatoid arthritis (RA) by analyzing the antibody response to the P gingivalis virulence factor arginine gingipain type B (RgpB) in relation to anti-citrullinated protein antibodies (ACPAs), smoking, and HLA-DRB1 shared epitope (SE) alleles in patients with periodontitis, patients with RA, and controls.  Methods: Anti-RgpB IgG was measured by ELISA in 65 periodontitis patients and 59 controls without periodontitis, and in 1,974 RA patients and 377 controls without RA from the Swedish population-based case-control Epidemiol. Investigation of Rheumatoid Arthritis (EIRA) study.  Autoantibody status, smoking habits, and genetic data were retrieved from the EIRA database.  Differences in antibody levels were examd. using the Mann-Whitney U test.  Unconditional logistic regression was used to calc. odds ratios (ORs) with 95% confidence intervals (95% CIs) for the assocn. of anti-RgpB IgG with different subsets of RA patients.  Results: Anti-RgpB antibody levels were significantly elevated in periodontitis patients compared to controls without periodontitis, in RA patients compared to controls without RA, and in ACPA-pos. RA patients compared to ACPA-neg. RA patients.  There was a significant assocn. between anti-RgpB IgG and RA (OR 2.96 [95% CI 2.00, 4.37]), which was even stronger than the assocn. between smoking and RA (OR 1.37 [95% CI 1.07, 1.74]), and in ACPA-pos. RA there were interactions between anti-RgpB antibodies and both smoking and the HLA-DRB1 SE.  Conclusion: Our study suggests that the previously reported link between periodontitis and RA could be accounted for by P gingivalis infection, and we conclude that P gingivalis is a credible candidate for triggering and/or driving autoimmunity and autoimmune disease in a subset of RA patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZVz8WqP0kLVg90H21EOLACvtfcHk0lhule9ywU2gsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFejs7g%253D&md5=eb120132bcdd1e4feff9d2f70178d92c</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Fart.39491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39491%26sid%3Dliteratum%253Aachs%26aulast%3DKharlamova%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSherina%26aufirst%3DN.%26aulast%3DPotempa%26aufirst%3DB.%26aulast%3DIsraelsson%26aufirst%3DL.%26aulast%3DQuirke%26aufirst%3DA.%2BM.%26aulast%3DEriksson%26aufirst%3DK.%26aulast%3DYucel-Lindberg%26aufirst%3DT.%26aulast%3DVenables%26aufirst%3DP.%2BJ.%26aulast%3DPotempa%26aufirst%3DJ.%26aulast%3DAlfredsson%26aufirst%3DL.%26aulast%3DLundberg%26aufirst%3DK.%26atitle%3DAntibodies%2520to%2520porphyromonas%2520gingivalis%2520indicate%2520interaction%2520between%2520oral%2520infection%252C%2520smoking%252C%2520and%2520risk%2520genes%2520in%2520rheumatoid%2520arthritis%2520etiology%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26spage%3D604%26epage%3D613%26doi%3D10.1002%2Fart.39491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lundberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yucel-Lindberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venables, P. J.</span><span> </span><span class="NLM_article-title">Periodontitis in RA-the citrullinated enolase connection</span> <span class="citation_source-journal">Nat. Rev. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1038/nrrheum.2010.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1038%2Fnrrheum.2010.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=20820197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=727-730&author=K.+Lundbergauthor=N.+Wegnerauthor=T.+Yucel-Lindbergauthor=P.+J.+Venables&title=Periodontitis+in+RA-the+citrullinated+enolase+connection&doi=10.1038%2Fnrrheum.2010.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Periodontitis in RA-the citrullinated enolase connection</span></div><div class="casAuthors">Lundberg, Karin; Wegner, Natalia; Yucel-Lindberg, Tulay; Venables, Patrick J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">727-730</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibodies to citrullinated enolase define a subset of rheumatoid arthritis (RA) assocd. with smoking and DR4 alleles.  In this Perspectives article, the authors review epidemiol. and genetic links between periodontitis (a disease in which Porphyromonas gingivalis is a major pathogen) and RA and propose that that the assocn. might be causal, due to mol. mimicry between epitopes on host and P. gingivalis citrullinated enolases driving the autoimmune response.  Autoimmunity in rheumatoid arthritis (RA) is characterized by an antibody response to citrullinated proteins.  Two of the risk factors for RA-HLA-DRB1 shared epitope alleles and smoking-are also assocd. with periodontitis, which is largely, but not exclusively, caused by Porphyromonas gingivalis infection.  Furthermore, RA and periodontitis have a similar pathophysiol., characterized by destructive inflammation.  The citrullination of proteins by P. gingivalis and the subsequent generation of autoantigens that drive autoimmunity in RA represents a possible causative link between these two diseases.  Antibodies directed towards the immunodominant epitope of human citrullinated α-enolase cross-react with a conserved sequence on citrullinated P. gingivalis enolase.  On the basis of this cross-reactivity, in this Perspectives article we explore the hypothesis of mol. mimicry in the etiol. of RA, with citrullinated enolase as the specific antigen involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAuxMkj0Tgk7Vg90H21EOLACvtfcHk0ljo3hOfbrKTSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLzI&md5=adae31402135be903bbc4d710422188d</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2010.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2010.139%26sid%3Dliteratum%253Aachs%26aulast%3DLundberg%26aufirst%3DK.%26aulast%3DWegner%26aufirst%3DN.%26aulast%3DYucel-Lindberg%26aufirst%3DT.%26aulast%3DVenables%26aufirst%3DP.%2BJ.%26atitle%3DPeriodontitis%2520in%2520RA-the%2520citrullinated%2520enolase%2520connection%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2010%26volume%3D6%26spage%3D727%26epage%3D730%26doi%3D10.1038%2Fnrrheum.2010.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Koziel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mydel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potempa, J.</span><span> </span><span class="NLM_article-title">The link between periodontal disease and rheumatoid arthritis: an updated review</span> <span class="citation_source-journal">Curr. Rheumatol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="refDoi"> DOI: 10.1007/s11926-014-0408-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1007%2Fs11926-014-0408-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=24458478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC2czovFGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=408&author=J.+Kozielauthor=P.+Mydelauthor=J.+Potempa&title=The+link+between+periodontal+disease+and+rheumatoid+arthritis%3A+an+updated+review&doi=10.1007%2Fs11926-014-0408-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">The link between periodontal disease and rheumatoid arthritis: an updated review</span></div><div class="casAuthors">Koziel Joanna; Mydel Piotr; Potempa Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current rheumatology reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">408</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Porphyromonas gingivalis is a leading pathogen in chronic periodontitis, a disease process involving progressive destruction of the tissues that support the teeth.  Recently, the organism has been reported to produce a unique bacterial enzyme, P. gingivalis peptidyl-arginine deiminase (PPAD), which has the ability to convert arginine residues in proteins to citrulline.  Protein citrullination alters protein structure and function; hence, PPAD may be involved in deregulation of the host's signalling network and immune evasion.  Further, accumulating evidence suggests a role for autoimmunity against citrullinated proteins in the development of rheumatoid arthritis (RA).  As inflammatory conditions in the lungs of cigarette smokers contribute to the breakdown of immune tolerance to citrullinated epitopes, chronic exposure to citrullinated proteins at periodontitis sites may also predispose susceptible individuals to the development of autoantibodies and the initiation of RA.  In this review, we discuss evidence that PPAD may represent a mechanistic link between periodontitis and RA, diseases that are known to be significantly associated at the epidemiological level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRec_aWYOizrNj_Vg2vObihfW6udTcc2eYJsZavbRagv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czovFGmsQ%253D%253D&md5=9fe703574164ad0b5dd9b69e0e8f204f</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1007%2Fs11926-014-0408-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11926-014-0408-9%26sid%3Dliteratum%253Aachs%26aulast%3DKoziel%26aufirst%3DJ.%26aulast%3DMydel%26aufirst%3DP.%26aulast%3DPotempa%26aufirst%3DJ.%26atitle%3DThe%2520link%2520between%2520periodontal%2520disease%2520and%2520rheumatoid%2520arthritis%253A%2520an%2520updated%2520review%26jtitle%3DCurr.%2520Rheumatol.%2520Rep.%26date%3D2014%26volume%3D16%26spage%3D408%26doi%3D10.1007%2Fs11926-014-0408-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Trabocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krimmelbein, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guarna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span> </span><span class="NLM_article-title">Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.3109/14756366.2014.947976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2014.947976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=25198885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=466-471&author=A.+Trabocchiauthor=N.+Palaauthor=I.+Krimmelbeinauthor=G.+Menchiauthor=A.+Guarnaauthor=M.+Sechiauthor=T.+Drekerauthor=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Peptidomimetics+as+protein+arginine+deiminase+4+%28PAD4%29+inhibitors&doi=10.3109%2F14756366.2014.947976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors</span></div><div class="casAuthors">Trabocchi, Andrea; Pala, Nicolino; Krimmelbein, Ilga; Menchi, Gloria; Guarna, Antonio; Sechi, Mario; Dreker, Tobias; Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The protein arginine deiminase 4 (PAD4) is a calcium-dependent enzyme, which catalyzes the irreversible conversion of peptidyl-arginines into peptidyl-citrullines and plays an important role in several diseases such as in the rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, Creutzfeldt-Jacob's disease and cancer.  In this study, the authors report the inhibition profiles and computational docking toward the PAD4 enzyme of a series of 1,2,3-triazole peptidomimetic-based derivs. incorporating the β-phenylalanine and guanidine scaffolds.  Several effective, low micromolar PAD4 inhibitors are reported in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgnjqFPrxaT7Vg90H21EOLACvtfcHk0ljo3hOfbrKTSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbvE&md5=3524acfe15eeb79049a7bceb6dd1b6e7</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.3109%2F14756366.2014.947976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2014.947976%26sid%3Dliteratum%253Aachs%26aulast%3DTrabocchi%26aufirst%3DA.%26aulast%3DPala%26aufirst%3DN.%26aulast%3DKrimmelbein%26aufirst%3DI.%26aulast%3DMenchi%26aufirst%3DG.%26aulast%3DGuarna%26aufirst%3DA.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DDreker%26aufirst%3DT.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DPeptidomimetics%2520as%2520protein%2520arginine%2520deiminase%25204%2520%2528PAD4%2529%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2015%26volume%3D30%26spage%3D466%26epage%3D471%26doi%3D10.3109%2F14756366.2014.947976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Witalison, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofseth, L. J.</span><span> </span><span class="NLM_article-title">Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.2174/1389450116666150202160954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.2174%2F1389450116666150202160954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=25642720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSht7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=700-710&author=E.+E.+Witalisonauthor=P.+R.+Thompsonauthor=L.+J.+Hofseth&title=Protein+arginine+deiminases+and+associated+citrullination%3A+physiological+functions+and+diseases+associated+with+dysregulation&doi=10.2174%2F1389450116666150202160954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation</span></div><div class="casAuthors">Witalison, Erin E.; Thompson, Paul R.; Hofseth, Lorne J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">700-710</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Human proteins are subjected to more than 200 known post-translational modifications (PTMs) (e.g., phosphorylation, glycosylation, ubiquitination, S-nitrosylation, methylation, Nacetylation, and citrullination) and these PTMs can alter protein structure and function with consequent effects on the multitude of pathways necessary for maintaining the physiol. homeostasis.  When dysregulated, however, the enzymes that catalyze these PTMs can impact the genesis of countless diseases.  In this review, we will focus on protein citrullination, a PTM catalyzed by the Protein Arginine Deiminase (PAD) family of enzymes.  Specifically, we will describe the roles of the PADs in both normal human physiol. and disease.  The development of PAD inhibitors and their efficacy in a variety of autoimmune disorders and cancer will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdv_o7-kOsurVg90H21EOLACvtfcHk0ljyOfawaUrVww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSht7vJ&md5=9d0072b3b5e23308858bb4cd4ed0cab7</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.2174%2F1389450116666150202160954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450116666150202160954%26sid%3Dliteratum%253Aachs%26aulast%3DWitalison%26aufirst%3DE.%2BE.%26aulast%3DThompson%26aufirst%3DP.%2BR.%26aulast%3DHofseth%26aufirst%3DL.%2BJ.%26atitle%3DProtein%2520arginine%2520deiminases%2520and%2520associated%2520citrullination%253A%2520physiological%2520functions%2520and%2520diseases%2520associated%2520with%2520dysregulation%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2015%26volume%3D16%26spage%3D700%26epage%3D710%26doi%3D10.2174%2F1389450116666150202160954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maddur, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miossec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaveri, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayry, J.</span><span> </span><span class="NLM_article-title">Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">181</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2012.03.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.ajpath.2012.03.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=22640807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOitbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2012&pages=8-18&author=M.+S.+Maddurauthor=P.+Miossecauthor=S.+V.+Kaveriauthor=J.+Bayry&title=Th17+cells%3A+biology%2C+pathogenesis+of+autoimmune+and+inflammatory+diseases%2C+and+therapeutic+strategies&doi=10.1016%2Fj.ajpath.2012.03.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Th 17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies</span></div><div class="casAuthors">Maddur, Mohan S.; Miossec, Pierre; Kaveri, Srini V.; Bayry, Jagadeesh</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-18</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Th17 cells that secrete the cytokines IL-17A and IL-17F and express lineage-specific transcription factor RORC (RORγt in mice) represent a distinct lineage of CD4+ T cells.  Transforming growth factor-β and inflammatory cytokines, such as IL-6, IL-21, IL-1β, and IL-23, play central roles in the generation of Th17 cells.  Th17 cells are crit. for the clearance of extracellular pathogens, including Candida and Klebsiella.  However, under certain conditions, these cells and their effector mols., such as IL-17, IL-21, IL-22, GM-CSF, and CCL20, are assocd. with the pathogenesis of several autoimmune and inflammatory diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, inflammatory bowel disease, and allergy and asthma.  This review discusses these disease states and the various therapeutic strategies under investigation to target Th17 cells, which include blocking the differentiation and amplification of Th17 cells, inhibiting or neutralizing the cytokines of Th17 cells, and suppressing the transcription factors specific for Th17 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8EspukaEizbVg90H21EOLACvtfcHk0ljyOfawaUrVww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOitbbF&md5=15b79f41578ef7eaef6798a93e175c16</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.03.044%26sid%3Dliteratum%253Aachs%26aulast%3DMaddur%26aufirst%3DM.%2BS.%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKaveri%26aufirst%3DS.%2BV.%26aulast%3DBayry%26aufirst%3DJ.%26atitle%3DTh17%2520cells%253A%2520biology%252C%2520pathogenesis%2520of%2520autoimmune%2520and%2520inflammatory%2520diseases%252C%2520and%2520therapeutic%2520strategies%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D181%26spage%3D8%26epage%3D18%26doi%3D10.1016%2Fj.ajpath.2012.03.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Skapenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipsky, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Koops, H.</span><span> </span><span class="NLM_article-title">The role of the T cell in autoimmune inflammation</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">S4</span><span class="NLM_x">–</span> <span class="NLM_lpage">S14</span><span class="refDoi"> DOI: 10.1186/ar1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1186%2Far1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=15833146" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=S4-S14&author=A.+Skapenkoauthor=J.+Leipeauthor=P.+E.+Lipskyauthor=H.+Schulze-Koops&title=The+role+of+the+T+cell+in+autoimmune+inflammation&doi=10.1186%2Far1703"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1186%2Far1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far1703%26sid%3Dliteratum%253Aachs%26aulast%3DSkapenko%26aufirst%3DA.%26aulast%3DLeipe%26aufirst%3DJ.%26aulast%3DLipsky%26aufirst%3DP.%2BE.%26aulast%3DSchulze-Koops%26aufirst%3DH.%26atitle%3DThe%2520role%2520of%2520the%2520T%2520cell%2520in%2520autoimmune%2520inflammation%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2005%26volume%3D7%26spage%3DS4%26epage%3DS14%26doi%3D10.1186%2Far1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kanda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimura, T.</span><span> </span><span class="NLM_article-title">Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios</span> <span class="citation_source-journal">Mod. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.3109/s10165-007-0589-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2Fs10165-007-0589-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=17929126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGgs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=364-368&author=H.+Kandaauthor=K.+Yokotaauthor=C.+Kohnoauthor=T.+Sawadaauthor=K.+Satoauthor=M.+Yamaguchiauthor=Y.+Komagataauthor=K.+Shimadaauthor=K.+Yamamotoauthor=T.+Mimura&title=Effects+of+low-dosage+simvastatin+on+rheumatoid+arthritis+through+reduction+of+Th1%2FTh2+and+CD4%2FCD8+ratios&doi=10.3109%2Fs10165-007-0589-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios</span></div><div class="casAuthors">Kanda, Hiroko; Yokota, Kazuhiro; Kohno, Chieko; Sawada, Tetsuji; Sato, Kojiro; Yamaguchi, Masao; Komagata, Yoshinori; Shimada, Kota; Yamamoto, Kazuhiko; Mimura, Toshihide</div><div class="citationInfo"><span class="NLM_cas:title">Modern Rheumatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">364-368</span>CODEN:
                <span class="NLM_cas:coden">MROHA4</span>;
        ISSN:<span class="NLM_cas:issn">1439-7595</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">The objective of this study was to assess both the anti-inflammatory and immunomodulatory effects of low-dosage simvastatin on rheumatoid arthritis (RA).  In each patient, simvastatin at 10 mg/day was administered for 12 wk.  The other treatments were unchanged at least 3 mo before simvastatin administration to the end of the study.  Patients were assessed for the improvement in clin., lab., and immunol. parameters of RA and for adverse events.  Twenty-four patients with RA were enrolled.  Clin. symptoms, including patient's assessment of pain and disease activity on visual analog scale (VAS), the swollen joint and tender joint counts, and handgrip strength significantly improved.  Physician's assessment of disease activity on VAS, a period of morning stiffness and modified health assessment questionnaire showed a tendency of improving after administration of low-dosage of simvastatin.  Of special interest was that the median levels of erythrocytes sedimentation rate, C-reactive protein, and rheumatoid factor were significantly decreased from 54.0 mm/h to 45.5 mm/h, from 1.50 mg/dL to 0.85 mg/dL, and from 57.0 IU/mL to 28.0 IU/mL, resp., after administration of simvastatin.  ACR20 and ACR50 responses were achieved in 62% and 38%, resp., of simvastatin-treated patients for 12 wk.  Immunol. assessment in peripheral blood revealed that the Th1/Th2 and CD4/CD8 ratios were significantly reduced by simvastatin.  No adverse events were reported during simvastatin treatment.  Immunomodulation through the alteration of Th1/Th2 and CD4/CD8 ratios may be a pharmacol. mechanism in the anti-rheumatic effect of low-dosage simvastatin.  Although it is necessary to evaluate the long-term effects of statins, low-dosage statins appear to be good as addnl. therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo71tTjmt1TOLVg90H21EOLACvtfcHk0ljTUYiBGXhW8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGgs7rL&md5=d2d8b418160109620bb7ec906003c2b9</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.3109%2Fs10165-007-0589-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252Fs10165-007-0589-4%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DH.%26aulast%3DYokota%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DC.%26aulast%3DSawada%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DKomagata%26aufirst%3DY.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DMimura%26aufirst%3DT.%26atitle%3DEffects%2520of%2520low-dosage%2520simvastatin%2520on%2520rheumatoid%2520arthritis%2520through%2520reduction%2520of%2520Th1%252FTh2%2520and%2520CD4%252FCD8%2520ratios%26jtitle%3DMod.%2520Rheumatol.%26date%3D2007%26volume%3D17%26spage%3D364%26epage%3D368%26doi%3D10.3109%2Fs10165-007-0589-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Leipe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dechant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerzendorf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Koops, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skapenko, A.</span><span> </span><span class="NLM_article-title">Role of Th17 cells in human autoimmune arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">2876</span><span class="NLM_x">–</span> <span class="NLM_lpage">2885</span><span class="refDoi"> DOI: 10.1002/art.27622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1002%2Fart.27622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=20583102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=2876-2885&author=J.+Leipeauthor=M.+Grunkeauthor=C.+Dechantauthor=C.+Reindlauthor=U.+Kerzendorfauthor=H.+Schulze-Koopsauthor=A.+Skapenko&title=Role+of+Th17+cells+in+human+autoimmune+arthritis&doi=10.1002%2Fart.27622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Th17 cells in human autoimmune arthritis</span></div><div class="casAuthors">Leipe, Jan; Grunke, Mathias; Dechant, Claudia; Reindl, Christiane; Kerzendorf, Ulrike; Schulze-Koops, Hendrik; Skapenko, Alla</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2876-2885</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To delineate the role of Th17 cells in the pathogenesis of autoimmune arthritides.  Th17 cells were analyzed in well-defined homogeneous cohorts of patients with the prototypical autoimmune arthritides rheumatoid arthritis (RA) and psoriatic arthritis (PsA), grouped according to patients who had very early active RA (n = 36; mean disease duration 2.8 mo, Disease Activity Score in 28 joints 5.0) and those who had very early active PsA (n = 20; mean disease duration 2.3 mo), none of whom had received treatment with glucocorticoids or disease-modifying antirheumatic drugs, as well as patients with established RA (n = 21; mean disease duration 68 mo) who were considered either responders or nonresponders to therapy.  Groups of healthy individuals and patients with osteoarthritis (a noninflammatory arthritis) were used as control cohorts.  Expression of T lineage-specific transcription factors (RORC, T-bet, GATA-3, and FoxP3) and the response of CD4 T cells to Th17 cell-inducing conditions were analyzed in vitro.  The frequencies of Th17 cells and levels of interleukin-17 strongly correlated with systemic disease activity at both the onset and the progression of RA or PsA.  The values were reduced to control levels in patients with treatment-controlled disease activity.  Th17 cells were enriched in the joints, and increased frequencies of synovial Th17 cells expressed CCR4 and CCR6, indicative of selective migration of Th17 cells to the joints.  The intrinsically elevated expression of RORC, accompanied by biased Th17 cell development, and the resistance of Th17 cells to a natural cytokine antagonist in patients with RA and patients with PsA were suggestive of the underlying mol. mechanisms of uncontrolled Th17 activity in these patients.  Th17 cells play an important role in inflammation in human autoimmune arthritides, both at the onset and in established disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp62F0RUDGaUrVg90H21EOLACvtfcHk0ljTUYiBGXhW8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrrK&md5=922bf3cabf3d6ad57ebeb90c07def4c2</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1002%2Fart.27622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27622%26sid%3Dliteratum%253Aachs%26aulast%3DLeipe%26aufirst%3DJ.%26aulast%3DGrunke%26aufirst%3DM.%26aulast%3DDechant%26aufirst%3DC.%26aulast%3DReindl%26aufirst%3DC.%26aulast%3DKerzendorf%26aufirst%3DU.%26aulast%3DSchulze-Koops%26aufirst%3DH.%26aulast%3DSkapenko%26aufirst%3DA.%26atitle%3DRole%2520of%2520Th17%2520cells%2520in%2520human%2520autoimmune%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D2876%26epage%3D2885%26doi%3D10.1002%2Fart.27622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Souza-Moreira, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos-Salinas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Rey, E.</span><span> </span><span class="NLM_article-title">Neuropeptides as pleiotropic modulators of the immune response</span> <span class="citation_source-journal">Neuroendocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1159/000328636</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1159%2F000328636" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21734355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yltbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2011&pages=89-100&author=L.+Souza-Moreiraauthor=J.+Campos-Salinasauthor=M.+Caroauthor=E.+Gonzalez-Rey&title=Neuropeptides+as+pleiotropic+modulators+of+the+immune+response&doi=10.1159%2F000328636"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptides as pleiotropic modulators of the immune response</span></div><div class="casAuthors">Souza-Moreira, Luciana; Campos-Salinas, Jenny; Caro, Marta; Gonzalez-Rey, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Neuroendocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">NUNDAJ</span>;
        ISSN:<span class="NLM_cas:issn">0028-3835</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Although necessary to eliminate pathogens, inflammation can lead to serious deleterious effects in the host if left unchecked.  During the inflammatory response, further damage may arise from potential autoimmune responses occurring when the immune cells and mols. that respond to pathogen-derived antigens also react to self-antigens.  In this sense, the identification of endogenous factors that control exacerbated immune responses is a key goal for the development of new therapeutic approaches for inflammatory and autoimmune diseases.  Some neuropeptides that are produced during the ongoing inflammatory response have emerged as endogenous anti-inflammatory agents that could collaborate in tuning the balanced steady state of the immune system.  These neuropeptides participate in maintaining immune tolerance through two distinct mechanisms: by regulating the balance between pro-inflammatory and anti-inflammatory factors, and by inducing the emergence of regulatory T cells with suppressive activity against autoreactive T cell effectors.  Indeed, a functioning neuropeptide system contributes to general health, and alterations in the levels of these neuropeptides and/or their receptors lead to changes in susceptibility to inflammatory and autoimmune diseases.  Recently, we found that some neuropeptides also have antimicrobial and antiparasitic actions, suggesting that they could act as primary mediators of innate defense, even in the most primitive organisms.  In this review, we use the vasoactive intestinal peptide as example of an immunomodulatory neuropeptide to summarize the most relevant data found for other neuropeptides with similar characteristics, including adrenomedullin, urocortin, cortistatin and ghrelin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroOMkNxl3ofbVg90H21EOLACvtfcHk0ljTUYiBGXhW8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yltbzJ&md5=948602015c5ab1cda2af2c4b6f7c2ea8</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1159%2F000328636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000328636%26sid%3Dliteratum%253Aachs%26aulast%3DSouza-Moreira%26aufirst%3DL.%26aulast%3DCampos-Salinas%26aufirst%3DJ.%26aulast%3DCaro%26aufirst%3DM.%26aulast%3DGonzalez-Rey%26aufirst%3DE.%26atitle%3DNeuropeptides%2520as%2520pleiotropic%2520modulators%2520of%2520the%2520immune%2520response%26jtitle%3DNeuroendocrinology%26date%3D2011%26volume%3D94%26spage%3D89%26epage%3D100%26doi%3D10.1159%2F000328636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Delgado, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganea, D.</span><span> </span><span class="NLM_article-title">Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents</span> <span class="citation_source-journal">Brain, Behav., Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span><span class="refDoi"> DOI: 10.1016/j.bbi.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bbi.2008.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1146-1151&author=M.+Delgadoauthor=D.+Ganea&title=Anti-inflammatory+neuropeptides%3A+a+new+class+of+endogenous+immunoregulatory+agents&doi=10.1016%2Fj.bbi.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DM.%26aulast%3DGanea%26aufirst%3DD.%26atitle%3DAnti-inflammatory%2520neuropeptides%253A%2520a%2520new%2520class%2520of%2520endogenous%2520immunoregulatory%2520agents%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2008%26volume%3D22%26spage%3D1146%26epage%3D1151%26doi%3D10.1016%2Fj.bbi.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Margheri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceruso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurenzana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzeri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annunziato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Rosso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimaz, R.</span><span> </span><span class="NLM_article-title">Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">60</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1080/14756366.2016.1217857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1080%2F14756366.2016.1217857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=27539792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOmt7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=60-63&author=F.+Margheriauthor=M.+Cerusoauthor=F.+Cartaauthor=A.+Laurenzanaauthor=L.+Maggiauthor=S.+Lazzeriauthor=G.+Simoniniauthor=F.+Annunziatoauthor=M.+Del+Rossoauthor=C.+T.+Supuranauthor=R.+Cimaz&title=Overexpression+of+the+transmembrane+carbonic+anhydrase+isoforms+IX+and+XII+in+the+inflamed+synovium&doi=10.1080%2F14756366.2016.1217857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium</span></div><div class="casAuthors">Margheri, Francesca; Ceruso, Mariangela; Carta, Fabrizio; Laurenzana, Anna; Maggi, Laura; Lazzeri, Simone; Simonini, Gabriele; Annunziato, Francesco; Del Rosso, Mario; Supuran, Claudiu T.; Cimaz, Rolando</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup4</span>),
    <span class="NLM_cas:pages">60-63</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Juvenile idiopathic arthritis (JIA) is the most common form of chronic rheumatic disease affecting children worldwide, with some features similar to adult rheumatoid arthritis (RA).  In the present study, we aim at investigating novel markers that will allow in the future for tailored, more personalized treatment strategies.  Hence, taking notice of several reports proving the role of local acidosis as a causal link between inflammatory diseases and related pain, and the involvement of several carbonic anhydrases (CA, EC 4.2.1.1) isoforms in articular diseases, we evaluated in JIA patients the expression of these metalloenzymes.  We identified that JIA patients show high levels of active CA IX and XII isoforms.  Our results represent the first evidence of the identification of these enzymes as potential therapeutic targets and development of novel innovative therapies for arthritis, also considering that the two isoforms are validated antitumor targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4HZAqJSLZZLVg90H21EOLACvtfcHk0ljJ5zcHducziA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOmt7%252FI&md5=780b2ae6f9d02050c0c167e8cec91c8c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1080%2F14756366.2016.1217857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2016.1217857%26sid%3Dliteratum%253Aachs%26aulast%3DMargheri%26aufirst%3DF.%26aulast%3DCeruso%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DLaurenzana%26aufirst%3DA.%26aulast%3DMaggi%26aufirst%3DL.%26aulast%3DLazzeri%26aufirst%3DS.%26aulast%3DSimonini%26aufirst%3DG.%26aulast%3DAnnunziato%26aufirst%3DF.%26aulast%3DDel%2BRosso%26aufirst%3DM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCimaz%26aufirst%3DR.%26atitle%3DOverexpression%2520of%2520the%2520transmembrane%2520carbonic%2520anhydrase%2520isoforms%2520IX%2520and%2520XII%2520in%2520the%2520inflamed%2520synovium%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D60%26epage%3D63%26doi%3D10.1080%2F14756366.2016.1217857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Chang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, Y.</span><span> </span><span class="NLM_article-title">Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis</span> <span class="citation_source-journal">BMC Musculoskeletal Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span><span class="refDoi"> DOI: 10.1186/1471-2474-11-279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1186%2F1471-2474-11-279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21143847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=279-290&author=X.+Changauthor=J.+Hanauthor=Y.+Zhaoauthor=X.+Yanauthor=S.+Sunauthor=Y.+Cui&title=Increased+expression+of+carbonic+anhydrase+I+in+the+synovium+of+patients+with+ankylosing+spondylitis&doi=10.1186%2F1471-2474-11-279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis</span></div><div class="casAuthors">Chang, Xiaotian; Han, Jinxiang; Zhao, Yan; Yan, Xinfeng; Shun, Shui; Cui, Yazhou</div><div class="citationInfo"><span class="NLM_cas:title">BMC Musculoskeletal Disorders</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279</span>CODEN:
                <span class="NLM_cas:coden">BMDMCE</span>;
        ISSN:<span class="NLM_cas:issn">1471-2474</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: One of the most distinctive features of ankylosing spondylitis (AS) is new bone formation and bone resorption at sites of chronic inflammation.  Previous studies have indicated that the hyperplasia and inflammation of synovial tissues are significantly related to the pathogenic process of AS.  The present study used a proteomic approach to identify novel AS-specific proteins by simultaneously comparing the expression profiles of synovial membranes from patients with AS, rheumatoid arthritis (RA) and osteoarthritis (OA).  Methods: Synovial tissues were collected from the hip joints of patients with AS and knee joints of patients with RA or OA (n = 10 for each disease) during joint replacement surgery.  Proteins extd. from the synovial tissues were sepd. by 2-D electrophoresis (2-DE), and the proteins with significantly increased expression in the AS samples were subjected to MALDI-TOF/TOF-MS anal.  The results were verified using western blotting and immunohistochem.  Levels of the candidate proteins in synovial fluids from knee joints (n = 40 for each disease) were measured using ELISA.  Results: The proteomic approach revealed significantly increased expression of carbonic anhydrase I (CA1) in the synovial membrane of patients with AS as compared with the RA and OA tissue samples.  Immunohistochem. and western blotting anal. confirmed the findings described above.  The ELISA detected a higher level of CA1 in synovial fluids from patients with AS than those with OA.  The mean value of the CA1 level was also higher in AS patients as compared with RA patients.  This study also detected increased expression of alpha-1-antitrypsin in the synovial tissues from AS patients, which is in agreement with other reports.  Conclusion: In vitro expts. by other groups indicated that CA1 catalyzes the generation of HCO3- through the hydration of CO2, which then combines with Ca2+ to form a CaCO3 ppt.  Calcification is an essential step of bone formation.  Substantial evidence indicates that carbonic anhydrase also stimulates bone resorption.  Hence, overexpression of CA1 in the synovial tissues of AS patients may promote improper calcification and bone resorption in AS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCHbyoabCvlrVg90H21EOLACvtfcHk0ljJ5zcHducziA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrjK&md5=3fe0aded3642803229d61d98ea2471d0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2F1471-2474-11-279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2474-11-279%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DY.%26atitle%3DIncreased%2520expression%2520of%2520carbonic%2520anhydrase%2520I%2520in%2520the%2520synovium%2520of%2520patients%2520with%2520ankylosing%2520spondylitis%26jtitle%3DBMC%2520Musculoskeletal%2520Disord.%26date%3D2010%26volume%3D11%26spage%3D279%26epage%3D290%26doi%3D10.1186%2F1471-2474-11-279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X.</span><span> </span><span class="NLM_article-title">Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction</span> <span class="citation_source-journal">BMC Musculoskeletal Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1186/1471-2474-13-256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1186%2F1471-2474-13-256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23256642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Oqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=256-265&author=Y.+Zhengauthor=L.+Wangauthor=W.+Zhangauthor=H.+Xuauthor=X.+Chang&title=Transgenic+mice+over-expressing+carbonic+anhydrase+I+showed+aggravated+joint+inflammation+and+tissue+destruction&doi=10.1186%2F1471-2474-13-256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction</span></div><div class="casAuthors">Zheng, Yabing; Wang, Lin; Zhang, Wei; Xu, Hengwei; Chang, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">BMC Musculoskeletal Disorders</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">256</span>CODEN:
                <span class="NLM_cas:coden">BMDMCE</span>;
        ISSN:<span class="NLM_cas:issn">1471-2474</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Studies have demonstrated that carbonic anhydrase I (CA1) stimulates calcium salt pptn. and cell calcification, which is an essential step in new bone formation.  Our study had reported that CA1 encoding gene has a strong assocn. with rheumatoid arthritis (RA) and ankylosing spondylitis (AS), two rheumatic diseases with abnormal new bone formation and bone resorption in joints.  This study investigated the effect of CA1 on joint inflammation and tissue destruction in transgenic mice that over-express CA1 (CA1-Tg).  Methods: CA1-Tg was generated with C57BL/6J mice by conventional methods.  CA1-Tg was treated with collagen-II to induce arthritis (CIA).  Wild-type mice, CA1-Tg treated with bovine serum albumin (BSA) and transgenic mice over-expressing PADI4 (PADI4-Tg), a gene known to be involved in rheumatoid arthritis, were used as controls.  Histochem. and X-ray radiog. assay were used to examine joint destruction.  Western blotting and real time-PCR were used to examine CA1 expression.  Results: CIA was obsd. in 60% of CA1-Tg, 20% of PADI4-Tg and 20% of wild-type mice after collagen injections.  No CIA was found in CA1-Tg mice that received injections of BSA.  The arthritic score was 5.5 ± 0.84 in the CA1-Tgs but the score was less than 2 in the injected wild-type mice and the PADI4-Tgs.  The thickness of the hind paws in the CA1-Tgs was 3.46 ± 0.11 mm, which was thicker than that of PADI4-Tgs (2.23 ± 0.08 mm), wild-type mice (2.08 ± 0.06 mm) and BSA-treated CA1-Tgs (2.04 ± 0.07 mm).  Histochem. showed obvious inflammation, synovial hyperplasia and bone destruction in the joints of CA1-Tg that was not detected in PADI4-Tgs or wild-type mice.  X-ray assays showed bone fusion in the paws and spines of CA1-Tg mice.  Conclusion: Over-expression of CA1 may aggravate joint inflammation and tissue destruction in the transgenic mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBgR7O5Re0G7Vg90H21EOLACvtfcHk0ljJ5zcHducziA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Oqtrw%253D&md5=ccd41a8452b65cf7e8d510302ca8f44d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1471-2474-13-256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2474-13-256%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DX.%26atitle%3DTransgenic%2520mice%2520over-expressing%2520carbonic%2520anhydrase%2520I%2520showed%2520aggravated%2520joint%2520inflammation%2520and%2520tissue%2520destruction%26jtitle%3DBMC%2520Musculoskeletal%2520Disord.%26date%3D2012%26volume%3D13%26spage%3D256%26epage%3D265%26doi%3D10.1186%2F1471-2474-13-256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Deutsch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krief, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konttinen, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaks, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aframian, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmon, A.</span><span> </span><span class="NLM_article-title">Identification of Sjögren’s syndrome oral fluid biomarker candidates following high-abundance protein depletion</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1093/rheumatology/keu405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1093%2Frheumatology%2Fkeu405" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=884-890&author=O.+Deutschauthor=G.+Kriefauthor=Y.+T.+Konttinenauthor=B.+Zaksauthor=D.+T.+Wongauthor=D.+J.+Aframianauthor=A.+Palmon&title=Identification+of+Sj%C3%B6gren%E2%80%99s+syndrome+oral+fluid+biomarker+candidates+following+high-abundance+protein+depletion&doi=10.1093%2Frheumatology%2Fkeu405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkeu405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkeu405%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DO.%26aulast%3DKrief%26aufirst%3DG.%26aulast%3DKonttinen%26aufirst%3DY.%2BT.%26aulast%3DZaks%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DD.%2BT.%26aulast%3DAframian%26aufirst%3DD.%2BJ.%26aulast%3DPalmon%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520Sj%25C3%25B6gren%25E2%2580%2599s%2520syndrome%2520oral%2520fluid%2520biomarker%2520candidates%2520following%2520high-abundance%2520protein%2520depletion%26jtitle%3DRheumatology%26date%3D2015%26volume%3D54%26spage%3D884%26epage%3D890%26doi%3D10.1093%2Frheumatology%2Fkeu405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span> </span><span class="NLM_article-title">Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure</span> <span class="citation_source-journal">Clin. Dev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">354594</span><span class="refDoi"> DOI: 10.1155/2012/354594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1155%2F2012%2F354594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23049597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FjslSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=354594&author=C.+Liuauthor=Y.+Weiauthor=J.+Wangauthor=L.+Piauthor=J.+Huangauthor=P.+Wang&title=Carbonic+anhydrases+III+and+IV+autoantibodies+in+rheumatoid+arthritis%2C+systemic+lupus+erythematosus%2C+diabetes%2C+hypertensive+renal+disease%2C+and+heart+failure&doi=10.1155%2F2012%2F354594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure</span></div><div class="casAuthors">Liu Chengeng; Wei Yue; Wang Jianmin; Pi Langan; Huang Jianjun; Wang Peichang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & developmental immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">354594</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In the present study, the CA III and IV autoantibodies, CA activity, antioxidant enzymes and cytokines in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), diabetes, hypertensive renal disease, and heart failure were investigated.  The anti-CA III antibody titers in patients with RA, SLE, and type 1 diabetes (T1D) were significantly higher than that in control groups (P < 0.05).  The anti-CA IV antibody titers in patients with RA, SLE, type 1 diabetic nephropathy (T1DN), and heart failure were significantly higher than that in control groups (P < 0.05) while anti-CA IV antibody could suppress the total CA activity.  The SOD and GPx levels in patients with RA, SLE, and T1DN were significantly lower than that in control groups (P < 0.05).  IL-6, IL-17, IFN-γ, and TNF-α levels were significantly higher in SLE group compared with the control group (P < 0.05).  Weak but significant correlations were found between anti-CA III antibodies and ESR in RA (r = 0.403, P = 0.013) and SLE patients (r = 0.397, P = 0.007).  These results suggested that the generation of CA III and IV autoantibodies, antioxidant enzymes, and cytokines might influence each other and CA autoantibodies might affect the normal physiology function of CA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMwJt9ij_06p6KlWarZTAzfW6udTcc2eYmsw9SXcIm7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FjslSksQ%253D%253D&md5=7b1a21e831746b620169ecc4b4b16211</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1155%2F2012%2F354594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F354594%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPi%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DCarbonic%2520anhydrases%2520III%2520and%2520IV%2520autoantibodies%2520in%2520rheumatoid%2520arthritis%252C%2520systemic%2520lupus%2520erythematosus%252C%2520diabetes%252C%2520hypertensive%2520renal%2520disease%252C%2520and%2520heart%2520failure%26jtitle%3DClin.%2520Dev.%2520Immunol.%26date%3D2012%26volume%3D2012%26spage%3D354594%26doi%3D10.1155%2F2012%2F354594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1038/nrd2467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1038%2Fnrd2467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=18167490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Khsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=168-181&author=C.+T.+Supuran&title=Carbonic+anhydrases%3A+novel+therapeutic+applications+for+inhibitors+and+activators&doi=10.1038%2Fnrd2467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrases: novel therapeutic applications for inhibitors and activators</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">168-181</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are involved in numerous physiol. and pathol. processes, including gluconeogenesis, lipogenesis, ureagenesis, tumorigenicity and the growth and virulence of various pathogens.  In addn. to the established role of CA inhibitors (CAIs) as diuretics and antiglaucoma drugs, it has recently emerged that CAIs could have potential as novel antiobesity, anticancer and anti-infective drugs.  Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer's disease.  This article discusses the biol. rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases, and highlights progress in the development of specific modulators of the relevant CA isoforms, some of which are now being evaluated in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8lavoPtcpPrVg90H21EOLACvtfcHk0liLK2Y_pNVjuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Khsr0%253D&md5=f00fe348bbcf38048727c1283496cdfa</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fnrd2467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2467%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrases%253A%2520novel%2520therapeutic%2520applications%2520for%2520inhibitors%2520and%2520activators%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D168%26epage%3D181%26doi%3D10.1038%2Fnrd2467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tanc, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">α-Carbonic anhydrases possess thioesterase activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span><span class="refDoi"> DOI: 10.1021/ml500470b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500470b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=292-295&author=M.+Tancauthor=F.+Cartaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=%CE%B1-Carbonic+anhydrases+possess+thioesterase+activity&doi=10.1021%2Fml500470b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fml500470b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500470b%26sid%3Dliteratum%253Aachs%26aulast%3DTanc%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3D%25CE%25B1-Carbonic%2520anhydrases%2520possess%2520thioesterase%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D292%26epage%3D295%26doi%3D10.1021%2Fml500470b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">How many carbonic anhydrase inhibition mechanisms exist?</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.3109/14756366.2015.1122001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2015.1122001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=26619898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=345-360&author=C.+T.+Supuran&title=How+many+carbonic+anhydrase+inhibition+mechanisms+exist%3F&doi=10.3109%2F14756366.2015.1122001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">How many carbonic anhydrase inhibition mechanisms exist?</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-360</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Six genetic families of the enzyme carbonic anhydrase (CA, EC 4.2.1.1) were described to date.  Inhibition of CAs has pharmacol. applications in the field of antiglaucoma, anticonvulsant, anticancer, and anti-infective agents.  New classes of CA inhibitors (CAIs) were described in the last decade with enzyme inhibition mechanisms differing considerably from the classical inhibitors of the sulfonamide or anion type.  Five different CA inhibition mechanisms are known: (i) the zinc binders coordinate to the catalytically crucial Zn(II) ion from the enzyme active site, with the metal in tetrahedral or trigonal bipyramidal geometries.  Sulfonamides and their isosters, most anions, dithiocarbamates and their isosters, carboxylates, and hydroxamates bind in this way; (ii) inhibitors that anchor to the zinc-coordinated water mol./hydroxide ion (phenols, carboxylates, polyamines, 2-thioxocoumarins, sulfocoumarins); (iii) inhibitors which occlude the entrance to the active site cavity (coumarins and their isosters), this binding site coinciding with that where CA activators bind; (iv) compds. which bind out of the active site cavity (a carboxylic acid deriv. was seen to inhibit CA in this manner), and (v) compds. for which the inhibition mechanism is not known, among which the secondary/tertiary sulfonamides as well as imatinib/nilotinib are the most investigated examples.  As CAIs are used clin. in many pathologies, with a sulfonamide inhibitor (SLC-0111) in Phase I clin. trials for the management of metastatic solid tumors, this review updates the recent findings in the field which may be useful for a structure-based drug design approach of more selective/potent modulators of the activity of these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh8n13uOvB17Vg90H21EOLACvtfcHk0ljPQowfTii__A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGms7bE&md5=3f7f8071c39c4fbf59a8b71205ae973d</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.3109%2F14756366.2015.1122001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2015.1122001%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DHow%2520many%2520carbonic%2520anhydrase%2520inhibition%2520mechanisms%2520exist%253F%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D345%26epage%3D360%26doi%3D10.3109%2F14756366.2015.1122001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vullo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2182</span><span class="NLM_x">–</span> <span class="NLM_lpage">2185</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2012.01.129" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2182-2185&author=F.+Cartaauthor=D.+Vulloauthor=A.+Marescaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=New+chemotypes+acting+as+isozyme-selective+carbonic+anhydrase+inhibitors+with+low+affinity+for+the+offtarget+cytosolic+isoform+II&doi=10.1016%2Fj.bmcl.2012.01.129"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.129%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNew%2520chemotypes%2520acting%2520as%2520isozyme-selective%2520carbonic%2520anhydrase%2520inhibitors%2520with%2520low%2520affinity%2520for%2520the%2520offtarget%2520cytosolic%2520isoform%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2182%26epage%3D2185%26doi%3D10.1016%2Fj.bmcl.2012.01.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span> </span><span class="NLM_article-title">Antiobesity carbonic anhydrase inhibitors: a literature and patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span><span class="refDoi"> DOI: 10.1517/13543776.2013.790957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1517%2F13543776.2013.790957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23607332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=725-735&author=A.+Scozzafavaauthor=C.+T.+Supuranauthor=F.+Carta&title=Antiobesity+carbonic+anhydrase+inhibitors%3A+a+literature+and+patent+review&doi=10.1517%2F13543776.2013.790957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12eR"><div class="casContent"><span class="casTitleNuber">12e</span><div class="casTitle"><span class="NLM_cas:atitle">Antiobesity carbonic anhydrase inhibitors: a literature and patent review</span></div><div class="casAuthors">Scozzafava, Andrea; Supuran, Claudiu T.; Carta, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">725-735</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Obesity is ranked as one of the top 10 global health problems and the major concern deriving from it is the exposure of the population to a vast array of chronic pathologies such as cardiovascular and musculoskeletal disorders, type 2 diabetes, cancer, such as colon, breast and endometrial cancer, together with psychol. disorders derived from this condition.  The discovery that the clin. used anticonvulsants topiramate (TPM) and zonisamide (ZNS) induced wt. loss in obese, epileptic patients, afforded the validation of the mitochondrial carbonic anhydrases (CAs, EC 4.2.1.1) VA and VB as targets for the development of antiobesity drugs.Areas covered: This review deals with the scientific and patent literature regarding obesity or obesity-related pathologies, being particularly focused on the use of carbonic anhydrase inhibitors (CAI) such as TPM and ZNS which inhibit the de novo lipogenesis. Expert opinion: There is an urgent need of new drugs for the treatment of obesity.  The identification that the mitochondrial CAs are implicated in the de novo lipogenesis allowed to consider selective inhibitors of such enzymes as useful for the development of new antiobesity drugs.  Actually TPM was approved 1 yr ago for this therapy, whereas ZNS is also an effective such agent.  These compds. are the lead mols. in this field and an intense research is on the way in order to develop new compds. based on the selective inhibition of mitochondrial CA isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpV5LUSX76OrVg90H21EOLACvtfcHk0ljPQowfTii__A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtL4%253D&md5=52482234cea242b5564460a01575053f</span></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.790957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.790957%26sid%3Dliteratum%253Aachs%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCarta%26aufirst%3DF.%26atitle%3DAntiobesity%2520carbonic%2520anhydrase%2520inhibitors%253A%2520a%2520literature%2520and%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D725%26epage%3D735%26doi%3D10.1517%2F13543776.2013.790957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Alterio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Ambrosio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span> </span><span class="NLM_article-title">Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">4421</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span><span class="refDoi"> DOI: 10.1021/cr200176r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200176r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2012&pages=4421-4468&author=V.+Alterioauthor=A.+Di+Fioreauthor=K.+D%E2%80%99Ambrosioauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Multiple+binding+modes+of+inhibitors+to+carbonic+anhydrases%3A+how+to+design+specific+drugs+targeting+15+different+isoforms%3F&doi=10.1021%2Fcr200176r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12fR"><div class="casContent"><span class="casTitleNuber">12f</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?</span></div><div class="casAuthors">Alterio, Vincenzo; Di Fiore, Anna; D'Ambrosio, Katia; Supuran, Claudiu T.; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4421-4468</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this review is to provide an exhaustive description of the structural studies on α-CAs (carbonic anhydrases) so far reported.  In particular, the main structural features of the catalytically active α-CA isoenzymes characterized to date will be described and the current state of the art on complexes of hCA II with the principal classes of inhibitors will be summarized.  A comparison with the corresponding adducts of other isoforms, when available, will be also performed, in order to find for each isoform the key residues responsible for enzyme/inhibitor interaction.  Finally, recent advances in the field of drug design of selective CAIs will be illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA0GdtMHwlZ7Vg90H21EOLACvtfcHk0ljPQowfTii__A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1Wrsbg%253D&md5=eb45ffb5efe07980f1388d99bf51406a</span></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=10.1021%2Fcr200176r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200176r%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DMultiple%2520binding%2520modes%2520of%2520inhibitors%2520to%2520carbonic%2520anhydrases%253A%2520how%2520to%2520design%2520specific%2520drugs%2520targeting%252015%2520different%2520isoforms%253F%26jtitle%3DChem.%2520Rev.%26date%3D2012%26volume%3D112%26spage%3D4421%26epage%3D4468%26doi%3D10.1021%2Fcr200176r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Structure-based drug discovery of carbonic anhydrase inhibitors</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span><span class="refDoi"> DOI: 10.3109/14756366.2012.672983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2012.672983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=22468747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCgtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=759-772&author=C.+T.+Supuran&title=Structure-based+drug+discovery+of+carbonic+anhydrase+inhibitors&doi=10.3109%2F14756366.2012.672983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12gR"><div class="casContent"><span class="casTitleNuber">12g</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug discovery of carbonic anhydrase inhibitors</span></div><div class="casAuthors">Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">759-772</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Inhibition of the metalloenzyme carbonic anhydrase (CA; EC 4.2.1.1) has pharmacol. applications in the field of anti-glaucoma, anti-convulsant and anti-cancer agents.  But recently, it has also emerged that these enzymes have the potential for designing anti-infective drugs (anti-fungal and anti-bacterial agents) with a novel mechanism of action.  Sulfonamides and their isosteres (sulfamates/sulfamides) constitute the main class of CA inhibitors (CAIs), which bind to the metal ion from the enzyme active site.  Recently, the dithiocarbamates (DTCs), possessing a similar mechanism of action, were reported as a new class of inhibitors.  These types of CAIs will be discussed in detail in this review.  Novel drug design strategies have been reported ultimately based on the tail approach for obtaining sulfonamides/DTCs, which exploit more external binding regions within the enzyme active site (in addn. to coordination to the metal ion), leading thus to isoform-selective compds.  Most of the promising data have been obtained by combining x-ray crystallog. of enzyme-inhibitor adducts with novel synthetic approaches for generating chem. diversity.  Whereas sulfonamide - NO donating hybrid drugs were reported as effective anti-glaucoma agents, most of the interesting new inhibitors were designed for inhibiting specifically the tumor-assocd. isoforms CA IX and XII, validated targets for imaging and treatment of hypoxic tumors.  Promising compds. that inhibit CAs from bacterial and fungal pathogens, of the DTC and carboxylate types, will be also reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsmAtcxdWfHbVg90H21EOLACvtfcHk0lhgsblW_zol1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCgtL7N&md5=55a993be904b13c63eb52b9d0229e187</span></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=10.3109%2F14756366.2012.672983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2012.672983%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DStructure-based%2520drug%2520discovery%2520of%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2012%26volume%3D27%26spage%3D759%26epage%3D772%26doi%3D10.3109%2F14756366.2012.672983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Farr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, P. A.</span><span> </span><span class="NLM_article-title">Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis</span> <span class="citation_source-journal">Clin. Exp. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=4017318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADyaL2M3lsFOgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1985&pages=99-104&author=M.+Farrauthor=K.+Garveyauthor=A.+M.+Boldauthor=M.+J.+Kendallauthor=P.+A.+Bacon&title=Significance+of+the+hydrogen+ion+concentration+in+synovial+fluid+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis</span></div><div class="casAuthors">Farr M; Garvey K; Bold A M; Kendall M J; Bacon P A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental rheumatology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-104</span>
        ISSN:<span class="NLM_cas:issn">0392-856X</span>.
    </div><div class="casAbstract">The hydrogen ion (H+) concentration and pCO2 were measured in the synovial fluid (SF) from the knee joints of 130 patients with arthritis by an acid-base analyser (ABL2 Acid-Base Laboratory), using a simple technique which prevented contact with air.  H+ concentration was significantly higher in SF from 60 RA patients (mean 64.4 n mol/l; range 38-142 n mol/l) compared with patients with OA (mean 44 n mol/l; range 29-56 n mol/l), and 40 with other arthritides (mean 52 n mol/l).  The H+ concentration in the SF showed a significant association with other variables of local inflammation-platelet, total leucocyte and polymorph counts, 5-nucleotidase, acid phosphatase and IgA levels in the SF and the clinical knee score, but not with the volume of the effusion.  A similar relationship between these variables of inflammatory activity and SF pCO2 was also established.  A higher SF H+ concentration was also found in systemically active disease, but no difference in SF pH between seropositive and seronegative patients.  Whilst the pH of SF approximated to that of the blood in OA, it was significantly lower in the SF in RA.  SF pH is a useful marker of local inflammatory activity, and its measurement is simple, reliable and rapid.  It is relevant because changes in pH influence many of the processes involved in inflammation and the pH difference between SF and blood influences the transfer of drugs into the joint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWQDsjjJW6DkQ0lWbKiCflfW6udTcc2eYA4FVocd5b7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M3lsFOgsQ%253D%253D&md5=85e9c6f8a2d7772871e0368759fcadb5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarr%26aufirst%3DM.%26aulast%3DGarvey%26aufirst%3DK.%26aulast%3DBold%26aufirst%3DA.%2BM.%26aulast%3DKendall%26aufirst%3DM.%2BJ.%26aulast%3DBacon%26aufirst%3DP.%2BA.%26atitle%3DSignificance%2520of%2520the%2520hydrogen%2520ion%2520concentration%2520in%2520synovial%2520fluid%2520in%2520rheumatoid%2520arthritis%26jtitle%3DClin.%2520Exp.%2520Rheumatol.%26date%3D1985%26volume%3D3%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Steen, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeh, P. W.</span><span> </span><span class="NLM_article-title">A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1523%2FJNEUROSCI.15-05-03982.1995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=7751959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADyaK2MXls1aisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=3982-3989&author=K.+H.+Steenauthor=A.+E.+Steenauthor=P.+W.+Reeh&title=A+dominant+role+of+acid+pH+in+inflammatory+excitation+and+sensitization+of+nociceptors+in+rat+skin%2C+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro</span></div><div class="casAuthors">Steen, Kay H.; Steen, Astrid E.; Reeh, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5, Pt. 2</span>),
    <span class="NLM_cas:pages">3982-9</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A major role of local acidosis in long lasting excitation and sensitization of cutaneous nociceptors has recently been demonstrated.  In inflamed tissue, acid pH meets with a mixt. of inflammatory mediators which, by themselves, stimulate nociceptors though being subject to profound tachyphylaxis.  We have mimicked this condition in a rat skin-saphenous nerve prepn. in vitro which allows direct application of chems. to the isolated receptive fields at the corium side.  Stimulant solns. used were CO2-satd. "synthetic interstitial fluid" (CO2-SIF, pH 6.1), an "inflammatory soup" (IS) in submaximal concn. contg. bradykinin, 5-HT, histamine, prostaglandin E2 (all 10-6M in SIF at 38.5° and pH 7.0), and a combination made of CO2-satd. IS (CO2-IS, pH 6.1).  Identified mechano-heat sensitive ("polymodal") C-fiber terminals (n = 36) were treated with these solns. for 5 min at 10 min intervals or for 30 min of sustained stimulation: 20 units responded to CO2-SIF, 12 to IS, whereas 27 units (75%) were excited by CO2-IS.  Thus, 6 out of 15 units insensitive to either of the two basic solns. were stimulated by their combination.  This enhanced effect of CO2-IS was also expressed in shorter latencies (than with CO2-SIF) and in a significantly larger mean response magnitude of the fiber population: 152 spikes with the combination vs. 45 spikes evoked by IS and 93 spikes by CO2-SIF (n = 25; p < 0.002 and < 0.02, resp., Wilcoxon test).  The synergistic interaction between CO2 and IS also showed up during sustained nociceptor stimulation (30 min) by either CO2SIF (n = 7) or IS (n = 1) when, during the middle 10 min, CO2-IS was applied which significantly increased the discharge.  There is a strong, potentially algogenic, interaction between acid pH and inflammatory mediators in terms of prevalence and magnitude of nociceptor excitation.  At equal and pathophysiol. relevant concn., however, hydrogen ions play a dominant role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8eLXfegRJPLVg90H21EOLACvtfcHk0lhgsblW_zol1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls1aisbs%253D&md5=35d850f5272831214c9af2aa43859320</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.15-05-03982.1995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.15-05-03982.1995%26sid%3Dliteratum%253Aachs%26aulast%3DSteen%26aufirst%3DK.%2BH.%26aulast%3DSteen%26aufirst%3DA.%2BE.%26aulast%3DReeh%26aufirst%3DP.%2BW.%26atitle%3DA%2520dominant%2520role%2520of%2520acid%2520pH%2520in%2520inflammatory%2520excitation%2520and%2520sensitization%2520of%2520nociceptors%2520in%2520rat%2520skin%252C%2520in%2520vitro%26jtitle%3DJ.%2520Neurosci.%26date%3D1995%26volume%3D15%26spage%3D3982%26epage%3D3989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Lardner, A.</span><span> </span><span class="NLM_article-title">The effects of extracellular pH on immune function</span> <span class="citation_source-journal">J. Leukocyte Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=11310837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=522-530&author=A.+Lardner&title=The+effects+of+extracellular+pH+on+immune+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of extracellular pH on immune function</span></div><div class="casAuthors">Lardner, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">522-530</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 80 refs.  The effect of alterations in extracellular pH on cellular and humoral immune function is reviewed.  Because acidic pH predominates at inflammatory loci and other sites of immune activity, most studies to date focus on the effect of acidic rather than alk. pH.  Investigations on polymorphonuclear leukocytes demonstrate mainly inhibition of chemotaxis, respiratory activity, and bactericidal capacity at reduced pH.  Evidence of impaired lymphocyte cytotoxicity and proliferation at acidic pH is also beginning to emerge.  Many of the clin. acidosis are accompanied similarly by immunodeficiency.  Studies on macrophages and eosinophils are few and inconclusive.  A small no. of studies demonstrate acid-induced activation of complement proteins and the alternative complement pathway, plus increased antibody-binding to leukocytes at lowered pH.  A differential effect of acidic pH on humoral and cellular immunity may, therefore, exist.  Increasing recognition of the significance of extracellular pH in relation to immune function warrants further studies in this presently incomplete but rewarding field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi8Hr7d3nZXbVg90H21EOLACvtfcHk0licY4UKFEbjMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVagurs%253D&md5=86f05548986270622e403e359f0f2422</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLardner%26aufirst%3DA.%26atitle%3DThe%2520effects%2520of%2520extracellular%2520pH%2520on%2520immune%2520function%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2001%26volume%3D69%26spage%3D522%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Crofford, L. J.</span><span> </span><span class="NLM_article-title">Use of NSAIDs in treating patients with arthritis</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">S2</span><span class="refDoi"> DOI: 10.1186/ar4174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1186%2Far4174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=24267197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=S2&issue=Suppl.+3&author=L.+J.+Crofford&title=Use+of+NSAIDs+in+treating+patients+with+arthritis&doi=10.1186%2Far4174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Use of NSAIDs in treating patients with arthritis</span></div><div class="casAuthors">Crofford, Leslie J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S2/1-S2/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Patients with rheumatic diseases, including rheumatoid arthritis and osteoarthritis, almost universally describe pain and stiffness as important contributors to reduced health-related quality of life.  Of the treatment options available, NSAIDs are the most widely used agents for symptomatic treatment.  NSAIDs are effective anti-inflammatory and analgesic drugs by virtue of their ability to inhibit biosynthesis of prostaglandins at the level of the cyclooxygenase enzyme.  However, many of the adverse effects of NSAIDs are also related to inhibition of prostaglandin prodn., making their use problematic in some patient populations.  For the clinician, understanding the biol. of prostaglandin as it relates to gastrointestinal, renal and cardiovascular physiol. and the pharmacol. properties of specific NSAIDs is key to using these drugs safely.  Of particular importance is the recognition of co-morbid conditions and concomitant drugs that may increase the risk of NSAIDs in particular patients.  In patients with risk factors for NSAID toxicity, using the lowest dose of a drug with a short half-life only when it is needed is likely to be the safest treatment option.  For those patients whose symptoms cannot be managed with intermittent treatment, using protective strategies is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5mE_VnWwGBbVg90H21EOLACvtfcHk0licY4UKFEbjMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWiuro%253D&md5=b4bc116857f63677befd0520c9c9d400</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Far4174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far4174%26sid%3Dliteratum%253Aachs%26aulast%3DCrofford%26aufirst%3DL.%2BJ.%26atitle%3DUse%2520of%2520NSAIDs%2520in%2520treating%2520patients%2520with%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2013%26volume%3D15%26issue%3DSuppl.%25203%26spage%3DS2%26doi%3D10.1186%2Far4174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">3057</span><span class="NLM_x">–</span> <span class="NLM_lpage">3062</span><span class="refDoi"> DOI: 10.1021/ja809683v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja809683v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVCgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=3057-3062&author=A.+Marescaauthor=C.+Temperiniauthor=H.+Vuauthor=N.+B.+Phamauthor=S.+A.+Poulsenauthor=A.+Scozzafavaauthor=R.+J.+Quinnauthor=C.+T.+Supuran&title=Non-zinc+mediated+inhibition+of+carbonic+anhydrases%3A+coumarins+are+a+new+class+of+suicide+inhibitors&doi=10.1021%2Fja809683v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors</span></div><div class="casAuthors">Maresca, Alfonso; Temperini, Claudia; Vu, Hoan; Pham, Ngoc B.; Poulsen, Sally-Ann; Scozzafava, Andrea; Quinn, Ronald J.; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3057-3062</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The x-ray crystal structure of the adduct between the zinc metalloenzyme carbonic anhydrase II (CA, E.C. 4.2.1.1) with the recently discovered natural product coumarin deriv. 6-(1S-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one showed the coumarin hydrolysis product, a cis-2-hydroxy-cinnamic acid deriv., and not the parent coumarin, bound within the enzyme active site.  The bound inhibitor exhibits an extended, two-arm conformation that effectively plugs the entrance to the enzyme active site with no interactions with the catalytically crucial zinc ion.  The inhibitor is sandwiched between Phe131, with which it makes an edge-to-face stacking, and Asn67/Glu238sym, with which it makes several polar and hydrogen bonding interactions.  This unusual binding mode, with no interactions between the inhibitor mol. and the active site metal ion is previously unobserved for this enzyme class and presents a new opportunity for future drug design campaigns to target a mode of inhibition that differs substantially from classical inhibitors such as the clin. used sulfonamides and sulfamates.  Several structurally simple coumarin scaffolds were also shown to inhibit all 13 catalytically active mammalian CA isoforms, with inhibition consts. ranging from nanomolar to millimolar.  The inhibition is time dependent, with max. inhibition being obsd. after 6 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jUFnGCNktbVg90H21EOLACvtfcHk0licY4UKFEbjMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVCgtrc%253D&md5=dfec471d2bade2177549dedebfd33808</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fja809683v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja809683v%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DTemperini%26aufirst%3DC.%26aulast%3DVu%26aufirst%3DH.%26aulast%3DPham%26aufirst%3DN.%2BB.%26aulast%3DPoulsen%26aufirst%3DS.%2BA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNon-zinc%2520mediated%2520inhibition%2520of%2520carbonic%2520anhydrases%253A%2520coumarins%2520are%2520a%2520new%2520class%2520of%2520suicide%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D3057%26epage%3D3062%26doi%3D10.1021%2Fja809683v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pochet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1021/jm901287j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901287j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWhtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=335-344&author=A.+Marescaauthor=C.+Temperiniauthor=L.+Pochetauthor=B.+Masereelauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Deciphering+the+mechanism+of+carbonic+anhydrase+inhibition+with+coumarins+and+thiocoumarins&doi=10.1021%2Fjm901287j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins</span></div><div class="casAuthors">Maresca, Alfonso; Temperini, Claudia; Pochet, Lionel; Masereel, Bernard; Scozzafava, Andrea; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">335-344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coumarin derivs. were recently shown to constitute a totally new class of inhibitors of the zinc metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1), being hydrolyzed within the CA active site to 2-hydroxycinnamic acids.  We explore here a new series of variously substituted coumarins and a thiocoumarin for their interaction with 13 mammalian CA isoforms, detecting low nanomolar and isoform selective inhibitors.  The mechanism of action of this class of inhibitors is delineated in detail by resolving the X-ray crystal structure of CA II in complex with trans-2-hydroxy-cinnamic acid, the in situ hydrolysis product of simple coumarin.  Thiocoumarins also act as efficient CAIs, similarly to coumarins.  The versatility of the (thio)coumarin chem., the cis-trans isomerization evidenced here, and easy derivatization of the (thio)coumarin rings, coupled with the nanomolar inhibition range of several isoenzymes, afford isoform-selective CAIs with various biomedical applications, which render these classes of compds. superior to the clin. used sulfonamides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFIEKoRM8VErVg90H21EOLACvtfcHk0ljUY08JShRRDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWhtrrP&md5=10282540175101bb94a3fc7d841055a1</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm901287j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901287j%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DTemperini%26aufirst%3DC.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DDeciphering%2520the%2520mechanism%2520of%2520carbonic%2520anhydrase%2520inhibition%2520with%2520coumarins%2520and%2520thiocoumarins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D335%26epage%3D344%26doi%3D10.1021%2Fjm901287j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ferraroni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01720</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01720" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=462-473&author=M.+Ferraroniauthor=F.+Cartaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Thioxocoumarins+show+an+alternative+carbonic+anhydrase+inhibition+mechanism+compared+to+coumarins&doi=10.1021%2Facs.jmedchem.5b01720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins</span></div><div class="casAuthors">Ferraroni, Marta; Carta, Fabrizio; Scozzafava, Andrea; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">462-473</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of coumarins and the corresponding 2-thioxocoumarines were prepd. and tested for their inhibition profiles against four physiol. relevant human carbonic anhydrases (hCAs, EC 4.2.1.1), isoforms hCA I, II, IX, and XII.  The X-ray crystal structure of 6-hydroxy-2-thioxocoumarin bound to hCA II revealed an unprecedented and unexpected inhibition mechanism for this new class of inhibitors when compared to isostructural coumarins.  Unlike coumarins which are hydrolyzed by the esterase CA activity to the corresponding 2-hydroxy-cinnamic acid derivs., the 2-thioxocoumarin was obsd. intact when bound to hCA II, with its exo-sulfur atom anchored to the zinc-coordinated water mol., whereas the scaffold establishing favorable contacts with amino acid residues from the active site.  This inhibition mechanism is very different from the one obsd. for hydrolyzed coumarins, which occlude the entrance of the active site cavity.  This versatility in the binding mode of coumarins/thioxocoumarins has important consequences for the design of isoform-selective CA inhibitors, some of which are in clin. use or clin. development for various pathologies, among which glaucoma, edema, epilepsy, neuropathic pain, and hypoxic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplbMRXrFgfp7Vg90H21EOLACvtfcHk0ljUY08JShRRDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGrs7rE&md5=dade9ac32a35bfe4a7f640dac26c9f03</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01720%26sid%3Dliteratum%253Aachs%26aulast%3DFerraroni%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DThioxocoumarins%2520show%2520an%2520alternative%2520carbonic%2520anhydrase%2520inhibition%2520mechanism%2520compared%2520to%2520coumarins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D462%26epage%3D473%26doi%3D10.1021%2Facs.jmedchem.5b01720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Touisni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Glycosylcumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8271</span><span class="NLM_x">–</span> <span class="NLM_lpage">8277</span><span class="refDoi"> DOI: 10.1021/jm200983e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200983e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8271-8277&author=N.+Touisniauthor=A.+Marescaauthor=P.+C.+McDonaldauthor=Y.+Louauthor=A.+Scozzafavaauthor=S.+Dedharauthor=J.-Y.+Winumauthor=C.+T.+Supuran&title=Glycosylcumarin+carbonic+anhydrase+IX+and+XII+inhibitors+strongly+attenuate+the+growth+of+primary+breast+tumors&doi=10.1021%2Fjm200983e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Fjm200983e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200983e%26sid%3Dliteratum%253Aachs%26aulast%3DTouisni%26aufirst%3DN.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DP.%2BC.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DDedhar%26aufirst%3DS.%26aulast%3DWinum%26aufirst%3DJ.-Y.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DGlycosylcumarin%2520carbonic%2520anhydrase%2520IX%2520and%2520XII%2520inhibitors%2520strongly%2520attenuate%2520the%2520growth%2520of%2520primary%2520breast%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8271%26epage%3D8277%26doi%3D10.1021%2Fjm200983e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bonneau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.3109/14756366.2011.650692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2011.650692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=22299576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC38vhvVWmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=397-401&author=A.+Bonneauauthor=A.+Marescaauthor=J.+Y.+Winumauthor=C.+T.+Supuran&title=Metronidazole-coumarin+conjugates+and+3-cyano-7-hydroxy-coumarin+act+as+isoform-selective+carbonic+anhydrase+inhibitors&doi=10.3109%2F14756366.2011.650692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors</span></div><div class="casAuthors">Bonneau Adeline; Maresca Alfonso; Winum Jean-Yves; Supuran Claudiu T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of enzyme inhibition and medicinal chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">397-401</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Reaction of 6-/7-hydroxycoumarin with metronidazole afforded conjugates which incorporate two interesting chemotypes which may inhibit carbonic anhydrases (CAs, EC 4.2.1.1) due to the presence of the coumarin moiety and possess radiosensitizing effects due to the presence of the nitroazole.  Another dual action compound, which may act both as CA inhibitor as well as monocarboxylate transporter inhibitor, is 3-cyano-7-hydroxy-coumarin.  These compounds have been investigated as inhibitors of 11 human CA isoforms.  Submicromolar inhibition was observed against hCA VA, hCA VB, hCA VI, hCA VII, hCA IX, hCA XII and hCA XIV, whereas isoforms hCA I, II and XIII were not inhibited by these compounds.  These coumarins thus act as isoform-selective CA inhibitors with the possibility to target isoforms involved in pathologies such as obesity (CA VA/VB) or cancer (CA IX and XII) without inhibiting the physiologically dominant, highly abundant hCA I and II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6507i8s2belUIs6wFK5xJfW6udTcc2eYlMePI5EoAhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vhvVWmtg%253D%253D&md5=b33d67e750820e963bed42c987fa4738</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.3109%2F14756366.2011.650692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2011.650692%26sid%3Dliteratum%253Aachs%26aulast%3DBonneau%26aufirst%3DA.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DWinum%26aufirst%3DJ.%2BY.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DMetronidazole-coumarin%2520conjugates%2520and%25203-cyano-7-hydroxy-coumarin%2520act%2520as%2520isoform-selective%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26spage%3D397%26epage%3D401%26doi%3D10.3109%2F14756366.2011.650692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Sharma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span><span class="refDoi"> DOI: 10.3109/14756366.2013.777334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2013.777334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23488741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVSmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=292-296&author=A.+Sharmaauthor=M.+Tiwariauthor=C.+T.+Supuran&title=Novel+coumarins+and+benzocoumarins+acting+as+isoform-selective+inhibitors+against+the+tumor-associated+carbonic+anhydrase+IX&doi=10.3109%2F14756366.2013.777334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17fR"><div class="casContent"><span class="casTitleNuber">17f</span><div class="casTitle"><span class="NLM_cas:atitle">Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX</span></div><div class="casAuthors">Sharma, Aditi; Tiwari, Meena; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">292-296</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of coumarins and benzocoumarins incorporating Me and hydroxyl moieties in the heterocyclic ring were investigated for the inhibition of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1).  These coumarins were very weak or ineffective as inhibitors of the house-keeping, offtarget isoforms CA I and II, but showed effective, submicromolar inhibition of the transmembrane, tumor-assocd. isoforms CA IX and to a slightly less extent, CA XII.  The nature and position of the groups substituting the coumarin ring influenced CA inhibitory properties. 4-Methyl-5,7-dihydroydroxycoumarin showed KIs >200 μM against CA I and II, of 0.19 μM against CA IX and of 6.4 μM against CA XII, being thus a selective, efficient inhibitor for the tumor-assocd. over cytosolic CA isoforms.  These compds. are interesting leads for designing isoform-selective enzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8OlpnmvNMKrVg90H21EOLACvtfcHk0lh_3eMqmOtZGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVSmtb4%253D&md5=9994867a241b31b5c5fe9e63f5e13eb0</span></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=10.3109%2F14756366.2013.777334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2013.777334%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DTiwari%26aufirst%3DM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DNovel%2520coumarins%2520and%2520benzocoumarins%2520acting%2520as%2520isoform-selective%2520inhibitors%2520against%2520the%2520tumor-associated%2520carbonic%2520anhydrase%2520IX%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2014%26volume%3D29%26spage%3D292%26epage%3D296%26doi%3D10.3109%2F14756366.2013.777334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7258</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2010.10.094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7255-7258&author=A.+Marescaauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=7%2C8-Disubstituted-+but+not+6%2C7-disubstituted+coumarins+selectively+inhibit+the+transmembrane%2C+tumor-associated+carbonic+anhydrase+isoforms+IX+and+XII+over+the+cytosolic+ones&doi=10.1016%2Fj.bmcl.2010.10.094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.094%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3D7%252C8-Disubstituted-%2520but%2520not%25206%252C7-disubstituted%2520coumarins%2520selectively%2520inhibit%2520the%2520transmembrane%252C%2520tumor-associated%2520carbonic%2520anhydrase%2520isoforms%2520IX%2520and%2520XII%2520over%2520the%2520cytosolic%2520ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7255%26epage%3D7258%26doi%3D10.1016%2Fj.bmcl.2010.10.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4511</span><span class="NLM_x">–</span> <span class="NLM_lpage">4514</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.06.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2010.06.040" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4511-4514&author=A.+Marescaauthor=C.+T.+Supuran&title=Coumarins+incorporating+hydroxy-+and+chloro-moieties+selectively+inhibit+the+transmembrane%2C+tumor-associated+carbonic+anhydrase+isoforms+IX+and+XII+over+the+cytosolic+ones+I+and+II&doi=10.1016%2Fj.bmcl.2010.06.040"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.040%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCoumarins%2520incorporating%2520hydroxy-%2520and%2520chloro-moieties%2520selectively%2520inhibit%2520the%2520transmembrane%252C%2520tumor-associated%2520carbonic%2520anhydrase%2520isoforms%2520IX%2520and%2520XII%2520over%2520the%2520cytosolic%2520ones%2520I%2520and%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4511%26epage%3D4514%26doi%3D10.1016%2Fj.bmcl.2010.06.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bozdag, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alafeefy, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamimi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vullo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.11.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmc.2016.11.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=677-683&issue=2&author=M.+Bozdagauthor=A.+M.+Alafeefyauthor=A.+M.+Altamimiauthor=D.+Vulloauthor=F.+Cartaauthor=C.+T.+Supuran&title=Coumarins+and+other+fused+bicyclic+heterocycles+with+selective+tumor-associated+carbonic+anhydrase+isoforms+inhibitory+activity&doi=10.1016%2Fj.bmc.2016.11.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.11.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.11.039%26sid%3Dliteratum%253Aachs%26aulast%3DBozdag%26aufirst%3DM.%26aulast%3DAlafeefy%26aufirst%3DA.%2BM.%26aulast%3DAltamimi%26aufirst%3DA.%2BM.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCoumarins%2520and%2520other%2520fused%2520bicyclic%2520heterocycles%2520with%2520selective%2520tumor-associated%2520carbonic%2520anhydrase%2520isoforms%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D2%26spage%3D677%26epage%3D683%26doi%3D10.1016%2Fj.bmc.2016.11.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastrolorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span> </span><span class="NLM_article-title">COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span><span class="refDoi"> DOI: 10.2174/1389557043403792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.2174%2F1389557043403792" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=625-632&author=C.+T.+Supuranauthor=A.+Casiniauthor=A.+Mastrolorenzoauthor=A.+Scozzafava&title=COX-2+selective+inhibitors%2C+carbonic+anhydrase+inhibition+and+anticancer+properties+of+sulfonamides+belonging+to+this+class+of+pharmacological+agents&doi=10.2174%2F1389557043403792"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.2174%2F1389557043403792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557043403792%26sid%3Dliteratum%253Aachs%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DMastrolorenzo%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26atitle%3DCOX-2%2520selective%2520inhibitors%252C%2520carbonic%2520anhydrase%2520inhibition%2520and%2520anticancer%2520properties%2520of%2520sulfonamides%2520belonging%2520to%2520this%2520class%2520of%2520pharmacological%2520agents%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D625%26epage%3D632%26doi%3D10.2174%2F1389557043403792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Khalifah, R. G.</span><span> </span><span class="NLM_article-title">The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">2561</span><span class="NLM_x">–</span> <span class="NLM_lpage">2573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2FS0021-9258%2818%2962326-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=4994926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1971&pages=2561-2573&author=R.+G.+Khalifah&title=The+carbon+dioxide+hydration+activity+of+carbonic+anhydrase.+I.+Stop-flow+kinetic+studies+on+the+native+human+isoenzymes+B+and+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon dioxide hydration activity of carbonic anhydrase.  I.  Stop-flow kinetic studies on the native human isoenzymes B and C</span></div><div class="casAuthors">Khalifah, Raja G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2561-73</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The kinetics of catalysis of carbon dioxide hydration by human carbonic anhydrases B and C (EC 4.2.1.1) has been reinvestigated with the use of an improved pH indicator stop-flow approach that was checked by studying the uncatalyzed rate of hydration, with Michaelis-Menten parameters being detd. between pH 5.8 and 8.8 in noninhibitory buffers.  For both isoenzymes, Km was independent of pH, whereas Vmax increased with increasing pH with results being similar to the finding of others on bovine carbonic anhydrase, but differing from earlier reports of Gibbons and Edsall (1964) in the finding that Km was pH-independent.  Despite the differences between the low and high activity forms of the enzyme, there were close kinetic similarities between them that indicated underlying similarities in active site structure.  Imidazole (I) (0.22-1.32M) inhibited the B enzyme, apparently competitively, and had no effect on the C enzyme.  N-Methyl substitution of I abolished its inhibitory effect.  Nitrous oxide (11-45mM) did not inhibit catalysis of carbon dioxide hydration by either of the 2 human isoenzymes, or by bovine carbonic anhydrase.  The enzyme-catalyzed hydration of carbon dioxide probably requires not only water activation by a basic group, but also charge neutralization in the transition state by an electron acceptor function.  The zinc-bound water in carbonic anhydrase could be involved in both donor and acceptor roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri57EkpgPMx7Vg90H21EOLACvtfcHk0lhOMR6MA48smw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtlGmu7k%253D&md5=2764970fcd4f08250b28b9e8e9474681</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2962326-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252962326-9%26sid%3Dliteratum%253Aachs%26aulast%3DKhalifah%26aufirst%3DR.%2BG.%26atitle%3DThe%2520carbon%2520dioxide%2520hydration%2520activity%2520of%2520carbonic%2520anhydrase.%2520I.%2520Stop-flow%2520kinetic%2520studies%2520on%2520the%2520native%2520human%2520isoenzymes%2520B%2520and%2520C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1971%26volume%3D246%26spage%3D2561%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Di Cesare Mannelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bencini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calosi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carossino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtancoli, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Failli, P.</span><span> </span><span class="NLM_article-title">Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats</span> <span class="citation_source-journal">Mediators Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">905360</span><span class="refDoi"> DOI: 10.1155/2013/905360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1155%2F2013%2F905360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23861563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3sfhtleltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=905360&author=L.+Di+Cesare+Mannelliauthor=D.+Baniauthor=A.+Benciniauthor=M.+L.+Brandiauthor=L.+Calosiauthor=M.+Cantoreauthor=A.+M.+Carossinoauthor=C.+Ghelardiniauthor=B.+Valtancoliauthor=P.+Failli&title=Therapeutic+effects+of+the+superoxide+dismutase+mimetic+compound+MnIIMe2DO2A+on+experimental+articular+pain+in+rats&doi=10.1155%2F2013%2F905360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic effects of the superoxide dismutase mimetic compound MnIIMe2DO2A on experimental articular pain in rats</span></div><div class="casAuthors">Di Cesare Mannelli Lorenzo; Bani Daniele; Bencini Andrea; Brandi Maria Luisa; Calosi Laura; Cantore Miriam; Carossino Anna Maria; Ghelardini Carla; Valtancoli Barbara; Failli Paola</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">905360</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Superoxide anion (O(2) (•-)) is overproduced in joint inflammation, rheumatoid arthritis, and osteoarthritis.  Increased O(2) (•-) production leads to tissue damage, articular degeneration, and pain.  In these conditions, the physiological defense against O(2) (•-), superoxide dismutases (SOD) are decreased.  The Mn(II) complex MnL4 is a potent SOD mimetic, and in this study it was tested in inflammatory and osteoarticular rat pain models.  In vivo protocols were approved by the animal Ethical Committee of the University of Florence.  Pain was measured by paw pressure and hind limb weight bearing alterations tests.  MnL4 (15 mg kg(-1)) acutely administered, significantly reduced pain induced by carrageenan, complete Freund's adjuvant (CFA), and sodium monoiodoacetate (MIA).  In CFA and MIA protocols, it ameliorated the alteration of postural equilibrium.  When administered by osmotic pump in the MIA osteoarthritis, MnL4 reduced pain, articular derangement, plasma TNF alpha levels, and protein carbonylation.  The scaffold ring was ineffective.  MnL4 (10(-7) M) prevented the lipid peroxidation of isolated human chondrocytes when O(2) (•-) was produced by RAW 264.7.  MnL4 behaves as a potent pain reliever in acute inflammatory and chronic articular pain, being its efficacy related to antioxidant property.  Therefore MnL4 appears as a novel protective compound potentially suitable for the treatment of joint diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRcle_nAtSdN4McDoIzZtNkfW6udTcc2eaAPNZZeItOD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfhtleltQ%253D%253D&md5=27844eb625538d174767e71a08a6f4ac</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1155%2F2013%2F905360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F905360%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DBani%26aufirst%3DD.%26aulast%3DBencini%26aufirst%3DA.%26aulast%3DBrandi%26aufirst%3DM.%2BL.%26aulast%3DCalosi%26aufirst%3DL.%26aulast%3DCantore%26aufirst%3DM.%26aulast%3DCarossino%26aufirst%3DA.%2BM.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DValtancoli%26aufirst%3DB.%26aulast%3DFailli%26aufirst%3DP.%26atitle%3DTherapeutic%2520effects%2520of%2520the%2520superoxide%2520dismutase%2520mimetic%2520compound%2520MnIIMe2DO2A%2520on%2520experimental%2520articular%2520pain%2520in%2520rats%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D905360%26doi%3D10.1155%2F2013%2F905360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mishra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazari, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, A. K.</span><span> </span><span class="NLM_article-title">In vitro and in vivo evaluation of 99mTc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors</span> <span class="citation_source-journal">J. Drug Target.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span><span class="refDoi"> DOI: 10.3109/1061186X.2011.561857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F1061186X.2011.561857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21425922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaisLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=761-769&author=G.+Mishraauthor=P.+P.+Hazariauthor=N.+Kumarauthor=A.+K.+Mishra&title=In+vitro+and+in+vivo+evaluation+of+99mTc-DO3A-EA-Folate+for+receptor-mediated+targeting+of+folate+positive+tumors&doi=10.3109%2F1061186X.2011.561857"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluation of 99mTc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors</span></div><div class="casAuthors">Mishra, Gauri; Hazari, Puja Panwar; Kumar, Nitin; Mishra, Anil K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">761-769</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Background: The cell membrane folate receptor is a potential mol. target for tumor selective drug delivery via receptor-mediated endocytosis, including delivery of radiolabeled folate-chelate conjugates for diagnostic imaging.  Method: A new radiopharmaceutical, 99mTc-1,4,7-tris (carboxymethyl)-10-(4-aminoethyl)-1,4,7,10-tetraazacyclododecane (DO3A-EA)-Folate has been synthesized introducing DO3A-EA to the γ-carboxyl group of folic acid and was characterized by different spectroscopic techniques.  Cytotoxicity was detd. by macrocolony and MTT assay on three different cell lines.  Cell uptake studies and receptor binding assay were performed using 99mTc-DO3A-EA-Folate.  Tumor imaging was performed in KB cell line implanted tumor bearing nude mice, and uptake of the radiotracer was estd.  Results: The synthesized conjugate binds with 99mTc at high efficiency at ambient temp.  The resulting conjugate is stable under physiol. conditions for 24 h after radiocomplexation.  Using an in vitro receptor binding assay, the conjugate showed Kd in μM range on human tumor cell lines (KB, U-87MG and OAW).  The pharmacokinetic data revealed rapid wash out of the more than 75% activity within 5 min from the circulation with hepato-biliary clearance.  Data from γ scintigraphic and biodistribution studies performed in KB tumor bearing nude mice revealed major accumulation of radiotracer at tumor site.  High tumor uptake was shown in the tumor bearing mice; tumor to blood ratios reached 2.27 ± 0.32 and 6.05 ± 1.02 at 1 and 4 h after post injection, resp.  Conclusion: These results suggest that 99mTc-DO3A-EA-Folate may be clin. useful as a noninvasive radiodiagnostic imaging agent for the detection of FR-pos. human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovryu6U4RRdbVg90H21EOLACvtfcHk0lhOMR6MA48smw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaisLrJ&md5=dcbd8d2b893d67a6f241825ea849f260</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3109%2F1061186X.2011.561857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1061186X.2011.561857%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DG.%26aulast%3DHazari%26aufirst%3DP.%2BP.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DMishra%26aufirst%3DA.%2BK.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%252099mTc-DO3A-EA-Folate%2520for%2520receptor-mediated%2520targeting%2520of%2520folate%2520positive%2520tumors%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2011%26volume%3D19%26spage%3D761%26epage%3D769%26doi%3D10.3109%2F1061186X.2011.561857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innocenti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5511</span><span class="NLM_x">–</span> <span class="NLM_lpage">5522</span><span class="refDoi"> DOI: 10.1021/jm1003667</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1003667" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5511-5522&author=F.+Cartaauthor=C.+Temperiniauthor=A.+Innocentiauthor=A.+Scozzafavaauthor=K.+Kailaauthor=C.+T.+Supuran&title=Polyamines+inhibit+carbonic+anhydrases+by+anchoring+to+the+zinc-coordinated+water+molecule&doi=10.1021%2Fjm1003667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm1003667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1003667%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DTemperini%26aufirst%3DC.%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DKaila%26aufirst%3DK.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DPolyamines%2520inhibit%2520carbonic%2520anhydrases%2520by%2520anchoring%2520to%2520the%2520zinc-coordinated%2520water%2520molecule%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5511%26epage%3D5522%26doi%3D10.1021%2Fjm1003667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Innocenti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1857</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2009.02.088" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1855-1857&author=A.+Innocentiauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+Inhibition+of+cytosolic+isoforms+I%2C+II%2C+III%2C+VII+and+XIII+with+less+investigated+inorganic+anions&doi=10.1016%2Fj.bmcl.2009.02.088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.088%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520Inhibition%2520of%2520cytosolic%2520isoforms%2520I%252C%2520II%252C%2520III%252C%2520VII%2520and%2520XIII%2520with%2520less%2520investigated%2520inorganic%2520anions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1855%26epage%3D1857%26doi%3D10.1016%2Fj.bmcl.2009.02.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Innocenti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII and XIV with less investigated inorganic anions</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1548</span><span class="NLM_x">–</span> <span class="NLM_lpage">1550</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2010.01.081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1548-1550&author=A.+Innocentiauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+Inhibition+of+transmembrane+isoforms+IX%2C+XII+and+XIV+with+less+investigated+inorganic+anions&doi=10.1016%2Fj.bmcl.2010.01.081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.081%26sid%3Dliteratum%253Aachs%26aulast%3DInnocenti%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520Inhibition%2520of%2520transmembrane%2520isoforms%2520IX%252C%2520XII%2520and%2520XIV%2520with%2520less%2520investigated%2520inorganic%2520anions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1548%26epage%3D1550%26doi%3D10.1016%2Fj.bmcl.2010.01.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Temperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors. X-Ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct. An inhibitor mimicking the sulfonamide and urea binding to the enzyme</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.11.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2Fj.bmcl.2009.11.124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=474-478&author=C.+Temperiniauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors.+X-Ray+crystal+studies+of+the+carbonic+anhydrase+II-trithiocarbonate+adduct.+An+inhibitor+mimicking+the+sulfonamide+and+urea+binding+to+the+enzyme&doi=10.1016%2Fj.bmcl.2009.11.124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.11.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.11.124%26sid%3Dliteratum%253Aachs%26aulast%3DTemperini%26aufirst%3DC.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors.%2520X-Ray%2520crystal%2520studies%2520of%2520the%2520carbonic%2520anhydrase%2520II-trithiocarbonate%2520adduct.%2520An%2520inhibitor%2520mimicking%2520the%2520sulfonamide%2520and%2520urea%2520binding%2520to%2520the%2520enzyme%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D474%26epage%3D478%26doi%3D10.1016%2Fj.bmcl.2009.11.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1868</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span><span class="refDoi"> DOI: 10.1039/c2cc16395k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1039%2Fc2cc16395k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=1868-1870&author=F.+Cartaauthor=M.+Aggarwalauthor=A.+Marescaauthor=A.+Scozzafavaauthor=R.+McKennaauthor=C.+T.+Supuran&title=Dithiocarbamates%3A+a+new+class+of+carbonic+anhydrase+inhibitors.+Crystallographic+and+kinetic+investigations&doi=10.1039%2Fc2cc16395k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1039%2Fc2cc16395k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc16395k%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DAggarwal%26aufirst%3DM.%26aulast%3DMaresca%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DDithiocarbamates%253A%2520a%2520new%2520class%2520of%2520carbonic%2520anhydrase%2520inhibitors.%2520Crystallographic%2520and%2520kinetic%2520investigations%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26spage%3D1868%26epage%3D1870%26doi%3D10.1039%2Fc2cc16395k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Avram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milac, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">More effective dithiocarbamate derivatives inhibiting carbonic anhydrases, generated by QSAR and computational design</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span><span class="refDoi"> DOI: 10.3109/14756366.2012.727410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.3109%2F14756366.2012.727410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=23116520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FpvFClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=350-359&author=S.+Avramauthor=A.+L.+Milacauthor=F.+Cartaauthor=C.+T.+Supuran&title=More+effective+dithiocarbamate+derivatives+inhibiting+carbonic+anhydrases%2C+generated+by+QSAR+and+computational+design&doi=10.3109%2F14756366.2012.727410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">More effective dithiocarbamate derivatives inhibiting carbonic anhydrases, generated by QSAR and computational design</span></div><div class="casAuthors">Avram Speranta; Milac Adina Luminita; Carta Fabrizio; Supuran Claudiu T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of enzyme inhibition and medicinal chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">350-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dithiocarbamates (DTC) are promising compounds with potential applications in antitumoral and glaucoma therapy.  Our aim is to understand molecular features affecting DTC interaction with carbonic anhydrases (CAs), zinc-containing enzymes maintaining acid-base balance in blood and other tissues.  To this end, we generate QSAR models based on a compound series containing 25 DTC, inhibitors of four human (h) CAs isoforms: hCA I, II, IX and XII.  We establish that critical physicochemical parameters for DTC inhibitory activity are: hydrophobic, electronic, steric, topological and shape.  The predictive power of our QSAR models is indicated by significant values of statistical coefficients: cross-validated correlation q(2) (0.55-0.73), fitted correlation r(2) (0.75-0.84) and standard error of prediction (0.47-0.23).  Based on the established QSAR equations, we analyse 22 new DTC derivatives and identify DTC dicarboxilic acids derivatives and their esters as potentially improved inhibitors of CA I, II, IX and XII.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-IK0lC_yKw6x48Rj5GnGofW6udTcc2eahxt_lF7hSaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FpvFClsQ%253D%253D&md5=f16f7d2f862ecb0b04ab6ffaff7963d8</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.3109%2F14756366.2012.727410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2012.727410%26sid%3Dliteratum%253Aachs%26aulast%3DAvram%26aufirst%3DS.%26aulast%3DMilac%26aufirst%3DA.%2BL.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DMore%2520effective%2520dithiocarbamate%2520derivatives%2520inhibiting%2520carbonic%2520anhydrases%252C%2520generated%2520by%2520QSAR%2520and%2520computational%2520design%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26spage%3D350%26epage%3D359%26doi%3D10.3109%2F14756366.2012.727410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akdemir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4691</span><span class="NLM_x">–</span> <span class="NLM_lpage">4700</span><span class="refDoi"> DOI: 10.1021/jm400414j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400414j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4691-4700&author=F.+Cartaauthor=A.+Akdemirauthor=A.+Scozzafavaauthor=E.+Masiniauthor=C.+T.+Supuran&title=Xanthates+and+trithiocarbonates+strongly+inhibit+carbonic+anhydrases+and+show+antiglaucoma+effects+in+vivo&doi=10.1021%2Fjm400414j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Xanthates and Trithiocarbonates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Effects in Vivo</span></div><div class="casAuthors">Carta, Fabrizio; Akdemir, Atilla; Scozzafava, Andrea; Masini, Emanuela; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4691-4700</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dithiocarbamates (DTCs ) were recently discovered as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors.  A series of xanthates and a trithiocarbonate, structurally related to the DTCs, were prepd. by reaction of alcs./thiols with carbon disulfide in the presence of bases.  These compds. were tested for the inhibition of four human (h) isoforms, hCA I, II, IX, and XII, involved in pathologies such as glaucoma (CA II and XII) or cancer (CA IX).  Several low nanomolar xanthate/trithiocarbonate inhibitors targeting these CAs were detected.  A docking study of some xanthates within the CA II active site showed that these compds. bind in a similar manner with the dithiocarbamates, coordinating monodentately to the Zn(II) ion from the enzyme active site.  Several xanthates showed potent intraocular pressure lowering activity in two animal models of glaucoma via the topical administration.  Xanthates and thioxanthates represent two novel, promising classes of CA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV6dqMR8Qxe7Vg90H21EOLACvtfcHk0litJ4rCjbe7vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtbc%253D&md5=25eee80ff4504abc86442850af883eaa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm400414j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400414j%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DAkdemir%26aufirst%3DA.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMasini%26aufirst%3DE.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DXanthates%2520and%2520trithiocarbonates%2520strongly%2520inhibit%2520carbonic%2520anhydrases%2520and%2520show%2520antiglaucoma%2520effects%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4691%26epage%3D4700%26doi%3D10.1021%2Fjm400414j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kilkenny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuthill, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, D. G.</span><span> </span><span class="NLM_article-title">Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research</span> <span class="citation_source-journal">J. Pharmacol. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.4103/0976-500X.72351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.4103%2F0976-500X.72351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21350617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BC3M3hvVyksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=94-99&author=C.+Kilkennyauthor=W.+J.+Browneauthor=I.+C.+Cuthillauthor=M.+Emersonauthor=D.+G.+Altman&title=Improving+bioscience+research+reporting%3A+the+ARRIVE+guidelines+for+reporting+animal+research&doi=10.4103%2F0976-500X.72351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research</span></div><div class="casAuthors">Kilkenny Carol; Browne William J; Cuthill Innes C; Emerson Michael; Altman Douglas G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacology & pharmacotherapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">94-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTFwcJ9W7T-OWyYR5VtavbzfW6udTcc2eYH2uMDSuTjH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3hvVyksg%253D%253D&md5=adb67f1d88a6f9cf879d5b5bab56dd40</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.4103%2F0976-500X.72351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0976-500X.72351%26sid%3Dliteratum%253Aachs%26aulast%3DKilkenny%26aufirst%3DC.%26aulast%3DBrowne%26aufirst%3DW.%2BJ.%26aulast%3DCuthill%26aufirst%3DI.%2BC.%26aulast%3DEmerson%26aufirst%3DM.%26aulast%3DAltman%26aufirst%3DD.%2BG.%26atitle%3DImproving%2520bioscience%2520research%2520reporting%253A%2520the%2520ARRIVE%2520guidelines%2520for%2520reporting%2520animal%2520research%26jtitle%3DJ.%2520Pharmacol.%2520Pharmacother.%26date%3D2010%26volume%3D1%26spage%3D94%26epage%3D99%26doi%3D10.4103%2F0976-500X.72351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Butler, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godefroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weil-Fugazza, J.</span><span> </span><span class="NLM_article-title">A limited arthritic model for chronic pain studies in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/0304-3959(92)90133-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2F0304-3959%2892%2990133-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1738577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADyaK387ltVSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1992&pages=73-81&author=S.+H.+Butlerauthor=F.+Godefroyauthor=J.+M.+Bessonauthor=J.+Weil-Fugazza&title=A+limited+arthritic+model+for+chronic+pain+studies+in+the+rat&doi=10.1016%2F0304-3959%2892%2990133-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A limited arthritic model for chronic pain studies in the rat</span></div><div class="casAuthors">Butler S H; Godefroy F; Besson J M; Weil-Fugazza J</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-81</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">Freund's adjuvant induced polyarthritis in rats has been used extensively to study pain processes of long duration.  There are limitations of this model for chronic studies of pain/arthritis since the severe systemic changes provoke ethical concerns and also affect behaviour, physiology and biochemistry.  Attempts to limit adjuvant-induced arthritis by plantar injection of the inoculum have been made.  In this model, however, the process evolved to produce widespread polyarthritis if followed for the 6-plus-weeks necessary for chronic studies.  Therefore, although it offers the researcher a reliable limited model of inflammation and nociception at the outset, for longer studies it may have all the disadvantages of the polyarthritic rat.  The purpose of the present study was to produce a limited arthritic process in rats, stable over 6 weeks and suitable for behavioural and neurochemical studies of various chronic pain treatment methods.  Injection (0.05 ml) of complete adjuvant containing 300 micrograms Mycobacterium butyricum in the tibio-tarsal joint produces a predictable monoarthritis, stable clinically and behaviourly from weeks 2 through 6 post injection.  As revealed by clinical observations and X-ray examinations, the arthritis produced was limited anatomically, pronounced, prolonged and stable.  A marked increase in sensitivity to paw pressure was seen in the affected limb.  Animals gained weight and remained active, indicating little systemic disturbance as opposed to polyarthritic rats.  We propose this limited model of arthritis as a suitable alternative to the polyarthritic rat for prolonged studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8JqpNUe2Bd9XdcedVHT5tfW6udTcc2eYH2uMDSuTjH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387ltVSqug%253D%253D&md5=3e5b40828514fb38a83a8ca180f889b3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990133-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990133-V%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DS.%2BH.%26aulast%3DGodefroy%26aufirst%3DF.%26aulast%3DBesson%26aufirst%3DJ.%2BM.%26aulast%3DWeil-Fugazza%26aufirst%3DJ.%26atitle%3DA%2520limited%2520arthritic%2520model%2520for%2520chronic%2520pain%2520studies%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D1992%26volume%3D48%26spage%3D73%26epage%3D81%26doi%3D10.1016%2F0304-3959%2892%2990133-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Di Cesare Mannelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelardini, C.</span><span> </span><span class="NLM_article-title">Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1285</span><span class="NLM_x">–</span> <span class="NLM_lpage">1294</span><span class="refDoi"> DOI: 10.1093/rheumatology/kew055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1093%2Frheumatology%2Fkew055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=27032424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotF2i" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=1285-1294&author=L.+Di+Cesare+Mannelliauthor=L.+Micheliauthor=L.+Cinciauthor=M.+Marescaauthor=C.+Vergelliauthor=A.+Paciniauthor=M.+T.+Quinnauthor=M.+P.+Giovannoniauthor=C.+Ghelardini&title=Effects+of+the+neutrophil+elastase+inhibitor+EL-17+in+rat+adjuvant-induced+arthritis&doi=10.1093%2Frheumatology%2Fkew055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis</span></div><div class="casAuthors">Di Cesare Mannelli, Lorenzo; Micheli, Laura; Cinci, Lorenzo; Maresca, Mario; Vergelli, Claudia; Pacini, Alessandra; Quinn, Mark T.; Giovannoni, Maria Paola; Ghelardini, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1285-1294</span>CODEN:
                <span class="NLM_cas:coden">RUMAFK</span>;
        ISSN:<span class="NLM_cas:issn">1462-0324</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Neutrophil elastase (NE), a granule-assocd. enzyme, participates in connective tissue breakdown and promotes cytokine release and specific receptor activation during various inflammatory diseases like RA.  NE is increased in the SF and cartilage of RA patients and represents a target for the development of new therapeutic possibilities.  The present research aimed to evaluate the preclin. pharmacol. profile of the N -benzoylpyrazole deriv. EL-17, a potent and selective NE inhibitor, in a rat model of RA.  Complete Freund's Adjuvant (CFA) was injected in the tibiotarsal joint and the effect of acute or repeated treatments with EL-17 (1-30 mg/kg by mouth) were evaluated.  On day 14 after CFA injection, a single administration of EL-17 significantly reduced CFA-dependent hypersensitivity to mech. noxious stimuli and the postural unbalance related to spontaneous pain.  To evaluate the preventive efficacy, EL-17 was administered daily starting from the day of CFA treatment.  Behavioral measurements performed on days 7 and 14 showed a progressive efficacy of EL-17 against hypersensitivity to mech. noxious and non-noxious stimuli, as well as a decrease of hind limb wt.-bearing alterations.  Histol. evaluation of the tibiotarsal joint (day 14) demonstrated significant prevention of articular derangement after EL-17 (30 mg/kg) treatment.  The protective effects of EL-17 directly correlated with a complete reversion of the plasma NE activity increase induced by CFA.  The NE inhibitor EL-17 relieved articular pain after acute administration.  Furthermore, repeated treatment reduced the development of hypersensitivity and protected joint tissue, revealing a disease-modifying profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsXPV9foauHLVg90H21EOLACvtfcHk0lgf-4F-ExF8Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotF2i&md5=eb0ca4a2f5b4d3aede873ffcd1069ad5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkew055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkew055%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DMicheli%26aufirst%3DL.%26aulast%3DCinci%26aufirst%3DL.%26aulast%3DMaresca%26aufirst%3DM.%26aulast%3DVergelli%26aufirst%3DC.%26aulast%3DPacini%26aufirst%3DA.%26aulast%3DQuinn%26aufirst%3DM.%2BT.%26aulast%3DGiovannoni%26aufirst%3DM.%2BP.%26aulast%3DGhelardini%26aufirst%3DC.%26atitle%3DEffects%2520of%2520the%2520neutrophil%2520elastase%2520inhibitor%2520EL-17%2520in%2520rat%2520adjuvant-induced%2520arthritis%26jtitle%3DRheumatology%26date%3D2016%26volume%3D55%26spage%3D1285%26epage%3D1294%26doi%3D10.1093%2Frheumatology%2Fkew055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Leighton, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, J.</span><span> </span><span class="NLM_article-title">κ-Opioid agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1988.tb10310.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1111%2Fj.1476-5381.1988.tb10310.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=2836010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADyaL1cXhvVSjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1988&pages=553-560&author=G.+E.+Leightonauthor=R.+E.+Rodriguezauthor=R.+G.+Hillauthor=J.+Hughes&title=%CE%BA-Opioid+agonist+produce+antinociception+after+i.v.+and+i.c.v.+but+not+intrathecal+administration+in+the+rat&doi=10.1111%2Fj.1476-5381.1988.tb10310.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">κ-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat</span></div><div class="casAuthors">Leighton, G. E.; Rodriguez, R. E.; Hill, R. G.; Hughes, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">553-60</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Following i.v. administration to rats, PD117302, U50488, U69593, and morphine produced steep parallel dose-response curves indicating antinociceptive activity when evaluated in the paw-pressure test.  When U50488 and U69593 were tested at a single dose of 3.3 mg/kg no effect was seen in the tail-flick test.  When given by the intrathecal route, only morphine was effective at increasing the nociceptive threshold.  PD117302, U50488 and U69593 were without effect in either the paw-pressure or tail-flick tests at ≤100 μg per rat.  PD117302 caused flaccid paralysis of the hindlimbs following intrathecal administration at the top dose tested.  This effect was not reversible by naloxone.  All 3 κ-opioid receptor agonists produced naloxone-reversible antinociception in the paw-pressure test, and to a lesser extent in the tail-flick test, when injected directly into the 3rd cerebral ventricle with the max. effect occurring between 5 and 10 min after administration and declining back to control levels by 60 min.  Morphine had a much slower onset of action with the peak effect being obsd. 30 min after dosing.  The antinociceptive effects of κ-agonists are likely to operate via an action at a supraspinal rather than a spinal site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRnCwR2n4YdLVg90H21EOLACvtfcHk0lg8jkhwpExqkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhvVSjtLo%253D&md5=a07f811b47c181c8d06a9abf42fbf83e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1988.tb10310.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1988.tb10310.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeighton%26aufirst%3DG.%2BE.%26aulast%3DRodriguez%26aufirst%3DR.%2BE.%26aulast%3DHill%26aufirst%3DR.%2BG.%26aulast%3DHughes%26aufirst%3DJ.%26atitle%3D%25CE%25BA-Opioid%2520agonist%2520produce%2520antinociception%2520after%2520i.v.%2520and%2520i.c.v.%2520but%2520not%2520intrathecal%2520administration%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1988%26volume%3D93%26spage%3D553%26epage%3D560%26doi%3D10.1111%2Fj.1476-5381.1988.tb10310.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bove, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calcaterra, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juneau, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrier, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilgore, K. S.</span><span> </span><span class="NLM_article-title">Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis</span> <span class="citation_source-journal">Osteoarthr. Cartil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span><span class="refDoi"> DOI: 10.1016/S1063-4584(03)00163-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1016%2FS1063-4584%2803%2900163-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=14609535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A280%3ADC%252BD3srjt1KitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=821-830&author=S.+E.+Boveauthor=S.+L.+Calcaterraauthor=R.+M.+Brookerauthor=C.+M.+Huberauthor=R.+E.+Guzmanauthor=P.+L.+Juneauauthor=D.+J.+Schrierauthor=K.+S.+Kilgore&title=Weight+bearing+as+a+measure+of+disease+progression+and+efficacy+of+anti-inflammatory+compounds+in+a+model+of+monosodium+iodoacetate-induced+osteoarthritis&doi=10.1016%2FS1063-4584%2803%2900163-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis</span></div><div class="casAuthors">Bove S E; Calcaterra S L; Brooker R M; Huber C M; Guzman R E; Juneau P L; Schrier D J; Kilgore K S</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">821-30</span>
        ISSN:<span class="NLM_cas:issn">1063-4584</span>.
    </div><div class="casAbstract">OBJECTIVE:  To describe an in vivo model in the rat in which change in weight distribution is used as a measure of disease progression and efficacy of acetaminophen and two nonsteroidal anti-inflammatory drugs (NSAIDs) in a model of monosodium iodoacetate (MIA)-induced osteoarthritis (OA).  METHODS:  Intra-articular injections of MIA and saline were administered to male Wistar rats (175-200 g) into the right and left knee joints, respectively.  Changes in hind paw weight distribution between the right (osteoarthritic) and left (contralateral control) limbs were utilized as an index of joint discomfort.  Acetaminophen and two archetypal, orally administered NSAIDs, naproxen and rofecoxib, were examined for their ability to decrease MIA-induced change in weight distribution.  RESULTS:  A concentration-dependent increase in change in hind paw weight distribution was noted after intra-articular injection of MIA.  Both naproxen and rofecoxib demonstrated the capacity to significantly (P<0.05) decrease hind paw weight distribution in a dose-dependent fashion, indicating that the change in weight distribution associated with MIA injection is susceptible to pharmacological intervention.  CONCLUSION:  The determination of differences in hind paw weight distribution in the rat MIA model of OA is a technically straightforward, reproducible method that is predictive of the effects of anti-inflammatory and analgesic agents.  This system may be useful for the discovery of novel pharmacologic agents in human OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXM-0hOfBxH_6xYuD7tu2XfW6udTcc2ebZwsWztxOWc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srjt1KitA%253D%253D&md5=12ee3d4de4609d794d4e4f4b176f25a3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS1063-4584%2803%2900163-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1063-4584%252803%252900163-8%26sid%3Dliteratum%253Aachs%26aulast%3DBove%26aufirst%3DS.%2BE.%26aulast%3DCalcaterra%26aufirst%3DS.%2BL.%26aulast%3DBrooker%26aufirst%3DR.%2BM.%26aulast%3DHuber%26aufirst%3DC.%2BM.%26aulast%3DGuzman%26aufirst%3DR.%2BE.%26aulast%3DJuneau%26aufirst%3DP.%2BL.%26aulast%3DSchrier%26aufirst%3DD.%2BJ.%26aulast%3DKilgore%26aufirst%3DK.%2BS.%26atitle%3DWeight%2520bearing%2520as%2520a%2520measure%2520of%2520disease%2520progression%2520and%2520efficacy%2520of%2520anti-inflammatory%2520compounds%2520in%2520a%2520model%2520of%2520monosodium%2520iodoacetate-induced%2520osteoarthritis%26jtitle%3DOsteoarthr.%2520Cartil.%26date%3D2003%26volume%3D11%26spage%3D821%26epage%3D830%26doi%3D10.1016%2FS1063-4584%2803%2900163-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Neri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Interfering with pH regulation in tumours as a therapeutic strategy</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span><span class="refDoi"> DOI: 10.1038/nrd3554</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=10.1038%2Fnrd3554" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=21921921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOlsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=767-777&author=D.+Neriauthor=C.+T.+Supuran&title=Interfering+with+pH+regulation+in+tumours+as+a+therapeutic+strategy&doi=10.1038%2Fnrd3554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Interfering with pH regulation in tumours as a therapeutic strategy</span></div><div class="casAuthors">Neri, Dario; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">767-777</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The high metabolic rate of tumors often leads to acidosis and hypoxia in poorly perfused regions.  Tumor cells have thus evolved the ability to function in a more acidic environment than normal cells.  Key pH regulators in tumor cells include: isoforms 2, 9 and 12 of carbonic anhydrase, isoforms of anion exchangers, Na+/HCO3- co-transporters, Na+/H+ exchangers, monocarboxylate transporters and the vacuolar ATPase.  Both small mols. and antibodies targeting these pH regulators are currently at various stages of clin. development.  These antitumor mechanisms are not exploited by the classical cancer drugs and therefore represent a new anticancer drug discovery strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl7enRfSHzprVg90H21EOLACvtfcHk0lg8jkhwpExqkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOlsL7L&md5=7a1e1b7badcf7d2e26bd70da2bfe0925</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd3554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3554%26sid%3Dliteratum%253Aachs%26aulast%3DNeri%26aufirst%3DD.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DInterfering%2520with%2520pH%2520regulation%2520in%2520tumours%2520as%2520a%2520therapeutic%2520strategy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D767%26epage%3D777%26doi%3D10.1038%2Fnrd3554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01607">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40367"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01607">10.1021/acs.jmedchem.6b01607</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES representation for compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01607/suppl_file/jm6b01607_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01607/suppl_file/jm6b01607_si_001.csv">jm6b01607_si_001.csv (1.15 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01607&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01607%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01607" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6679881a4c90d1d7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
